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Peri-implantitis is a bacterially induced inflammatory condition that results in resorption 
of the bone supporting an implant. The methods for treating it are mainly empirical, and 
none have been shown to be universally successful. 
The first part of this research aimed to identify and compare the composition of the 
microbiota around dental implants with and without peri-implantitis. Subgingival 
plaque samples were collected from twenty-one subjects and samples were cultured 
using non-selective media and bacterial identification was carried out using 16S rRNA 
PCR.  
The second phase of the study investigated surface characteristics of implants that could 
influence the formation of a biofilm.  Using a clinically relevant organism 
(Streptococcus oralis), an in vitro biofilm was developed and biofilm formation on four 
titanium implant surfaces exhibiting varying degrees of roughness with and without 
fluoride ions incorporated was evaluated using confocal laser scanning electron 
microscopy, bacterial culturing and scanning electron microscopy.  
The final phase examined the effects of mechanical debridement and air-polishing using 
glycine or 45S5 bioactive glass powders in re-establishing biocompatibility of the 
previously contaminated implant surfaces. Biocompatibility of the surfaces was tested 
using cell culture with alveolar human osteoblasts for cell viability, proliferation and 
cell differentiation. 
Results showed that a complex subgingival microbiota was found around dental 
implants. Peri-implantitis was associated with an increased bacterial load. Filifactor 
alocis, Streptococcus constellatus, Parvimonas micra and Actinomyces meyeri were 
significantly more prevalent in peri-implantitis, while Veillonella parvula/ dispar and 
Neisseria elongata were more prevalent in healthy sites.  
There were no significant differences in biofilm volume, surface area covered by the 
biofilm, nor number of bacteria found on any of the surfaces tested or at different levels 
within the biofilm suggesting that once colonization has been established, the effect of 
the surface diminishes with maturation of the biofilm. 
Although cleaning efficiency was different, all decontamination methods tested were 
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Figure 1 Simplified model of oral bacterial colonization. Adapted from (Kolenbrander 
et al., 2010) 43!
Figure 2 Decision tree for cumulative interceptive supportive therapy (CIST). 
Depending on the mucosal condition, probing depth and bone loss, either A, A+B, 
A+B+C, or A+B+C+D is performed. A: Mechanical debridement; B: antiseptic 
cleaning; C: antibiotic therapy; D: resective or regenerative surgery. Adopted from 
Lang et al. (Lang et al., 2000). 62!
Figure 3 Mandibular implants showing saucer-shaped osseous defects characteristic of 
the bone loss around implants (radiograph of patient number 1) 86!
Figure 4 Examples of radiographs taken from subjects enrolled in the study. Top 
picture: Implants with peri-implantitis showing saucer shaped bone loss commonly 
found with peri-implantitis. Top row left to right patient 13, 8, 11, 1 lower row 12, 14 
17, 6. Bottom picture: Healthy implants showing no loss of crestal bone around 
implants. Left patient 19, Top right 18, bottom right 9 99!
Figure 5 Difference in mean total viable counts (CFU/ml) between healthy implants 
(n=10) and those with peri-implantitis (n=11) 100!
Figure 6 Prevalence of taxa identified in 9 healthy implant samples 102!
Figure 7 Neighbour joining tree of bacterial species & phyla detected in healthy 
implants (n=9) constructed using the Jukes Cantor method. 103!
Figure 8 Prevalence of taxa identified in 11 peri-implantitis samples 104!
Figure 9 Neighbour joining tree of bacterial species & phyla detected in peri-implantitis 
(n=11) constructed using the Jukes Cantor method. 105!
Figure 10 Graph showing the percentage of samples in which most frequently observed 
species were found. *p< 0.05, **p < 0.01, ***p < 0.001 Fisher’s exact test 106!
Figure 11 Phylogenetic relationship (N-J) of all subgingival peri-implant bacterial 
species identified and their overall proportional abundance (%) in health (green) and in 




Figure 12 Schematic timeline of the biofilm experiment 124!
Figure 13 Growth curves for S. oralis. (media: mFUM, time = 48 h, absorbance λ = 
600nm, n= 4) showing a rapid growth rate till 5h then stationary phase for the rest of the 
experiment 130!
Figure 14 SEM of pristine rough surfaces 6905 (left) and 7874 (right) 131!
Figure 15 SEM of pristine smooth surfaces 7873 (left) and 7676 (right) at a) x800 
magnification and b) x6000 magnification. Test discs show undulating regions, with 
ridges, valleys and occasional “flakes” produced from the machining process 132!
Figure 16 Elemental spectrum obtained by the EDS analysis of rough surfaces a) 6905 
b) 7874 showing peaks caused by X-rays given off as electrons return to the K electron 
shell. Note the large peak for Titanium, which was the predominant element. Oxygen 
was also detected. 133!
Figure 17 Elemental spectrum obtained by the EDS analysis of smooth surfaces a) 7873 
b) 7676. Titanium is the predominant element. No Oxygen was detected 134!
Figure 18 Representative SEM micrographs of smooth surfaces 7873 (left) and 7676 
(right) with S. oralis 96h biofilm a) x800 magnification and b) x6000 magnification 
showing confluent layers of cocci on the surfaces 135!
Figure 19 Representative SEM micrographs of rough surfaces 6905 (left) and 7874 
(right) with 96h S. oralis biofilm showing confluent layers of cocci a) 800 x b) 3000x c) 
6000 x 136!
Figure 20 The number of colony forming units after 96 h in vitro biofilm growth 
(n=10). Medians and 25/75 percentiles are shown. Kruskal Wallis ANOVA analysis 
failed to reveal any significant differences (P>0.05) between the surfaces 137!
Figure 21 CLSM evaluation of 96h biofilm. Chains of S. oralis are apparent. Live green 
(STYO® 9 stain) bacteria, dead red (promidium iodide stain) bacteria and overlaid 
image showing both. Left panel is 2x magnification. Right panel is 6x magnification. 




Figure 22 Surface area covered with S. oralis after 96 h in vitro biofilm growth (n=10). 
Medians and 25/75 percentiles are shown. Kruskal Wallis ANOVA analysis failed to 
reveal any significant differences (P>0.05) between the surfaces. 140!
Figure 23 Biofilm volume formed on surfaces after 96h (n=10). Medians and 25/75 
percentiles are shown. Kruskal Wallis analysis failed to reveal any significant 
differences (p>0.05) between the surfaces. 141!
Figure 24   Percentage of biofilm coverage on the different surfaces after 96 h 
incubation with S. oralis (n=10). Medians and 25/75 percentiles of biofilm coverage are 
shown. Kruskal Wallis analysis failed to reveal any significant differences (p>0.05) 142!
Figure 25 Mean height of S. oralis biofilm after 96h on titanium surfaces (n=10). Mean 
height was lowest on the nanorough surface with fluoride (7874). 143!
Figure 26 a) Surface area and b) volume covered by live and dead S. oralis bacteria 
after 96h on different titanium surfaces (medians and interquartile range) n=10 144!
Figure 27 Distribution of S. oralis biofilms at different z-levels (n=10) after 96h 
incubation 146!
Figure 28 a) Experiment setting b) discs painted with nail polish c) left disc was blasted 
using rotation + static settings, middle disc static with tip 10 mm away, right disc static 
with tip at 5 mm away d) rotation movement only 157!
Figure 29 Proliferation of osteoblasts is shown to decrease as the cells terminally 
differentiate into matrix production. Taken from (Burling, 2005), adapted from (Stein et 
al., 1996) 162!
Figure 30 Schematic diagram showing the workflow of the tissue culture assays. Discs 
were decontaminated at day ‘0’ then sent for gamma radiation/ SEM. As soon as they 
were back, cells were plated at the desired concentration on the discs and assayed after 
1, 2 days of culture (MTT); 3, 7, 14, 21, 28 days of culture (AB); 7, 14, 21 days of 
culture (ALP). (AB, alamarBlue; MTT, 3-(4.5-dimethylthiazol-2-yl)-2.5-
diphenyltetrzoliumbromide; ALP, alkaline phosphatase) 166!
Figure 31 MTT assay showing mitochondrial activity of HOB cells after 24 h and 72 h 




different decontamination methods surface. Longer exposure time in elutions was 
accompanied by increased viability. (n=2) 168!
Figure 32 Results of MTT assay showing HOB cell response after 24 h and 72 h 
exposure to the 72h eluants of each surfaces. There was an increase in absorbance 
values after 72 h exposure for all the materials in general (n=2). 169!
Figure 33 Proliferation of HOB cells as determined by the alamarBlue assay showing 
each surface and variation with time after being subjected to various decontamination 
methods. Control discs were non-contaminated and non-treated. The values are means ± 
standard deviation (n=6). Significantly lower proliferation rate on surface 7873 at days 
7, 14 and 21 after air-blasting, with BAG and glycine, compared to the mechanical 
debridement (p<0.05).  Also on surface 7676 at day 14 after glycine blasting compared 
to mechanically debridement (p=0.04). 171!
Figure 34 HOB proliferation at different time points on different pristine implant 
surfaces. Highest proliferation rates were observed on surface 7873 (smooth) and lowest 
on 6905 (moderately rough) (n=6). Significant differences in proliferation are outlined 
in the table below. 173!
Figure 35 Alkaline phosphatase activity of alveolar osteoblasts cultured on different 
implant surfaces after being subjected to different decontamination methods. 175!
Figure 36 SEM micrographs of surfaces treated by mechanical debridement (left x3000 
magnification, right x6000 magnification). Scratch marks from mechanical debridement 
and remaining bacterial aggregates can be seen (Top to bottom: 6905, 7874, 7873, 
7676) 177!
Figure 37 SEM micrographs of surfaces treated by air-powder blasting using BAG (left 
x3000 magnification, right x6000 magnification). Surfaces appear homogenously rough 
regardless of original surface topography (Top to bottom: 6905, 7874, 7873, 7676 178!
Figure 38 SEM micrographs of surfaces treated by air-powder blasting using glycine 
(left x3000 magnification, right x6000 magnification) (Top to bottom: 6905, 7874, 
7873, 7676) Note the presence of rhomboidal – cylindrical glycine powder deposits. 179!
Figure 39 Elemental spectrum obtained by the EDS.  Analysis of different titanium 




titanium and oxygen typical of these surfaces as well as peaks for calcium, phosphate 
and silicon which are constituents of BAG. 180!
Figure 40 Elemental spectrum obtained by the EDS analysis of different titanium 
surfaces after decontamination using glycine air blasting (from top to bottom 6905, 
7874, 7873, 7676). Oxygen levels were comparable to the corresponding pristine 
surface, but titanium levels were lower. In addition, Silicon and Carbon were detected. 
The elemental constituents of glycine were not detected, however this could be due to 






Table 1 Implant success and failure definition according to ADI. 30!
Table 2 Risk Indicators for peri-implantitis; + strong evidence, (+) limited evidence 32!
Table 3 Summary of in vitro studies of biofilms on implant surfaces (sorted according 
to incubation time) 53!
Table 4 Summary of in vivo studies of biofilms on implant surfaces (sorted according to 
incubation time) 57!
Table 5 In vitro studies evaluating cell response on air-powder treated titanium implant 
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Table 6 Inclusion criteria for patients enrolled in the study (BOP, bleeding on probing)
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Table 8 Primer Sequences used for PCR 90!
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1µl of the DNA extraction (a total of 15µl for each PCR reaction). 94!
Table 10 Descriptive data for patients included in the study. 95!
Table 11 Clinical parameters for implant sites. Pi, peri-implantitis; PPD, probing pocket 
depth; (p), peri-implantitis; (h), healthy implants; Pdl, periodontal; H, Healthy. G, 
gingivitis. P, periodontitis 96!
Table 12 Summary of demographic and clinical variables of subjects (PPD, probing 
pocket depth). Data shown represent mean ± standard deviation. Tests of significance 
performed were t-test, MW (Mann-Whitney U-test), FE (Fisher’s exact test) according 
to whether or not data were normally distributed. *p<0.05, **p<0.001 98!
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Table 14 Means ± standard deviations of species that were significantly different 
between both groups *Fisher’s exact test (ND, not detected) 107!
Table 15 Summary of species found ‘only in healthy’ and ‘only in peri-implantitis. 108!
Table 16 Identification of Actinomyces using Met-G and 16S Universal primers 111!
Table 17 Summary of recent studies describing the microbiota around implants 114!
Table 18 Surfaces and surface modifications investigated in this study 123!
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*Kruskal Wallis analysis of variance 137!
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analysis of variance 140!
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Table 36 CLSM images of a 2 species biofilm composed of S. gordonii and F. 
nucleatum, stained using Live/Dead stain. The green channel represents the live cells, 
while the red represents the dead cells. The characteristic spindle shape for F. 
nucleatum and cocci for S. gordonii can be observed. 246!




Table 38 Endotoxin testing of discs - The accepted endotoxin value is 0.5EU /ml and all 
discs had acceptable results. 248!
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ADI Association of Implantology, UK 
ALP Alkaline phosphatase 
BAG Bioactive glass 
BHI Brain Heart Infusion 
BLAST Basic Local Alignment Search Tool 
BOP Bleeding on probing 
CBL Crestal bone loss 
CFUs Colony forming units 
CLSM Confocal Laser scanning Microscopy 
CP Commercially pure 
DMEM Dulbecco’s Modified Eagle’s Medium 
DPCM Dark Phase Contrast Microscopy 
DPT Dental Panoramic Topography 
EDS Energy Dispersive X-ray Spectroscopy 
EWOP European Workshop on Periodontology 
FAA Fastidious Anaerobic Agar 
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HOB Human osteoblasts 
HOMD Human Oral Microbiome Database 
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N.D. not detected 
NCBI National Centre for Biotechnology Information 
OD Optical density 
OH Oral hygiene 
PBS Phosphate Buffered Saline 
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Pdl Periodontal 
PID Peri-implant diseases 
PPD (PD) Probing pocket depths 
Ra Arithmetical mean roughness (profile, 2D) 
RDP Ribosomal Database Project 
Rtm Mean roughness depth (mean peak to valley heights) 
Sa Average roughness over the whole area (3D) 
SEM Scanning Electron Microscopy 
SFE Surface free energy 
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People have attempted to replace missing teeth with suitable synthetic materials since 
the start of human civilizations and archaeological findings show that attempts using 
seashells, ox teeth and human teeth date back to as early as the ancient Egyptian 
civilization.  
However, dental implants in their current form today were developed in 1952 by Dr. 
Per-Ingvar Brånemark, who discovered inadvertently that titanium chambers which he 
inserted into the tibia of rabbits to study the microcirculation during bone healing, could 
not be removed for further use and that a strong anchorage of the titanium to bone 
occurred. The application of a force of 100 kilograms was unable to dislodge the 
implants, and fracturing of the implant site was necessary (Sullivan, 2001).  
Brånemark named this phenomenon osseointegration and defined it as a “direct 
structural and functional connection between ordered living bone and the surface of a 
load-bearing artificial implant” 
At about the same time, the Swiss scientist Andre Shroeder described the same 
phenomenon, which he called “functional ankylosis” to describe the rigid fixation of the 
implant to the jaw bone, and stated that new bone is laid down directly upon the implant 
surface, provided that the rules for atraumatic implant placement are followed and the 
implant exhibits primary stability (Schroeder and Belser, 1996, Schroeder et al., 1981). 
Basic and animal research was conducted in the years that followed and 10-year implant 
integration with no adverse reactions was initially established in dogs. In 1965, Gösta 
Larsson, who presented with a secondary cleft and an edentulous mandible, became the 
first human patient in which dental implants were installed.  
But other implant treatments that were carried out during the same period (subperiosteal 
and blade implants) (Linkow and Mahler, 1975, Small, 1986) were unpredictable and 
results were erratic. They accepted the existence of a connective tissue capsule 
surrounding the implant acting as a "pseudo-periodontium" and such implants anchored 
in fibrous tissue ended up with high clinical failure rates. The scientific community met 
Brånemark’s findings with disbelief and ridicule, and suggested that titanium should not 
be used in dogs, let alone in humans (Branemark, 2005, Shulman and Driskell, 1997). It 




that treatment using titanium dental implants became accepted. The conference 
introduced the concept of osseointegration along with its applications. This was 
supported by the work published by Brånemark (Adell et al., 1981) which described the 
placement of 2768 implants in 410 jaws of 371 patients during the 15 year period from 
1965-1980. A group of these patients (130 jaws, 895 implants) were followed for 5 – 9 
years and 81% of the maxillary and 91% of the mandibular implants remained stable, 
supporting fixed bridges. 
This was a turning point for implant dentistry and brought it from a shunned field into 
one of dentistry’s most significant and important developments. It succeeded in 
changing traditional beliefs and promoted a profound academic and research interest, 
which has revolutionized dental care (McClarence, 2003). 
Consequently, in 1986, Albrektsson proposed the following criteria for implant success 
which have been the benchmark for many years (Albrektsson et al., 1986): 
1) The individual unattached implant is immobile when tested clinically 
2) No evidence of peri-implant radiolucency is present as assessed on an 
undistorted radiograph 
3) Mean vertical bone loss is less than 0.2 mm annually after the 1st year of 
function or service. 
4) There is no persistent pain, discomfort or infection attributable to the implant 
5) Implant design does not preclude placement of a crown or prosthesis with an 
appearance that is satisfactory to the patient or dentist 
6) There is an 85% success rate at the end of a five year post restorative period, 
with an 80% success rate at the end of 10 years post restorative function 
Dental implants have now come a long way since they were first introduced to the 
dental profession. In many cases, they can be considered the preferred treatment option 
for the replacement of missing teeth and provide a predictable treatment with average 
reported success rates of 95% (Albrektsson, 1988, Ellegaard et al., 1997, Vajdovich and 




However failure sometimes occurs and when that happens, it is traumatic, expensive, 
involves prolonged treatment time and is frustrating and psychologically depressing to 
both patient and dentist (Berglundh et al., 2002). 
Failures in implant dentistry can be chronologically divided into early and late failures 
(Esposito et al., 1998). Early failures have been attributed to surgical trauma, inadequate 
bone volume (Jaffin and Berman, 1991), lack of primary stability, intra-osseous 
infection and bacterial contamination of the recipient site, while late failures have been 
attributed to peri-implantitis and/or biomechanical overload with substantial evidence 






The sixth European Workshop on Periodontology EWOP (2008) has confirmed that 
peri-implant diseases are infectious in nature. Peri-implant mucositis describes an 
inflammatory lesion that resides in the mucosa, while peri-implantitis also affects the 
supporting bone (Lindhe et al., 2008). 
While these definitions are adequate, the diagnostic clinical criteria for them are less 
clear. It has been identified that the key parameter for the diagnosis of peri-implant 
mucositis is bleeding on gentle probing (< 0.25 N). Peri-implantitis however is 
characterized by changes in the crestal bone level in conjunction with bleeding on 
probing with or without concomitant deepening of peri-implant pockets and suppuration 
(Lang et al., 2011). Suppuration has been encountered more frequently in implants with 
“progressive” bone loss, particularly in smokers, and may be associated with episodes 
of active tissue destruction (Speechley, 2012). 
A wide variation in the prevalence of peri-implantitis has been reported in different 
studies. This has ranged between 28% - 56% of subjects and 12% - 43% of implants 
(Fransson et al., 2005, Fransson et al., 2008, Roos-Jansaker et al., 2006b, Zitzmann, 
2008 #569). A recent review reports that the prevalence of peri-implantitis occurs in 
10% of implants and 20% of patients, 5 – 10 years following implant placement 
(Mombelli et al., 2012). These variations, in part could be due to the historical 
misconception that probing around implants should be avoided (Ericsson and Lindhe, 
1993) leading to peri-implantitis being under-diagnosed. More importantly, these 
variations can be due to the lack of a consistent definition for the disease and the 
differences in disease criteria since authors have used different definitions of peri-
implantitis in clinical studies. For example, Behneke et al. (Behneke et al., 2002) 
suggested that peri-implantitis should include presence of clinical inflammation 
(bleeding, redness, swelling and pus) and progressive bone loss (not defined in 
millimetres). Ekelund et al. (Ekelund et al., 2003) described peri-implantitis as a 
combination of inflammation, pain and continuous bone loss. Ferreira et al. (Ferreira et 
al., 2006) suggested that the diagnosis of peri-implantitis had to meet the following 
criteria: (i) PPD ≥ 5mm, (ii) BOP and (iii) vertical bone loss. Karoussis et al. (Karoussis 
et al., 2004) presented almost similar criteria namely, PPD ≥ 5 mm and BOP (or pus) 




al. (Laine et al., 2006) and Renvert et al. (Renvert et al., 2007) suggested that peri-
implantitis required bone loss more than 1.8 mm after the first year of function in 
combination with bleeding and/ or suppuration.  
Furthermore, an additional confounding factor in the diagnosis of peri-implantitis is the 
time point used to establish baseline records. It is now agreed that peri-implant probing 
assessments and a radiograph should be obtained at the time of prosthesis installation to 
account for physiologic bone remodelling that occurs after implant placement.  
Therefore when changes in the clinical parameters indicate disease (BOP, increased 
PPD), further radiographs are recommended to evaluate possible bone loss (Lindhe et 
al., 2008). 
Last but not least, the most commonly used outcome measures to assess the 
predictability and validity in implant dentistry are survival and success of implants. 
Survival statistics use the “presence or absence” of implants as end-point outcome 
measures, and hence do not take into consideration the presence of biological problems 
arising from peri-implant diseases. This, in addition to the lack of universally accepted 
and standardized success criteria makes the comparison of data between studies difficult 
and this limits the usefulness of systematic reviews (Needleman et al., 2012, Sennerby 
and Becker, 2000). 
The limitations in the reporting of implant success have been summarized by Tonetti 
and Palmer (Tonetti et al., 2012) and can be attributed to: 
• Lack of consensus in the definition of success for implant therapy 
• Lack of consensus in the choice of outcomes to measure implant success 
• Validity and relevance of the outcome measures (e.g. difficulty in measuring 
probing depths due to implant designs (platform switching) and/ or restorative 
contours that may hinder effective probing)  
• Lack of clarity of characteristics of study or reference groups.  





• Lack of details in reporting (the extent as well as the severity i.e. amount of bone 
loss) of the lesion (Lang et al., 2011).  
• When peri-implantitis is reported, the implant is usually used as the unit of 
analysis although it has been recognized that the outcomes of individual 
implants, like teeth are usually clustered within individuals (Klinge et al., 2005). 
Thus it is important to also report prevalence on a ‘per subject’ or ‘per patient’ 
basis.  This in turn minimizes type 1 error which could occur when the implant 
is used as the unit of analysis, since increasing the “n” number of implants 
would increase the precision of the study and may create spurious statistically 
significant findings (Needleman et al., 2012) 
It is obvious that establishing clear success criteria to define implant performance is 
important. Accordingly, Needleman et al. (Needleman et al., 2012) have indicated that 
these criteria should be summarized according to the definition by Albrektsson et al. 
(Albrektsson et al., 1986) and adapted by Buser et al. (Buser et al., 1990) as well as 
Karoussis et al. (Karoussis et al., 2004), Roos- Jansaker et al. (Roos-Jansaker et al., 
2006a, Roos-Jansaker et al., 2006c) and Renvert et al. (Renvert et al., 2007) as follows: 
• Absence of mobility (Buser et al., 1990). 
• Absence of persistent subjective complaints (pain, foreign body sensation and/ 
or dysaesthesia) (Buser et al., 1990). 
• Absence of recurrent peri-implant infection with suppuration (Buser et al., 
1990). 
•  Absence of a continuous radiolucency around the implant (Buser et al., 1990). 
• No PPD > 5 mm (Bragger et al., 2001, Mombelli and Lang, 1994) 
• No PPD > 5 mm and bleeding on probing (BOP) (Mombelli and Lang, 1994) 
•  After the first year of service, the annual vertical bone loss should not exceed 
0.2 mm (mesially or distally) (Albrektsson et al., 1986, Albrektsson and Isidor, 
1994). 




Based on this, the Association of Implantology, UK (ADI)’s expert panel consensus 
meeting, held in 2012 in London, suggested the following classification for implant 
success or failure (Table 1). 
Success Failing  
Stable marginal bone levels after an 
initial crestal bone loss of < 1.5mm 
< 50% progressive bone loss which has not 
stabilized  
No BOP  Deep pocketing  
PD < 4mm  BOP  
Good plaque control  Less than ideal plaque control 
Inflamed peri-implant mucosa Healthy peri-implant mucosa 
At Risk Failed 
Initial bone loss < 4mm but bone loss 
has stabilized 
Deep pocketing  
PD < 5mm  Discharge  
No BOP immediate or delayed  BOP  
Plaque index less than ideal Mobility 
Table 1 Implant success and failure definition according to ADI.  
Failing implants often demonstrate few if any patient perceptible signs or symptoms. It 
is thus the responsibility of the clinician to recognise the disease especially in it’s early 
and reversible stages. When clinical signs are overlooked, implant mobility may be the 
first symptom perceived by the patient, by which time all treatment options are 





Since both diseases represent a host response to a bacterial challenge, there is no reason 
to assume that the response will be different in the peri-implant mucosa when compared 
to the gingiva (Lang et al., 2011). Most of our knowledge comparing similarities and 
differences of peri-implant and periodontal lesions stems from animal studies using 
plaque-retaining ligatures. Berglundh, Zitzmann and Donati (Berglundh et al., 2011) 
indicate that microbiologically and clinically, both lesions have considerable 
resemblance, where initial biofilm formation led to lesions similar in size and 
composition after 3 weeks. However histopathologically, the apical extension of the 
lesions in peri-implantitis were more pronounced, extending consistently apical of the 
pocket epithelium and was in direct contact with the biofilm residing on the implant 
surface. On the contrary, a “self-limiting” process existed in the tissues around teeth 
resulting in a protective connective tissue capsule separating the lesion from the 
alveolar bone. A similar connective tissue capsule could not be found in biopsies from 
the peri-implant tissues and the lesion extended to the bony crest. Plasma cells and 
lymphocytes dominated both types of lesions, but neutrophil, granulocytes and 
macrophages occurred in larger proportions in peri-implantitis. Also peri-implantitis, in 
contrast to periodontitis lesions, exhibited large amounts of osteoclasts lining the 
surface of the crestal bone.  
A clinically noticeable feature is that submucosal calculus formation is less common on 
implants than on teeth and that peri-implantis in general progresses faster than 
periodontitis. One factor that could explain the difference in progression of 
inflammation is the anatomical difference of the gingival architecture around implants 
and natural teeth. Histologically, around implants the circular supracrestal collagen 
fibres are parallel to the implant surface. In contrast, collagen fibres around teeth have 
insertions in cementum, which may provide greater protection against the spread of 
inflammation (Berglundh et al., 1991). 
Another difference is the circumferential nature of the intrabony defects commonly 
observed in peri-implantitis compared to the localized periodontitis lesions. Bone loss 
around implants often occurs as a saucer-shaped defect, which can be observed 
radiographically. The reason for this is unknown, but it may be speculated that the 




to lateral spread of infection, determining the morphology of the lesion and explaining 
the characteristic bony defects seen around implants (Berglundh et al., 1991).   1.2.3 RISK,FACTORS,FOR,PERI%IMPLANT,DISEASES,
The systematic review by Heitz-Mayfield summarizes the available evidence for risk 
factors associated with peri-implant diseases (Heitz-Mayfield, 2008). She concluded 
that poor oral hygiene (Ferreira et al., 2006, Lindquist et al., 1996), a history of 
periodontitis (Van der Weijden et al., 2005) and cigarette smoking (Strietzel et al., 
2007) are major risk factors for the development of peri-implant disease. Limited 
evidence existed linking peri-implant disease to alcohol consumption and diabetes. 
There was also limited and conflicting evidence associating genetic traits and implant 
surfaces with the development of peri-implant diseases. Nevertheless all the above may 
co-exist and their effects may be synergistic (Table 2) 
Risk Indicator Peri-implantitis 
History of periodontitis + 
Poor oral hygiene + 
Microorganisms + 
Smoking + 
Diabetes mellitus (+) 
Alcohol consumption (+) 
Implant design (+) 
Implant surface (+) 
Residual cement + 







It appears that the main contributory factor for peri-implantitis, as in periodontitis, is the 
accumulation of bacterial dental plaque (Schou et al., 1992, Lang et al., 2011). Bacteria 
in plaque have the ability to initiate an inflammatory response that may lead to bone 
destruction.  Whether this progresses to involve the supporting tissues (whether around 
teeth or implants) seems to be related to an interaction of factors e.g. microbiological, 
genetic susceptibility and immune response (Socransky and Haffajee, 1992). 
Due to the important role of the plaque biofilm in the initiation and progression of peri-
implantitis (Lang et al., 2011), the microbiology of the peri-implant tissues has attracted 
much attention in the scientific community. Although numerous studies have been 
published, research in this area has produced conflicting results and which species are 
responsible for peri-implantitis remains unclear. 
As mentioned previously, the definition of peri-implantitis was introduced at the first 
EWOP in 1993 (Lang and Karring, 1993). Later, at the sixth EWOP in 2008 (Lindhe et 
al., 2008), the distinction was made between peri-implantitis and peri-implant 
mucositis, both being peri-implant diseases. Studies before those dates used various 
terms to describe such implants, for example unsuccessful, diseased, failing, etc. Peri-
implantitis is now considered a more accurate term, that best describes the disease. In 
this review, the terms that were used in their original context will be referred to, as 
inclusion criteria in the early studies were not always clear.  
Similarly, many bacterial species have been renamed and reclassified. In the following 
review, the names used in the original text will be referred to.  
To determine the impact of microorganisms on peri-implant pathology, data from 
different kinds of studies need to be evaluated. Association studies can reveal which 
bacteria are detected more frequently and at higher levels in diseased sites than in 
health. Longitudinal investigations are required for the study of early colonization of 
implants, to determine the range of normal fluctuation in bacterial populations and to 
possibly demonstrate microbial changes prior to or concomitant with disease 
development. Treatment studies may answer the question of whether reducing or 





1.2.4.1  MICROSCOPIC ,AND,CULTURE,STUDIES,
Early studies mainly used dark field microscopy, phase contrast microscopy, differential 
phase microscopy, and selective and non-selective culture media to identify organisms.  
Lekholm et al. (Lekholm et al., 1986b) carried out one of the earliest longitudinal 
studies regarding the microbiota around healthy dental implants. They reported on the 
microbial composition associated with combined prostheses i.e. those that have natural 
teeth abutments connected to implants. Supra and subgingival plaque samples were 
taken from 10 partially edentulous patients who had fixed bridge restorations that had 
been in function for an average of 18 months. Bright – light phase contrast microscopic 
examination showed primarily cocci and non-motile rods with an absence of 
spirochaetes. The microbiota was similar for both tooth and titanium abutments. 
Cultural analysis revealed predominantly 80% of the Gram - positive facultative cocci 
were streptococcal isolates, the most predominant species being Streptococcus 
sanguinis, Streptococcus mitis and Streptococcus acidominimus. The remaining 20% of 
the Gram-positive facultative cocci were catalase-positive and belonged to the 
Staphylococcus and Micrococcus group of organisms. The Gram-positive anaerobic 
cocci were members of Peptococcus and Peptostreptococcus species. Concerning the 
Gram-positive facultative rods, about 50% of the isolates were catalase-positive 
organisms which were tentatively identified as Actinomyces viscosus and the other half 
were catalase-negative organisms, which were presumed to be Actinomyces naeslundii. 
All Gram-negative anaerobic cocci were considered Veillonella parvula. Among the 
Gram-negative anaerobic rods, Fusobacterium nucleatum was the most predominant 
species. 
The same authors conducted a retrospective study (Lekholm et al., 1986a) on 20 
edentulous patients who were selected at random from a pool of 400 subjects treated 
during the period between 1965 to 1981. The patients had a total of 125 implants 
supporting fixed bridges that had been in function for an average of 7.6 years. 40% of 
probing depths were 3 mm or less, 45% were between 4 and 5 mm and 15% were more 
than 6 mm. Samples of the subgingival microbiota were obtained using curettes from 
sites having the deepest and shallowest pockets in each jaw. Coccoid cells and non-
motile rods dominated the microbiota with a total frequency of 94%, while spirochaetes 
and motile rods were present in 1.5% only. Deeper pockets were correlated with 




Using the same Brånemark implant system, Bower et al. (Bower et al., 1989) examined 
10 supragingival and 9 subgingival plaque samples from around healthy implants, that 
had been in function for 3 years supporting fixed mandibular prostheses. The samples 
were collected using scalers and were examined under phase contrast microscopy. 
Results showed that coccoid and non-motile rods predominated all samples 
(supragingival 89% and subgingival 85%) while spirochaetes and motile rods were not 
found in the supragingival samples and was found in only one of the subgingival 
samples.  
Mombelli et al. (Mombelli et al., 1987) presented some of the earliest data associated 
with unsuccessful implants. They compared the subgingival microbiota surrounding 
healthy and failing plasma-coated titanium hollow cylinder implants in edentulous 
patients that had been wearing overdentures with bar or ball attachments, for over one 
year.  They divided the subjects into 2 groups; a successful implants group, comprising 
5 patients each with 2 healthy implants and a failing implants group of 7 patients, each 
with at least one failing implant and one healthy control implant. Failing implant sites 
were characterized by pocket formation > 6mm, suppuration and radiographic evidence 
of bone loss. Using dark field microscopy and culture, they found that failing implant 
sites had a significantly higher proportion of the micro-organisms traditionally 
associated with periodontal diseases. These were Gram-negative anaerobic rods, 
including Prevotella spp., Fusobacterium spp., spirochaetes and Wolinella spp. This 
was noticeably different from subgingival plaque from the clinically healthy dental 
implants, which were similar regardless of which patient group they came from and 
consisted predominantly of cocci. On the basis of these findings, peri-implantitis has 
been suggested to be a “site-specific”. 
The following year, Mombelli et al. (Mombelli et al., 1988), published another study 
that looked at bacterial colonization over a 180 day period of 9 newly inserted titanium 
hollow screw implants in 5 totally edentulous patients. The day before implant 
placement, microbial samples were obtained from the mucosal surface, thereafter 
samples were taken from the peri-implant pockets using paper points at weekly intervals 
for 8 weeks. Additional samples were obtained at 90, 120, 150 and 180 days after 
implant placement and were analyzed using dark field microscopy and culture. After 
insertion of the implants, gram-positive coccoid cells accounted for over 80% of the 




the study at all sites except one. Predominant isolates included A. naeslundii, 
Veillonella sp. and Actinomyces odontolyticus. One implant demonstrated clinical 
breakdown with increased probing depth, bleeding and suppuration. The failing implant 
showed a decrease in coccoid cells and an increase in motile rods after 21 days. A. 
odontolyticus was first detected after 21 days, Fusobacterium spp. were found for the 
first time on day 42 and finally spirochaetes were identified in the sample taken at day 
120, when pus formation was clinically evident. Black pigmented anaerobes were 
infrequently found. 
In a follow up study, Mombelli and Mericske-Stern (Mombelli and Mericske-Stern, 
1990) studied the microbiota from 18 edentulous patients, again with overdentures and 
with the same type of implants, 30 months after placement. They found 52.8% were 
facultative anaerobic cocci and 17.4% facultative anaerobic rods, but only 7.3% were 
Gram-negative rods. Fusobacterium spp and Prevotella intermedia were both found in 
only 9% of the samples. Porphyromonas gingivalis and spirochaetes were not detected, 
suggesting that they were rarely isolated from edentulous individuals. Moreover, 9 of 
the patients were followed up to see if there were any microbiological changes during 
the third, fourth and fifth years, but no significant time trends could be identified.  
Maxson et al. (Maxson et al., 1992) evaluated the microbiota associated with clinically 
stable implants by obtaining plaque samples from 14 completely edentulous patients 
that had been rehabilitated by either transosteal gold alloy implants (TMI system) or 
titanium endosseous implants (Brånemark). Cultures for selected organisms revealed 
Actinomyces to be present in high proportions whilst motile organisms and black-
pigmented anaerobic rods were virtually undetectable.  
In a widely cited study by Apse et al. (Apse et al., 1989), tooth and implant sites were 
compared in 15 partially edentulous patients (28 peri-implant and 19 periodontal sites) 
and 6 edentulous patients (13 implants). All implants and teeth assessed were clinically 
healthy and had been in function for an average of 16 and 44 months for the partially 
edentulous and edentulous groups respectively. The microbiological analysis included 
dark field microscopy, anaerobic culturing for total colony forming unit counts and 
identification of black-pigmented bacteria. Coccoid cells dominated all sites and non-
motile rods, motile rods and spirochaetes occurred in very low numbers. The proportion 
of motile rods from implant sites was significantly higher in the edentulous than in the 




Capnocytophaga spp. (p < 0.001) occurred more frequently at implant sites in the 
partially edentulous group when compared to the edentulous implant sites. This was 
attributed to the possibility that there were lower numbers of disease-associated 
organisms in edentulous mouths. Considering these distinct differences, in addition to 
the notable similarities between the implant and periodontal sites in the same patient, it 
was suggested pockets around teeth might serve as a reservoir of microorganisms for 
the colonization of the subgingival environment around implants in partially edentulous 
patients. This was contrary to the idea that peri-implantitis was a site-specific infection 
as Mombelli et al. had proposed regardless of the patient (Mombelli et al., 1987). 
The importance of staphylococci as one of the aetiological species was suggested by 
Rams et al. (Rams et al., 1990). They reported that a higher proportion of staphylococci 
(15.1%) were present in peri-implantitis lesions compared to gingivitis (0.06%) or 
periodontitis lesions (1.2%) potentially implicating these infrequently observed 
microorganisms. Samples from 13 patients with 20 titanium implants that demonstrated 
progressive pocketing, bone loss, and abscess formation, were obtained by inserting 
paper points for 10 seconds in the pockets. The bacterial samples were then plated onto 
Staphylococcus 110 medium and non-selective enriched Brucella blood agar and 
incubated anaerobically for 4 and 10 days respectively. Staphylococcal identification 
was based on colonial morphology, Gram-stain characteristics and a positive catalase 
reaction. Staphylococci were identified in 9 out of the 13 patients and 11 out of the 20 
implants. One third of the staphylococcus species were identified as Staphylococcus 
aureus, while two thirds were identified as Staphylococcus epidermis using biochemical 
methods. 
With the introduction of hydroxyapatite coatings to dental implants in the early nineties, 
it was inevitable that this would be accompanied by an interest in the surrounding 
microbial profile of these promising osteoinductive surfaces. Nakou and colleagues 
(Nakou et al., 1987) described the microbial colonization of 10 clinically healthy dental 
implants with a hydroxyapatite surface in 5 edentulous patients. The samples were taken 
from the supra and subgingival sites, two to ten weeks after implant placement from the 
deepest peri-implant pocket of each implant using a curette. The samples were 
investigated using non-selective and selective anaerobic culture media and dark field 
microscopy. The supragingival plaque was dominated by Gram-positive facultative 




parvula. No black-pigmented Bacteroides were found in any of the examined samples. 
This was explained by the short time that the implants were present in the edentulous 
mouth and the shallow, inflammation-free, clinically healthy peri-implant crevices that 
might not provide the nutritional factors necessary for growth of these fastidious 
microorganisms.  
Quirynen and Listgarten (Quirynen and Listgarten, 1990) analysed the distribution of 
bacterial morphotypes around natural teeth and healthy dental implants in 24 partially 
edentulous patients using differential phase contrast microscopy. They selected teeth 
and implants with comparable clinical indices and they found no significant 
microbiological differences between them. Coccoid cells dominated all the implant and 
dental surfaces (65.8% and 56.5% respectively) and motile rods and spirochetes 
occurred in very low proportions. When fully edentulous patients were considered, 
significantly less motile rods and spirochetes were found when compared with implants 
in dentate patients. This may reflect the diverse ecological characteristics of the 
edentulous and the partially edentulous mouths.  It may also indicate that the presence 
of teeth influences the composition of subgingival plaque around these implants, by 
serving as a source for the initial colonization of the implants. In the same study, the 
authors took 4 samples from failing implants. In the first 3, occlusal overload was 
deemed the cause of failure and samples showed a plaque containing no spirochaetes 
and few (0-3%) motile rods. However the fourth sample, which was accompanied by 
signs of inflammation, contained 11% spirochaetes and 16% motile rods. 
Rosenberg et al. (Rosenberg et al., 1991) argued that there were 2 distinct types of 
implant failures, infectious and traumatic failures, each with a different entity of 
surrounding microorganisms. In this respect, infectious failures were implants with deep 
pockets and bone loss demonstrating clinical signs of infection (bleeding, suppuration 
and granulomatous tissue upon removal). Dark field microscopic observations of these 
samples exhibited a microbiota characteristic of a pathogenic milieu, in which 
spirochetes and motile rods made up 42% of the total morphotypes (21% each). The 
results of cultural analysis showed high proportions of Peptostreptococcus micros, 
enteric Gram-negative rods, Fusobacterium spp. and yeasts. Moderate levels of the P. 
gingivalis, P. intermedia, Wolinella recta and Pseudomonas aeroginosa were seen as 
well Aggregatibacter actinomycetemcomitans, S. aureus and S. epidermis were 




signs of infection demonstrated few or no major suspected periodontal pathogens and 
were termed traumatic failures. 
Dharmar et al. (Dharmar et al., 1994) also compared the subgingival bacterial 
population around 64 healthy implants and 22 teeth in 18 partially edentulous and 6 
totally edentulous patients. They used phase contrast microscopy to observe the 
morphological bacterial composition. Results showed a similar microbiota for teeth and 
dental implants in partially edentulous patients. Spirochaetes, although very few, were 
positively correlated with increasing pocket depths and were absent in totally 
edentulous patients, again suggesting the possibility of colonization of the implants 
from the bacterial reservoir of teeth in the same mouth.  
Leonhardt et al. (Leonhardt et al., 1993) proposed a paradigm shift arguing that so-
called periodontopathogens, such as P. gingivalis, P. intermedia, Capnocytophaga spp., 
Campylobacter rectus, and A. actinomycetemcomitans, were also present in implants 
without any signs of destructive processes and could not be used as a marker, relating 
only to individuals with persisting deep pockets. In their study, 19 patients were 
provided with 63 implants and were sampled at baseline, 3, 6, 12, 24 and 36 months. 
Only 3 implants failed in one patient and this was accompanied by the presence of P. 
intermedia. Selective media and phase-contrast microscopy were used to identify the 
organisms leading to the conclusion that these organisms were also found around 
healthy implants and that the initiation of peri-implantitis is a multi-factorial process 
that involves technical, anatomical, microbiological and host-related factors. These 
organisms may still be important in maintaining the destructive process around the 
implants, however their presence will not necessarily result in failure. 1.2.4.2  MOLECULAR,BIOLOGY,STUDIES,
With the advancement of microbiological identification techniques, more researchers 
started using DNA – DNA checkerboard hybridization and PCR techniques for the 
identification of the microbiota around implants. 
Papaioannou and co-workers (Papaioannou et al., 1996), tested the hypothesis that teeth 
may act as a reservoir of microorganism using DNA probe analysis to test for the 
presence of 8 organisms, with disease associated potential, namely P. gingivalis, P. 
intermedia, Eikenella corrodens, F. nucleatum, Treponema denticola, C. rectus, 




The study included 6 patients divided into 2 groups, 3 patients with chronic adult 
periodontitis and 3 with refractory periodontitis. In each patient, plaque samples were 
obtained using paper points from deep (> 4.5mm) and shallow (< 3.5mm) pockets from 
around implants and teeth. Results suggested that ‘infected’ pockets around teeth were 
responsible for the transmission of suspected organisms to pockets around implants. 
They showed differences in the subgingival flora between the chronic adult 
periodontitis as well as refractory periodontitis, as well as between deep and shallow 
pockets, around both implants and teeth within the same patient, where deep pockets 
harboured more spirochaetes and motile organisms than the respective shallow pockets. 
DNA probe analysis detected all organisms except for A. actinomycetemcomitans 
contrary to what had been suggested (Becker et al. 1990 and Rosenberg et al. 1991). 
They concluded that pockets around teeth with periodontal breakdown contained 
‘pathogenic’ organisms that would lead to the colonization of implants placed. 
Although results were interesting and have been widely cited in other papers, the 
sample size was small (six patients out of which only 4 implants and 6 teeth with deep 
pockets were sampled) and only certain species were targeted and no healthy controls 
were included.  
Quirynen et al. (2006) followed the dynamics of initial subgingival colonization of 
‘pristine’ peri-implant pockets from 1 week till 78 weeks after abutment connection. 
The samples were analyzed by DNA-DNA hybridization, real-time PCR and/or 
culturing. In the 29 patients who completed the study, they observed that bacteria 
associated with periodontitis were found in healthy pockets within one week after 
abutment connection and that they increased only slightly after the second week and 
reached a more or less stable profile from 3 months onwards. They also found that 
deeper pockets, although not related to disease, harboured more suspected disease-
associated species. 
Shibli and colleagues (Shibli et al., 2008), compared the composition of the microbiota 
present in both supra and subgingival plaque in 44 subjects with and without peri-
implantitis. They used checkerboard DNA-DNA hybridization to test for the presence 
of 36 species. All of the species investigated were detected in both groups, however 
there were differences in proportions of species. Four species were detected at 
significantly higher levels in peri-implantitis group supragingivally, which were P. 




Subgingivally, the levels of P. gingivalis, T. forsythia, T. denticola, F. nucleatum ss. 
nucleatum, F. nucleatum ss. vincentii and P. intermedia were significantly higher in 
implants with peri-implantitis (P < 0.05) suggesting that organisms commonly 
associated with periodontal diseases could also be important in peri-implantitis.  
In an attempt to correlate, clinical indices with histological and microbiological 
findings, Ferreira et al., (Ferreira et al., 2009) used PCR and species-specific probes to 
check for the presence of A. actinomycetemcomitans, P. gingivalis, and T. forsythia in 
the subgingival plaque around 10 implants that ‘were indicated for treatment of the peri-
implant pockets’. They failed to find statistically significant correlations between the 
presence of these bacteria and the degree of inflammation. 
In summary, the peri-implant microbial community appears to be complex, however all 
previous studies have targeted specific organisms or focused on groups of organisms. 
This undermines the true complexity of this community and may create false 





Biofilms can be defined as one or more communities of micro-organisms embedded in a 
polymeric, extracellular substance of glycoproteins and attached to a solid surface 
(Socransky and Haffajee, 2002) 
Biofilms provide protection to the resident bacteria from both host defenses and 
exogenous antimicrobial treatments. It has been suggested that bacteria in a biofilm are 
up to 1000 times more resistant to antimicrobials than the same cells growing in liquid 
culture (Costerton et al., 1999, Mah and O'toole, 2001). This makes infections 
developing on permanently or temporarily implanted biomaterials such as heart valves, 
vascular prostheses or dental implants poorly responsive to antimicrobial treatment and 
generally difficult to manage. 
Biofilm formation is a step-wise process, which starts by the adhesion of planktonic or 
free-floating microorganisms on a surface. This initial adhesion is usually promoted in 
the oral cavity via receptors provided by the acquired pellicle, a salivary film that coats 
oral surfaces and contains albumin, glycoproteins, acidic proline-rich proteins, mucins, 
sialic acid and other components. Early colonizers attach to this pellicle, followed by 
other steps, which involve colonization, co-aggregation and co-adhesion of secondary/ 
late colonizers and subsequent growth and maturation of the biofilm, and finally 
detachment of some microorganisms. These can adhere to other regions of the oral 
cavity and produce other bacterial colonies. A simplified representation of biofilm 
formation is shown in Figure 1 (Kolenbrander et al., 2010, Kuramitsu et al., 2007). 
Quirynen and Bollen (Quirynen and Bollen, 1995) explained that initial adhesion is 
initiated when bacteria manage to get close enough (50 nm) to a surface by Brownian 
motion, convective fluid movements or active locomotion. This is accomplished via the 
long-range Van der Waal attractive forces, which in turn are opposed by electrostatic 
repulsive forces. The resultant net force will cause the bacteria to establish an initial 
reversible weak binding at a distance of 10 to 15 nm from the surface. After initial 
adhesion, a firmer anchorage can be achieved by extracellular filamentous appendages, 
by direct contact, or by specific interactions (covalent, ionic or hydrogen bonding). 







Figure 1 Simplified model of oral bacterial colonization. Adapted from 
(Kolenbrander et al., 2010) 
 
In the case of complex biofilms, it is not simply the presence of a single organism in a 
complex community which determines the properties of a biofilm, but it is the 
interactions between the biofilm residents which is crucial. Dental plaque is a classical 
example of a complex biofilm and it is not merely the sum of its bacterial components 
that make up its properties. Instead, a sophisticated microbial community is established 
resulting in novel functions that are essential for biofilm architecture and microbial 
physiology (Marsh, 1994, Marsh, 2005). For example, through the inter-species 
mechanism of protection, fastidious anaerobes are able to colonize supposedly aerobic 
environments (Socransky and Haffajee, 2002).  
Accumulation of multispecies communities such as dental plaque may lead to 
polymicrobial infections. Periodontitis, and similarly peri-implantitis represent one of 
the best documented polymicrobial infections. The clinician’s management of such 







Dental implants are mostly made of titanium or titanium alloys. Titanium is a highly 
biocompatible metal. It is lightweight and durable, having the highest strength-to-
weight ratio of any metal. It has the ability of forming an oxide layer (2 – 10 nm thick, 
usually TiO2) on its surface within seconds of being exposed to air. This oxide layer is 
extremely adherent and provides titanium with many desirable properties such as 
corrosion resistance and chemical stability (Palmquist et al., 2010a, Lautenschlager and 
Monaghan, 1993). 
These titanium implant surfaces, which have micro-surface roughness, provide an ideal 
biological niche for the development of a plaque biofilm. However, it must be borne in 
mind that surface roughness is only one of the parameters involved in plaque formation. 
Bacterial adherence is a complicated process, and involves the interplay of several 
factors. These include other surface characteristics such as chemical composition, 
surface energy, surface wettability, and surface topography as well as the surrounding 
environment (saliva, gingival crevicular fluid or culture media) (Ichikawa et al., 1998, 
Dorkhan et al., 2012, Almaguer-Flores et al., 2012) and bacterial composition. These 
factors act together to provide distinct patterns for protein adsorption (salivary pellicle) 
and subsequent bacterial binding (An and Friedman, 1998). 
During the past two decades, there has been considerable focus on the optimization of 
the physico-chemical and mechanical properties of implant materials. Different surface 
topographies with various chemical compositions have been developed aiming at 
enhancing osseointegration and increasing clinical success rates. The methods used to 
develop these surfaces include sandblasting, acid etching, titanium plasma spraying, 
plasma nitriding and the use of different chemical coatings. A major concern, however 
still lies in the accumulation of bacteria on these surfaces. Thus, surface optimization 
must also take in consideration the importance of minimizing bacterial adhesion to 
avoid development and progression of peri-implant disease. The effect of implant 
surfaces on bone cells will be discussed in more detail in the last part of this study. The 
following review will focus on titanium surface characteristics that affect the 





1.3.2 THE,IMPORTANCE,OF,DIFFERENT,SURFACE,PARAMETERS,THAT,AFFECT,BIOFILM,FORMATION,ON,TITANIUM,SURFACES,1.3.2.1  SURFACE,ROUGHNESS,
A particularly important structural property of oral implants is the surface topography, 
or surface roughness.  Most currently available implant surfaces are minimally or 
moderately rough with an average deviation of 0.5 – 2 µm (Albrektsson and 
Wennerberg, 2004a). Recently, interest has been directed at providing modifications at 
the nanometer level. Nanosurfaces are those with structures smaller than 100 nm in at 
least 1 dimension. At least four commercially available implants are presently 
characterized as having nanofeatures (Wennerberg and Albrektsson, 2010).  
Although many studies have been conducted assessing the effect of titanium surface 
roughness on biofilm formation, there is some controversy about the role of surface 
roughness and plaque accumulation.  
STUDIES 'WHICH'SUPPORT'THAT'INCREASING'SURFACE'ROUGHNESS '
INCREASES 'BIOFILM'FORMATION'
a) In vivo Studies 
Generally, it has been considered that the rougher the surface, the more biofilm is 
formed. From a series of split mouth studies, Bollen and Quirynen observed a positive 
correlation between plaque accumulation and surface roughness on different materials 
tested intraorally (Quirynen et al., 1990). This was less obvious in patients with optimal 
oral hygiene (Quirynen et al., 2002). After several days of undisturbed plaque 
formation, the rougher (Ra =0.8 and Ra =2.1um) surfaces not only seemed to harbour 
more plaque compared to the smooth surfaces (Ra =0.35 and 0.1um), but also a more 
pathogenic flora (i.e. spirochaetes and motile organisms) (Quirynen et al., 1993, 
Quirynen et al., 1990). This was similar for implant abutments, where rougher implant 
abutments harboured 25 times more subgingival biofilm than their smoother 
counterparts (Quirynen et al., 1993).  
Their explanation for this was that bacteria found it easier to accumulate on these 
rougher surfaces because at these locations, bacteria were sheltered from removal forces 
and had the time to establish a less reversible and stronger attachment. Moreover the 
increased surface roughness provided a greater surface area available for colonization. 




subgingival areas since shear removal forces are less in these locations making the 
environment more favourable for undisrupted plaque accumulation (Quirynen et al., 
1996a, Bollen et al., 1997). 
In this context, Nyvad and Fejerskov (Nyvad and Fejerskov, 1987) using scanning 
electron microscopy revealed that initial colonization started at the depths of surface 
irregularities, like pits and grooves making it more difficult to completely remove 
bacteria from these regions. 
Studies by other authors also support the theory by Bollen and Quirynen, that increasing 
surface roughness increases biofilm formation. Amarante et al. (Amarante et al., 2008) 
demonstrated that titanium plasma sprayed (TPS) rough surfaces accumulated more 
plaque, and showed that they were more difficult to clean by tooth brushing. 
Conversely, Burgers et al. (Burgers et al., 2010) compared 2 surfaces with significant 
differences in surface roughness. One had a microrough sand blasted acid etched (SLA) 
surface and the other a nanorough (machined titanium) surface from Camlog implants 
(Camlog Biotechnologies AG, Basel, Switzerland). They tested the surfaces both in vivo 
and in vitro using two fluorometric techniques (Resazurin and live/dead staining) and 
confirmed that surface roughness did indeed cause a greater accumulation of biofilm. 
This phenomenon was even more pronounced in in vivo testing probably because of the 
sheltering effect of rough surfaces against removal forces, which did not occur under 
semi-static in vitro conditions (Rimondini et al., 1997).  
Bollen et al., (Bollen et al., 1996, Quirynen et al., 1996a, Bollen et al., 1997) 
demonstrated that abutment smoothening below Ra of 0.2 µm showed no further 
reduction in the resultant biofilm. Thus an Ra value of 0.2 µm was proposed, and has 
been generally accepted, to be the average roughness threshold below which bacterial 
adhesion is not affected. They attributed this to the size of oral bacteria, which range in 
size from 0.5 µm to 10 µm. Thus the mean peak to valley heights (Rtm) and mean 
spaces between peaks (Sm) present in surfaces with an Ra of 0.2 µm or less, would be 
too small to offer any major sheltering possibilities and would not be able to protect 
these bacteria against removal forces (Quirynen et al., 1996a, Bollen et al., 1997).  
However, judging from the results of other studies in the literature, the proposed 
threshold value of 0.2 µm may be questionable. Rimondini et al. (Rimondini et al., 




and roughest surfaces (Ra 2.142 µm), but not between surfaces with an Ra 0.088 µm 
and Ra 0.2 µm nor between surfaces of Ra 0.2 µm and Ra 2.142 µm. Similarly, 
Nakazato et al. (Nakazato et al., 1989) did not detect any significant reduction of 
biofilm on surfaces with an Ra less than 0.37 µm questioning the 0.2 µm threshold 
value. 
c) In vitro studies 
An in vitro study demonstrated that surface roughness had a strong influence on plaque 
accumulation, where an exponential increase in the attachment of S. sanguinis was 
observed after 7 days on increasing surface roughness from Ra 0.17 µm to 1.14 µm to 
3.17 µm (Pereira da Silva et al., 2005).  
Similarly, in another study, colonization by the same bacterium was shown to be 
significantly different after 24 hours on titanium discs polished with 1 µm diamond 
paste (7x104 CFU/mm2), 800-grit silicon carbide sandpaper (2 x 106 CFU/mm2), or 
sandblasted (1x106 CFU/mm2), however the surface roughness produced by these 
methods was not reported (Drake et al., 1999).  
STUDIES 'WHICH'DO'NOT'SUPPORT'THAT'INCREASING'SURFACE'
ROUGHNESS ' INCREASES 'BIOFILM'FORMATION'
Even so, many other studies report that roughness is only a minor factor and do not 
support the relationship between biofilm formation and different implant surface 
roughness.  
a) In vivo studies 
An in vivo pilot study on 3 patients using implant surfaces from Straumann (Institut 
Straumann AG, Basel, Switzerland) showed that changes in microtopography had a 
highly uneven and unpredictable influence on supragingival plaque accumulation. On 
one hand, surface roughness of Ra 3.2 µm were covered with significantly more plaque 
than that on surfaces with Ra of 0.83 µm. On the other hand, the most polished group 
(Ra = 0.04 µm) revealed significantly higher plaque biofilm coverage after 12, 24 and 
48 hours compared to surfaces with a Ra of 0.83 µm (Schwarz et al., 2007b).  
Similarly, in an in vivo study in which implant abutments (Nobel Biocare, Goteborg, 
Sweden) were worn for 14 days, no influence of surface roughness could be detected in 




greater on rougher surfaces (Elter et al., 2008). This was contrary to the subgingival 
findings by Quirynen et al. mentioned in the previous section (Quirynen et al., 1993). 
In accordance with the above, analyses of the results from the biofilm produced on 
titanium discs embedded in intraoral splints worn by 12 volunteers failed to detect a 
significant difference in bacterial adhesion between the two titanium surfaces used in 
this study, although one of the surfaces, TiUnite® (Nobel Biocare, Gothenburg, 
Sweden) was 10 times rougher (Ra = 544 nm) than the machined titanium surface (Ra = 
54 nm) also from Nobel Biocare (Nobel Biocare, Gothenburg, Sweden). Using 
molecular probes, FISH and confocal examination, streptococcus species were shown to 
be the main component of the biofilm (Al-Ahmad et al., 2010). 
b) In vitro studies 
These results were confirmed by various in vitro studies. One study, using a three 
species bacterial consortium made of A. naeslundii, S. sanguinis and Lactobacillus 
salivarius, bacterial adhesion was found to be less on a rougher surface (Ra = 1.52 µm) 
when compared to a smoother surface (Ra = 0.22 µm) after 14h.  However these 
surfaces were also different regarding their chemical composition (blasted titanium and 
calcium-modified titanium surfaces respectively), and this supports that roughness is 
not the only contributing factor (Frojd et al., 2011a). 
Another short term in vitro study (Schmidlin et al., 2013) showed that regardless of a 
titanium’s surface roughness, bacterial colonization was quite comparable. Biofilms 
were made up of 6 species (Actinomyces oris, Veillonella dispar, F. nucleatum, 
Streptococcus oralis, Streptococcus sobrinus, and Candida albicans) and were grown 
on Straumann implant surfaces (Institut Straumann AG, Basel, Switzerland) with 4 
different degrees of roughness (Ra was 0.1µm, 0.3 µm, 0.6 µm and 3.2 µm). There were 
minute insignificant differences that remained constant over time (at 20 minutes, 2 
hours, 8 hours and 16 hours). 
Likewise, another short term in vitro study which used 9 species representing the 
various complexes of subgingival plaque (Actinomyces israelii, A. 
actinomycetemcomitans, C. rectus, E. corrodens, F. nucleatum, Parvimonas micra, P. 
gingivalis, P. intermedia, S. sanguinis) grown on three Straumann surfaces (Ra < 0.2, 
Ra = 0.8, Ra = 3.2) for 24 hours, revealed no consistent pattern indicating that rougher 




This was confirmed using resazurin metabolism assay and sonication–colony-forming 
unit counts to assess biofilm growth on two distinctly different surfaces in terms of 
roughness level (Sa 0.3 µm vs. 1.4 µm). Again no difference in biofilm growth could be 
detected when comparing both surfaces at days 1 and 3 (Lin et al., 2013). 
In the first part of the study by Duarte et al., a greater bacterial adhesion of S. sanguinis 
was exhibited on rough surfaces (Ra = 0.7 µm) compared to smooth ones (Ra = 0.2 µm) 
after incubation for 16 hours. However, after these surfaces were cleaned with various 
treatment methods and their roughness values changed (the air-powder cleaning system 
did not affect the surface roughness whereas the metal curettes made the smooth 
surfaces rougher), the resultant biofilms formed were similar on smooth and rough 
surfaces irrespective of treatment modality and roughness value. Thus it appears that the 
level of bacterial adhesion is affected by other factors in addition to surface roughness 
(Duarte et al., 2009b).  
Yoshinari et al., Almaguer-Flores et al., Schwarz et al. and Al- Ahmad et al. also 
reported more controversial findings where the influence of surface roughness was 
unpredictable in their studies (Yoshinari et al., 2000, Almaguer-Flores et al., 2012, 
Schwarz et al., 2007a, Al-Ahmad et al., 2010). 
A summary of in vitro and in vivo studies conducted on biofilm formation on dental 
implant surfaces can be found in tables 3 and 4. 1.3.2.2  SURFACE,FREE,ENERGY,AND,SURFACE,WETTABILITY,
Surface free energy (SFE) and Surface Wettability (Contact angle measurements) are 
proposed to be two other fundamental properties to the process of microbial adhesion. 
They will be discussed together since SFE is mostly calculated indirectly using contact 
angle measurements. 
The importance of SFE can be explained by the thermodynamic model of microbial 
adhesion which states that bacterial strains with a high SFE preferentially adhere to 
surfaces with high SFE because the bacteria have a negative interfacial free energy of 
adhesion (Weerkamp et al., 1985, Burgers et al., 2010). The wicking effect of 
hydrophilic surfaces on tissue fluids has been shown to enhance the absorption of cell 
attachment proteins like fibronectin which may at the same time provide binding sites 




The methods of altering SFE and wettability are similar to the methods used to alter 
surface roughness and hence a dichotomy appears to exist regarding the relative 
importance of each.  
Several studies have shown that SFE and surface wettability were the most prominent 
factors, while surface roughness was less important. For example, an increased biofilm 
thickness was observed on machined titanium, which although much smoother than 
many of the other substrates used, was hydrophobic in comparison to the other 
hydrophilic surfaces suggesting that surface wetting properties and SFE both play 
important roles (Al-Ahmad et al., 2010). Moreover, Al-Radha et al. (Al-Radha et al., 
2012) suggested that the influence of SFE was the most important factor determining 
initial bacterial adhesion to a smooth surface where a decrease in SFE from 37.58 
mN/m to 33.4 mN/m led to a decrease in the area covered by S. mitis from 7.38% to 
3.13% when using saliva as the culture media. Another study by Drake et al., (Drake et 
al., 1999) reported that when the SFE of dental implants of varying surface roughness 
was increased and the surfaces made more wettable; these surfaces showed a significant 
decrease in bacterial adhesion than the same surfaces that were hydrophobic (less 
wettable) and had lower SFE. Although effects of this latter study are opposite to what 
the previous studies had indicated, it still points out that SFE and wettability were the 
major determining surface characteristics. 
On the contrary, most studies suggest that roughness is the prominent parameter and 
overrules the effect of SFE and wettability (Nakazato et al., 1989, Quirynen and Bollen, 
1995, Burgers et al., 2010, Schwarz et al., 2007a, Quirynen et al., 1990).  
For instance, ultrahydrophilic surfaces with increased SFE (SLActive® Institut 
Straumann AG, Basel, Switzerland) showed slightly less bacterial adhesion at 12, 24 
and 48 hours compared to their non-modified counterparts (SLA® Institut Straumann 
AG, Basel, Switzerland). However this difference was not significant and they 
concluded that hydrophilicity had no influence on supragingival plaque formation 
(Schwarz et al., 2007a).  
The same surfaces used in another study by different authors showed the opposite where 
the ultrahydrophilic surfaces showed slightly more bacterial adhesion than the non-
modified surfaces at 20 minutes, 4 hours, 8 hours, and 16.5 hours. However, this was 




was quite similar on all implant materials over time regardless of their wetting and SFE 
properties (Schmidlin et al., 2013).  
A third group using the same surfaces confirmed that hydrophilicity and surface energy 
could not explain the differences in bacterial adhesion. The hydrophilic surfaces showed 
a minute increase in bacterial adhesion that was insignificant and inconsistent 
(Almaguer-Flores, Olivares-Navarrete et al. 2012). 
These findings were consistent with an in vivo study by Elter et al., where the influence 
of acid passivation and increased hydrophilicity did not play a key role in biofilm 
formation (Elter et al., 2008). 
In another study, surfaces that had significantly higher SFE (39.6 mj/m2) had 
significantly less microbial adhesion than surfaces with a lower SFE (18.1 mj/m2) both 
in vivo and in vitro. This supports the predominant influence of Ra in contrast to SFE 
(Burgers et al., 2010).  
Finally, Yoshinari et al. (2000) showed a weak and uneven importance for SFE. They 
indicated that it might selectively influence certain species such as P. gingivalis which 
showed a positive but weak correlation, whereas others such as A. 
actinomycetemcomitans were not correlated to SFE (Yoshinari et al., 2000). 1.3.2.3  BIOCHEMICAL,MODIFICATIONS,
Another interesting approach to improve osseointegration and enhance bone healing is 
to incorporate and/ or attach molecules and pharmacological substances for local release 
from the implant surface (biochemical modification). This is a promising area for the 
development of future oral implants for use in compromised clinical situations. Such 
modifications should however be tested to ensure they do not promote the accumulation 
of bacteria.  
Calcium incorporated on the surface of oral implants was found to decrease bacterial 
adhesion after two hours of incubation, but after 14 hours, this effect was reversed and 
implant surfaces with calcium on them seemed to attract more bacteria (Frojd et al., 
2011b), even though the surfaces were considerably smoother (surfaces with Ca++ had 
an Ra = 0.22 µm vs. blasted surfaces with an Ra = 1.52 µm). In another study (Badihi 
Hauslich et al., 2013), pretreatment of surfaces with calcium ions increased the adhesion 




gingivalis, while research using an in vitro model system and single species cultures, 
concluded that the incorporation of calcium ions in titanium increased the adhesion of 
late colonizers such as P. gingivalis and A. actinomycetemcomitans. In the same study, 
titanium implanted with fluoride ions significantly inhibited the growth of both P. 
gingivalis and A. actinomycetemcomitans when compared with the polished 
commercially pure titanium specimens (Yoshinari et al., 2001).  
When the effect of different proteins of the conditioning pellicle were tested, it was 
shown that albumin significantly reduced the adherence of gram positive S. mutans, but 
had no influence on the adherence of gram negative F. nucleatum and P. gingivalis, 
whilst fibronectin significantly increased adherence of F. nucleatum and P. gingivalis, 
but had no significant effect on the adherence of S. mutans, pointing to the fact that 
different components of the conditioning film might act differently on specific oral 
bacteria and verifying the complexity of the interactions between serum constituents, 
oral bacteria and titanium surface properties (Badihi Hauslich et al., 2013).  1.3.2.4  STERILIZATION,METHOD,
Even sterilization methods have an effect on surface behaviour in relation to bacterial 
colonization. Surfaces sterilized by ethylene oxide or by plasma cleaning using argon 
gas both showed significantly reduced bacterial adhesion. The authors attributed this to 
the residual effect of the biocidal elements of ethylene oxide gas and the highly 
wettable, contaminant-free surface produced using argon gas. On the other hand, 
titanium discs that were steam autoclaved multiple times showed significantly greater 
bacterial adhesion (regardless of surface roughness). In this case, it was explained that 
this might have been due to the fact that steam autoclaving increased surface oxide 
thickness and caused contamination with various elements like carbon, nitrogen, 
calcium, sodium, potassium and iron. This decreased surface energy and increased 




Table 3 Summary of in vitro studies of biofilms on implant surfaces (sorted according to incubation time).  
Authors 
Surfaces tested (Roughness value 
Ra except if stated) 
Incubation time 
and bacteria used 
Evaluation 
method 
Results (biofilm accumulation) 
 
(Schmidlin et al., 
2013) 
1) Machined (Sa 0.1µm) 
2) Machined (Sa 0.3µm) 
3) Stained (Sa 0.4µm) 
4) Acid-etched (Sa 0.6µm) 
5) Sandblasted/ acid-etched (SLA) 
(Sa 1.3µm) 
6) Modified acid-etched 






A. oris, V. dispar, 
F. nucleatum, S. 





Roughness and wettability did not 
influence biofilm formation (which 
increased over time) 
(Yoshinari et al., 
2000) 
1) Polished Titanium (0.07 µm) 
2) Blasted Ti (0.47 µm) 
3) Striated Ti (0.72 µm) 
4) + Calcium (0.1 µm) 
5) + Fluoride (0.08 µm) 
6) Titania sprayed (3.79 µm) 
7) Alumina coated (0.06 µm) 
 
+ several other modifications beyond 










- Roughness had unpredictable 
influence. 
- Some correlation of Pg (but not Aa) 
with SFE. 
- Blasted ↑ Aa and ↑ Pg than polished 
- Striated ↑Aa than polished, but ↓ 
than blasted (Pg same as polished) 
- Calcium: ↑Pg and Aa 
- Fluoride: No difference 
- Titania sprayed: ↓Pg (although Ra 
was very high) and ↑Aa than polished 





(Burgers et al., 
2010) 
Pure titanium (0.15µm) 





1) Alamar blue/ 
Resazurin 
2) CLSM 
1) 1.4x more on rougher surface 
(resazurin) 
2) 3.7x more on rougher surface 
(CLSM) 
(Frojd et al., 
2011a) 
1) Turned titanium (Sa 0.18 µm) 
2) Sol-gel nanoporous (Sa 0.16 µm) 
3) Anodized Ca++ (Sa 0.22µm) 
2 hours & 
14 hours 





and confocal laser 
scanning 
microscopy. 
No differences in adhesion between 
all relatively smooth surfaces at 2 or 
14 hours 
(Frojd et al., 
2011b) 
1) Turned (Sa 0.18 µm) 
2) Anodized (Sa 0.4 µm) 
3) Anodized + Calcium acetate (Sa 
0.22 µm) 
4) Blasted Al2O3 (1.52 µm) 
5) Blasted + anodized + Ca++ acetate 
(1.54 µm) 
2 hours & 
14 hours 















- At 2 hours rougher surfaces 
increased biofilm 
- At 14 hours surface roughness had 
no effect. 
- Calcium had inconsistent effects. 
- The species model used affected 
results 
(Al-Radha et al., 
2012) 
1) Polished titanium (0.043 µm) 
2) Polished zirconia (0.038 µm) 
3) Ti blasted with zirconia (0.158 
µm) 
4) Ti blasted w zirconia + acid etched 
(0.15µm) 
6 hours 
S. mitis and  
P. nigrescens 
CLSM 
SFE plays a major role in determining 
biofilm formation on smooth surfaces 





(Duarte et al., 
2009b) 
Before treatment: 
Smooth (0.2 µm) 
SLA (0.71 µm) 
 
After treatment (metal curettes / air-
powder system): 
Smooth (0.38 µm/ 0.2 µm) 
SLA (0.73 µm/ 0.7 µm) 
16 hours 
S. sanguinis Culture 
Controversial. Before treatment 
rougher surfaces had more biofilm. 
 
After treatment, all surfaces had the 
same biofilm irrespective of 
roughness 
(Badihi Hauslich 
et al., 2013) 
1) Machined (turned) 
2) Dual acid-etched 
3) Acid etched/ sandblasted 
 
+/- Coating by human serum albumin 
or fibronectin 
 
+/- Pretreatment with Ca++ or K 
Overnight 
 
S. mutans (S.m) 
P. gingivalis (P.g) 




Rougher surfaces had more biofilm. 
Albumin 
↓S.m (no effect on P.g or F.n) 
Fibronectin 
↑ P. g and F.n (no effect on S.m) 
Calcium 




Flores et al., 
2012) 
1) Grade II titanium (Sa < 0.2µm) 
2) Acid-etched (Sa 0.8µm) 
3) Modified (hydrophilic) acid-etched 
4) Sandblasted/ acid-etched (SLA) 
(Sa 3.2) 
5) Modified (hydrophilic) SLA 
24 hours 





P. intermedia,  







Differences in biofilm could not be 




(Lin et al., 2013) 
1) Pickled Ti surface (Sa 0.3 µm) 
2) Sandblasted acid etched (Sa 1.4 
µm) 
 




1) Resazurin  
2) Culture 
Surface roughness had no influence 
on amount of biofilm formed at either 
time points. 
(Yoshinari et al., 
2001) 
Same as their previous study 
 
48 hours 





Only fluoride implanted specimens 
exhibited antibacterial activity against 
both Aa and Pg 
(Drake et al., 
1999) 
3 Roughness Values 
a) Diamond paste 1um 
b) 800 grit silicon carbide sandpaper 
c) Sandblasted 
Acid 
a) Acid passivated 
b) Non-acid passivated 
Sterilization 
a) UV light 
b) Steam autoclaving 
c) Ethylene oxide gas 






- Greater adhesion on rougher 
surfaces. 
- Less adhesion on hydrophilic 
surfaces. 
- Autoclaving increased biofilm on all 
surfaces. 
-  Effect of hydrophilicity was more 
important than roughness 
(Pereira da Silva 
et al., 2005) 
1) Machined titanium (0.17 µm) 
2) Blasted titanium (1.14 µm) 












Table 4 Summary of in vivo studies of biofilms on implant surfaces (sorted according to incubation time) 
Author 
Surfaces tested  
(Roughness value Ra except if stated) 
Duration  Method Results 
(Nakazato et al., 
1989) 
1) Single crystal alumina (0.09µm)  
2) Polycrystal alumina (0.854µm) 
3) Partially stabilized zirconia (0.369µm) 
4) Hydroxyapatite (0.518µm) 
5) Pure titanium (0.142µm) 





At 4 hours biofilm formation tended to be 
affected by surface roughness rather than 
surface free energy.  
 
At 48 hours there was no significant 
difference.  
(Schwarz et al., 
2007a) 
a) Polished (0.04 µm) 
b) Acid-etched (0.83 µm) 
c) Modified acid etched 
d) Sandblasted acid etched (3.22 µm) 





stain + digital 
camera  
Hydrophilicity had no effect, while 
microtopography had an uneven and 
unpredictable influence  
(Burgers et al., 
2010) 
1) Pure titanium (0.15 µm) 
2) Textured titanium (0.95 µm) 
12 hours 
1) Alamar blue/ 
Resazurin  
2) CLSM 
7.7 fold biofilm increase on rougher 
surfaces 
(Rimondini et al., 
1997) 
a) 0.088 µm 
b) 0.2 µm  




More biofilm on roughest (2.1) compared 
to the smoothest (0.088), but not when 
groups a) & b) were compared or when b) 
and c) were compared 
(Rasperini et al., 
1998) 









2) Direct bacteria 
count 
No differences in bacterial adhesion.  
Maximum amount of colonization was 
achieved after 24 h and counts remained 




(Al-Ahmad et al., 
2010) 
1) Machined titanium (54nm) 
2) Modified titanium (TiUnite) (544nm) 
3) Modified zirconia (ZiUnite) (488nm) 
4) Machined alumina-toughened zirconia 
(21nm) 
5) Sandblasted alumina-toughened 
zirconia (275nm) 
6) Machined zirconia (129nm) 
7) Bovine enamel (14nm) 
3 days 
5 days 
FISH and CLSM 
With the exception of machined titanium 
(hydrophobic), biofilm was correlated 
with surface roughness at 3 days.  
 
At 5 days ! no differences 
 
Streptococci were the main component of 
the biofilm 
(Elter et al., 
2008) 
1) Untreated titanium (0.2 µm) 
2) Ground (0.3 µm) 
3) Acid etched (0.4 µm) 
4) Sandblasted (0.9 µm) 
14 days SEM 
Controversial: 
Supragingivally sandblasted more biofilm 
than the rest, but no difference between 
the other groups. 
Subgingivally no difference between any.  
(Quirynen et al., 
1993) 
1) Standard abutment (0.35 µm)  










sis & culturing 
 
When plaque was collected with paper 
points, only minor differences were found.  
 
When the microbiota adhering to the 
abutment were considered, rough surfaces 








(Quirynen et al., 
1996a) 
1) Standard Brånemark abutment (0.21 
µm) with a relatively smooth surface 
2) A machine-polished abutment (0.11 
µm) 
3) A machine-polished and 
electropolished abutment (0.13 µm) 






- No difference (quantitatively or 
qualitatively) between plaque build up, 
supra (curettes) or subgingivally (paper 
points). 
 
- Threshold roughness 0.2 µm proposed 
 
(Bollen et al., 
1996) 
Overdenture abutments 
- Titanium smooth (0.2 µm) 






No difference  






The limited data available does not show any evidence that a particular surface has a 
greater risk of developing peri-implantitis.  1.3.3.1  HUMAN+STUDIES+
A retrospective controlled trial comparing turned machined (Brånemark) surfaces and 
rough TPS (Straumann) surfaces showed an increased risk of peri-implantitis for TPS 
implants in comparison to turned implants. Peri-implantitis was seen in seven out of 77 
TPS implants, one of which subsequently failed completely at 12 months and another at 
three years (Astrand et al., 2004a). However other studies failed to detect an increased risk 
of peri-implantitis for rougher surfaces (Astra TiOblast and Biomet 3i fully dual acid 
etched) when compared to smoother turned surfaces (Astra turned and Biomet hybrid dual 
acid etched respectively) (Astrand et al., 2004a, Zetterqvist et al., 2010). 
1.3.4  ANIMAL+STUDIES+(LIGATURE3INDUCED+PERI3+IMPLANTITIS)+
All existing animal studies have used the ligature-induced peri-implantitis model in dogs. 
The design of these studies has changed after 2008 so that the hard tissue destruction that 
occurs after, not before the ‘‘active breakdown phase induced by the ligatures’’ is 
considered the starting point of the observation period. The ‘‘spontaneous progression’’ and 
plaque accumulation that occurs from thereon (plaque accumulation period) is considered a 
more valid representation of the naturally occurring peri-implantitis (Lang et al., 2011).  
Out of four implant surfaces tested in dogs  (Nobel TiUnite, Astra TiOblast, Biomet 3i 
turned, Straumann SLA), progression of peri-implantitis was significantly more 
pronounced clinically and histologically on the TiUnite surface, which is an anodized 
moderately rough surface (Albouy et al., 2008). In another study, there was increased bone 
loss radiographically and inflammatory cell infiltrate histologically with SLA surfaces 
compared to turned surfaces (both Straumann) suggesting a greater risk of peri-implantitis 






Based on our understanding about the aetiopathogenesis of peri-implantitis, different 
treatment methods have been proposed. Most of these are empirical recommendations and 
there is limited evidence to suggest superiority of one treatment modality over the other.  
However the general agreement is that it is essential to remove the plaque biofilm and 
maintain a biofilm-free surface (Subramani and Wismeijer, 2012). 
The methods that have been proposed to achieve this include: 
• Mechanical debridement (curettes, ultrasonic devices, air-polishing devices) 
• LASER treatment (e.g. CO2, ER:YAG)  
• The use of chemical and antimicrobial agents (eg. chlorhexidine, hydrogen 
peroxide, citric acid, local and systemic antibiotic therapy) 
• Surgical procedures. These involve open flap debridement to enable improved 
access to the implant surface in order to debride it effectively (using one of the 
methods mentioned above) and establish a plaque-free surface. Surgical 
procedures are usually accompanied by tissue resective or bone regenerative 
procedures in order to facilitate improved oral hygiene for the patient.  
In addition the following factors have been included: 
• Smoothening the implant surface to eliminate microbial retentive factors 
(implantoplasty) (Romeo et al., 2007). 
• Adjusting, if necessary, the prosthesis to allow proper oral hygiene.  
• Reinforcement of oral hygiene instructions, continuous maintenance and supportive 
peri-implant therapy. 
In many cases, more than one of these methods have been combined and the amount of 




The cumulative interceptive supportive therapy (CIST) is a strategy that has been proposed 
to manage peri-implant diseases (Figure 2). This protocol relies on periodic assessment of 
probing pocket depth (PPD), bleeding on probing (BOP), presence of suppuration, and, if 
indicated, radiographic evaluation. It includes four treatment modalities: A = mechanical 
debridement; B = antiseptic treatment; C = antibiotic treatment; and D = regenerative or 
resective surgery and is cumulative in nature, meaning that according to the score obtained 
from the diagnosis, the patient receives the treatment for that score in addition to those for 
the previous codes (Lang et al., 2000).  
 
Figure 2 Decision tree for cumulative interceptive supportive therapy (CIST). Depending on 
the mucosal condition, probing depth and bone loss, either A, A+B, A+B+C, or A+B+C+D is 
performed. A: Mechanical debridement; B: antiseptic cleaning; C: antibiotic therapy; D: 
resective or regenerative surgery. Adopted from Lang et al. (Lang et al., 2000). 
!
A helpful set of guidelines for the treatment of peri-implant diseases have also been 
developed and published by the Association of Dental Implantologists, UK (ADI). The 
algorithms for the non-surgical and surgical therapeutic approaches can be found in 





The available literature suggests that a non-surgical approach to peri-implantitis, although 
unpredictable could be beneficial as a first line of treatment before attempting a surgical 
approach, and various methods have been advocated with no definitive gold standard e.g. 
manual and ultrasonic debridement, air polishing/abrasion, laser, photodynamic therapy, 
saline and the application of various medications (e.g. topical antibiotics) and chemical 
agents (e.g. citric acid, hydrogen peroxide, chlorhexidine, etc.) (Lindhe et al., 2008). 1.4.1.1  MANUAL+DEBRIDEMENT+
Hand instruments made of titanium or ceramic materials and ultrasonic tips with plastic, 
teflon or carbon fibre coatings have been specifically developed for the mechanical 
debridement of dental implants (Renvert and Giovannoli, 2012). Some authors have 
questioned the efficacy of these different materials while others have advised against using 
instruments softer than titanium to avoid remnants of the instrument remaining on the 
implant surface and acting as a foreign body (Augthun et al., 1998).  
Furthermore, studies such as those conducted by Karring et al. (Karring et al., 2005) and 
Renvert et al. (Renvert et al., 2009) concluded that there were no differences in the 
treatment outcomes clinically and microbiologically using specifically developed tips such 
as the vector system (an ultrasonic device with a carbon fibre tip combined with an aerosol 
spray of hydroxyapatite particles) and traditional manual debridement using carbon fiber 
curettes or titanium curettes respectively.  1.4.1.2  AIR+–+POLISHING+AND+ABRASION+
The most commonly used mechanical method to debride implant surfaces and remove the 
plaque biofilm is to use manual or ultrasonic scalers. However accessibility problems in 
addition to the inherent difficulties for implant debridement imposed by implant threads 
and surface roughness may hinder effective cleaning of implants. Air polishing devices 
(APDs) may overcome some of these difficulties if direct access to the surface cannot be 
achieved. 
These devices have already been shown to be a viable treatment option in periodontal 




significantly more comfortable than scaling with curettes (Moene et al., 2010, Petersilka et 
al., 2003b, Petersilka et al., 2003c). 1.4.1.3  LASER+THERAPY+
Laser decontamination is based on its thermal effect, which denatures proteins and causes 
cellular necrosis (Kreisler et al., 2002). Among the lasers employed, the Er:YAG laser is 
considered to possess the best properties for both degranulation and implant surface 
decontamination. It has been shown to be effective for biofilm removal, having bactericidal 
effects, which do not damage implant surfaces (Schwarz et al., 2005b). However clinical 
studies using lasers for the treatment of peri-implantitis have failed to demonstrate any 
significant improvement in outcomes when compared to manual debridement (Schwarz et 
al., 2005c) or to air-polishing devices (Renvert et al., 2011).  1.4.1.4  PHOTODYNAMIC +THERAPY+
Photodynamic therapy is a technique based on marking the bacterial wall with a light 
sensitive dye (phenothiazine chloride), which when irradiated with laser (wavelength of 
660 nm) produces cytotoxic singlet oxygen, which is able to destroy bacterial cells. Schär et 
al. (Schar et al., 2013) compared locally administered minocycline microspheres (Arestin) 
and photodynamic therapy (HELBO) in the treatment of initial peri-implantitis (PPD 4-6 
mm) and did not find that using photodynamic therapy achieved any superior results. The 
initial debridement protocol in both groups involved the use of titanium curettes, glycine-
based air-powder abrasion, and irrigation using 3% hydrogen peroxide followed by 
photodynamic therapy in one group and minocycline in the control group. Both treatments 
led to clinical improvement with comparable results.  
 1.4.2 SURGICAL+TREATMENT+OF+PERI3IMPLANTITIS+
Limited accessibility and visibility of implant surfaces may in part explain why non-
surgical therapy has been associated with limited success, thus access surgery combined 
with implant surface decontamination is generally advocated in order to achieve complete 
removal of granulation tissue. Nevertheless, the evidence available for long-term treatment 




1.4.2.1  ACCESS +SURGERY+
Maximo, Duarte and de Mendonca (de Mendonca et al., 2009, Duarte et al., 2009a, 
Maximo et al., 2009) published a series of short-term (3 – 12 months) observations on 
treatment of peri-implantitis using access surgery without the use of antibiotics. Their 
decontamination method consisted of mechanical debridement using curettes followed by 
sodium bicarbonate air abrasion. This resulted in a significant reduction of microbiota, a 
reduction in TNF alpha levels in the peri-implant crevicular fluid and improved clinical 
parameters.  1.4.2.2  APICALLY+REPOSITIONED+FLAP+SURGERY+
A randomized comparative clinical trial (Romeo et al., 2005, Romeo et al., 2007) suggested 
that resective surgical procedures coupled with implantoplasty could be an effective 
treatment for rough-surface implants affected by peri-implantitis. 
The study by Serino and Turri (Serino and Turri, 2011) also reported on the outcome of a 
resective surgical procedure that included pocket elimination and bone 
recontouring.  Despite treatment, a total of 36 implants (42%) out of the 86 with initial 
diagnosis of peri-implantitis presented with peri-implant disease two years later. It was 
concluded that disease resolution depended on the initial bone loss where implants with no 
signs of peri-implantitis following treatment tended to remain healthy during the 2-year 
follow up period, while disease progression was observed for the implants that still showed 
signs of peri-implant disease following treatment. 1.4.2.3  THE+ADJUNTIVE+EFFECTS +OF +BONE+GRAFTS +WITH+AND+WITHOUT+MEMBRANES+
The consensus report of the sixth EWOP states that currently there seems to be no evidence 
that ‘regenerative procedures’ [bone grafts/ substitutes, guided bone regeneration (GBR)], 
performed in implant sites with bone craters, have additional beneficial effects on treatment 
outcome (Lindhe et al., 2008) and although they may be efficacious for the treatment of 
peri-implantitis lesions, it must be stressed that such techniques do not address disease 




The following is a review of case series and randomized controlled trials that have 
evaluated regenerative treatment of peri-implantitis using a) grafts without membranes and 
b) grafts with membranes. 
A)#WITHOUT#MEMBRANES#
Behneke et al. (Behneke et al., 2000) treated 25 implants in 17 patients using an air-powder 
abrasive, autogenous bone grafts, and systemic metronidazole. A positive result of the 
reconstructive therapy was observed during a re-evaluation period of up to 3 years. Median 
marginal bone loss was reduced from 5.3 to 2.3 mm. A radiographic median marginal bone 
gain of 4 mm was reported at 12 months. Complications occurred in 2 cases and not all 
implants were followed for the 3 years.  
Roccuzzo and co-workers (Roccuzzo et al., 2011) evaluated a regenerative surgical 
treatment modality for peri-implantitis lesions on two different implant surfaces, TPS and 
SLA. In 26 patients, implant surfaces were mechanically debrided with a plastic curette and 
treated using a 24% EDTA gel and a 1% chlorhexidine gel and antibiotics. The bone defect 
was filled with a bovine-derived xenograft and the flap was sutured around the non-
submerged implant. One-year follow-up demonstrated clinical and radiographic 
improvements in which pocket depths were reduced by 2.1 mm at implants with a TPS 
surface and 3.4 mm at implants with a SLA surface whereas mean BOP decreased from 
91% to 57% (TPS) and from 75% to 15% (SLA). Complete defect fill was not found 
around TPS surfaces, while it occurred in 3 out of 12 SLA-surface implants. Four of the 26 
patients had implants with suppuration and two of them were removed after 12 months. 
Wiltfang and colleagues (Wiltfang et al., 2012) studied the effect of regenerative treatment 
on peri-implantitis in 36 implants using a mixture (1:1) of autologous bone and a 
demineralized xenograft with growth factors. After resolving the acute infection by local 
rinsing, granulation tissue was removed. The implants were decontaminated with etching 
gel and the defects were filled with the bone mix and systemic antibiotics were prescribed. 
One year evaluation after treatment revealed a mean reduction of 4 mm in PPDs and a 
mean 3.5 mm gain in bone height. Regarding the implants in which the therapy did not 
work, 7 implants had PPDs greater than 4 mm, three implants had bone defects greater than 





The most common complication that was observed when using membranes in the following 
studies was membrane exposure. The submerged approach was used in half of these studies 
in order to allow for undisturbed healing and to reduce the risk of infection. 
Froum et al. (Froum et al., 2012) evaluated a regenerative approach which included surface 
decontamination, the use of enamel matrix derivative, a combination of platelet-derived 
growth factor with anorganic bovine bone or mineralized freeze-dried bone, and finally 
coverage using a collagen membrane or a subepithelial connective tissue graft. The results 
from 3 to 7.5 years follow up showed mean P.D. reduction of 5 mm and bone gain of 3 
mm. Nevertheless, six out of 38 patients required two to three surgical procedures to 
achieve the required outcome.  
Romanos and Nentwig (Romanos and Nentwig, 2008) used the CO2 laser to decontaminate 
failing implants in 15 patients (19 implants). Augmentation with autogenous bone grafting 
material or xenogenic bone bovine grafting material was used and covered with a collagen 
membrane. A 3.5 mm mean P.D. reduction was observed and radiographic bone fill varied 
from partial fill for the autogenous grafted sites to complete fill with the xenograft. Deppe 
et al. (Deppe et al., 2007) also tested CO2 laser therapy in a randomized control trial (32 
patients, 73 implants) in which conventional decontamination was compared to CO2 laser 
decontamination after surgical access was achieved. Augmentation with a mixture of 50:50 
autogenous bone and beta tri-calcium phosphate was used and covered with a 
nonresorbable Gore-Tex membrane. Improved clinical results were reported and laser did 
not yield additional beneficial effects results compared to conventional decontamination. 
Conversely, Schwarz and co-workers (Schwarz et al., 2011, Schwarz et al., 2012) compared 
decontamination using (1) Er:YAG laser and (2) plastic curettes, followed by cotton 
swabbing with pellets soaked in saline. Following access surgery, granulation tissue 
removal and implantoplasty, the implants (24 implants, 26 patients) were randomly 
subjected to the decontamination method chosen and then the intrabony defects were 
augmented with a bovine xenograft and covered with a collagen membrane. Clinical 
parameters were recorded at baseline and after 6 and 24 months of non-submerged healing. 
The decontamination method used for surface debridement seemed to be of subordinate 




PPD were reduced by an average of 2 mm and BOP sites were reduced from 80% to 
approximately 30%.  
Roos-Jansåker et al. (Roos-Jansaker et al., 2007) augmented the defects using a bone 
substitute (Algipore®), covered with a resorbable synthetic membrane (Osseoquest) after 
granulomatous tissue was removed and the implant surface was treated using 3% hydrogen 
peroxide. Systemic amoxicillin plus metronidazole was prescribed for 10 days and 
submerged healing was allowed for 6 months. 1 year follow up showed mean reduction of 
P.D. of 4 mm and bone fill of 2.3 mm.  
In a study by Schwarz et al., the healing of intrabony peri-implantitis defects following the 
application of a nanocrystalline hydroxyapatite or a bovine-derived xenograft in 
combination with a collagen membrane was evaluated. Results showed that both treatments 
improved clinical conditions at 6 months (Schwarz et al., 2006a). However, 2 and 4-year 
published results (Schwarz et al., 2008, Schwarz et al., 2009b) reported greater reductions 
and clinical attachment level gains in the group treated with xenogenic bone mineral and 
covered with a collagen membrane. Furthermore, another study by the same authors 
indicated that circumferential intrabony defects showed greater healing potential than 
circumferential or semi-circumferential lesions with a buccal dehiscence (Schwarz et al., 
2010). 
The following two randomized controlled trials have compared surgical techniques that 
have used bone grafts only to those that have used bone grafting in addition to membranes. 
They concluded that the addition of membranes did not provide any additional effects.  
Khoury and Buchmann (Khoury and Buchmann, 2001) evaluated the outcomes of three 
regenerative treatment protocols for peri-implantitis. In 25 patients, 41 peri-implant defects 
were treated with either flap surgery plus autogenous bone graft alone (n = 12); autogenous 
bone graft plus non-resorbable ePTFE membranes (n = 20); or autogenous bone graft plus 
resorbable membranes (n = 9) and systemic antimicrobials. Granulomatous tissue was 
removed and implants were rinsed with 0.2% chlorhexidine gluconate, citric acid, H2O2, 
and 0.9% saline. Three-year radiographic evaluation showed a mean bone gain in all 
treatment groups. The differences between the three surgical treatment protocols were not 




Similarly, Roos-Jansaker et al. (Roos-Jansaker et al., 2007, Roos-Jansaker et al., 2011) 
compared using a bone substitute (Algipore®) with a resorbable membrane to using the 
graft alone to fill the defects. Granulomatous tissue was removed using titanium curettes, 
the infected implant was cleansed using hydrogen peroxide (3%), followed by profuse 
rinsing with saline and the patients were ascribed to one of both groups and antimicrobials 
were prescribed. Again the use of membranes was accompanied with greater complications 
and did not improve outcome results.  1.4.3 ADJUNCTIVE+ANTBIOTIMICROBIALS+
Although several anti-infective treatment strategies have demonstrated beneficial clinical 
effects in humans, such as resolution of inflammation, decrease in probing depth and bone 
gain, there is insufficient evidence to support a specific treatment protocol (Klinge et al., 
2002).  
In addition, no clinical studies are available on the effects of antibiotics or antiseptic agents 
as the sole therapy for the treatment of peri-implantitis. In all clinical trials, administration 
of either antibiotics and/ or antiseptics is always combined with either non-surgical or 
surgical interventions. This leaves the question unanswered as to what extent antibiotics 
and antiseptic agents, delivered systemically or locally, add to the clinical outcome of the 
treatment and thus both these adjunctive agents will be considered together in the following 
review.  1.4.3.1  NON3SURGICAL+THERAPY+AND+ANTIMICROBIALS+
A study by Mombelli et al. (Mombelli and Lang, 1992) documents the clinical and 
microbiological effects of mechanical debridement in conjunction with systemic antibiotics. 
After mechanical debridement, peri-implant pockets were irrigated with 0.5% 
chlorhexidine. Subsequently, systemic ornidazole (1000 mg daily) was administered for 10 
days and patients were instructed to irrigate all deep pockets. Significant reduction of PPD, 
BOP and anaerobic microflora was observed during the 12 months monitoring period and 
in some lesions, bone fill was also noted.  
Büchter et al. (Buchter et al., 2004) compared manual debridement (plastic scaler and 




local delivery of 8.5% doxycycline hyclate gel (Atridox) in patients who lost at least 50% 
of the bone around implants (i.e. severe forms of peri-implantitis). After 4 months, both 
groups showed clinical improvements, however mean probing attachment levels improved 
by 0.61 mm and PPD were reduced by a mean of 0.59 mm in favour of the antibiotic group.  
Renvert et al. (Renvert et al., 2004) compared manual debridement using a plastic scaler 
and application of chlorhexidine gel to debridement using a plastic scaler and local delivery 
of minocycline HCl (Arestin). They did not find any significant differences between both 
treatments. They conducted another study (Renvert el al., 2006) in which the same 
treatments were repeated at 30 and 90 days. Again, no significant differences between 
groups could be observed, but the antibiotic group consistently showed marginal 
improvements.  1.4.3.2  SURGICAL+THERAPY+AND+ANTIMICROBIALS+
In a case series report by Leonhardt et al. (Leonhardt et al., 2003) the long-term outcome of 
access surgery was evaluated in 9 patients (26 implants). Implant surfaces were 
decontaminated with H2O2 and systemic antibiotics were prescribed. Results were 
somewhat poor where resolution of the peri-implant disease was obtained in only 58% of 
the implants, seven implants were lost and four others continued to lose bone during the 5-
year follow-up period.  
Heitz-Mayfield et al (Heitz-Mayfield et al., 2012) evaluated access surgery and implant 
surface cleaning with titanium-coated curettes and by rubbing with gauze soaked in saline, 
plus prescription of systemic amoxicillin and metronidazole in 24 patients (36 implants) 
who presented with moderate to advanced peri-implantitis. At 12 months, all treated 
implants had PPD < 5 mm and 47% of the implants had no BoP. 92% of the patients had 
stable crestal bone levels or bone gain and only three implants in three patients had bone 
loss.  
In summary, the optimum treatment modality for peri-implantitis remains unknown. Non-
surgical therapy appears to be insufficient and surgical therapy is generally advocated. 
Adjunctive chlorhexidine application had only limited effects on clinical and 
microbiological parameters, whereas adjunctive local or systemic antibiotics were shown to 





Whether or not a surgical or non-surgical, regenerative or resective approach is followed, 
removal of the biofilm and decontamination of the implant surface remains a necessity. The 
objective is to eliminate infection and resolve inflammation, rendering the surface 
conductive to bone regeneration and ideally re-osseointegration. Currently the use of 
abrasive air powder seems to provide sufficient implant detoxification and is a promising, 
economical and accessible method (Meyle, 2012), which will be discussed in detail in the 
following review. 1.4.4.1  POWDERS+USED+ IN +AIR +POLISHING+DEVICES+
1)#SODIUM#BICARBONATE#
Sodium bicarbonate has generally been the most popular polishing powder used for this. In 
vitro studies indicate that they may also be potentially useful for the treatment of peri-
implant infections. Using SEM, it was shown that the most efficient treatment that yielded 
a completely plaque-free surface on all implants regardless of their surface characteristics 
was sodium bicarbonate air-powder spray, whereas plastic curettes yielded only a partial 
removal of the biofilm layer since it was not possible to remove plaque from the depths of 
the implant threads, and the least effective was chlorhexidine 0.1% (Augthun et al., 1998).  
The same findings were confirmed in another study, in which 100% of bacteria were 
removed from implants with titanium plasma sprayed surfaces subjected to air-powder 
blasting with sodium carbonate (Parham et al., 1989). Moreover, 3 surfaces with different 
surface roughness (Ra = 0.17 µm, 1.14 µm and 3.17 µm) with an in vitro biofilm 
containing an average of 103, 104 and 105 of S. sanguinis cells showed a completely cell 
free surface after being blasted for one minute with a sodium bicarbonate air abrasion 
device (Pereira da Silva et al., 2005). Similarly, implants coated with P. gingivalis 
endotoxin were more effectively cleaned with sodium bicarbonate air polishing compared 
to burnishing with distilled water, chlorhexidine or citric acid (Dennison et al., 1994).  
Although it has been documented that sodium bicarbonate is highly abrasive to root 
cementum or dentin (Petersilka et al., 2003a) similar effects were not observed on titanium. 
The literature indicates that sodium bicarbonate air-polishing does not lead to significant 




(Chairay et al., 1997, Augthun et al., 1998, Mengel et al., 1998). Only minor alterations 
were observed in surface topography of plasma sprayed implants that consisted of rounding 
of angles and edges of the plasma-spray coating and occasional surface pitting (Augthun et 
al., 1998, Parham et al., 1989). This was also the case with surface changes documented 
microscopically on sandblasted acid-etched surfaces, where sharped-edged elevations were 
markedly flattened and smoother after 40 seconds (Schwarz et al., 2009a) and 60 seconds 
of blasting (Kreisler et al., 2005). On machined implants however, Augthun et al. reported 
no surface alterations after 60 seconds treatment with sodium bicarbonate, whereas Duarte 
et al. (Duarte et al., 2009b) observed minute crater-like defects on smooth surfaces as a 
result of the powder crystals hitting the implant surfaces.  
A clinical study has shown that surgical treatment of peri-implantis which included 
mechanical removal of the biofilm using carbon curettes followed by sodium bicarbonate 
air abrasion was effective in reducing pocket depths by an average of 3 mm and reducing 
levels of T. denticola, T. forsythia, P. micra, and F. nucleatum ss. nucleatum when 
evaluated three months after treatment (Maximo et al., 2009). 
Nevertheless, with a mean particle size of 75 µm and density of 2.16 g/cm3, the use of 
sodium bicarbonate subgingivally has not been recommended because of its abrasiveness 
and potential risk of soft tissue trauma (Kozlovsky et al., 2005).  
2)#GLYCINE#POWDER#
Recently, glycine has been proposed as an alternative to the traditional sodium bicarbonate 
powder in order to enable the application of periodontal maintenance subgingivally without 
inducing substantial soft and hard tissue damage.  
Glycine (greek = sweet) is a nonessential amino acid and an important component of most 
polypeptides that has very low toxicity, is non-allergenic and has a light, sweet taste and is 
thus commonly used in the food industry as a flavour enhancer. Glycine is odourless, 
colourless and is highly water-soluble making it suitable for intra-oral use. Previous studies 
have characterized these powder particles as having an average size of ~25 µm which is 
approximately four times smaller than that of conventional sodium bicarbonate powder 
(Schwarz et al., 2009a). This powder has a lower density (1.61 g/cm3) than sodium 




et al., 2007). This was demonstrated on titanium implant surfaces, where it was shown that 
40 seconds of treatment did not affect the surface topography under the scanning electronic 
microscope  (Schwarz et al., 2009a). In a comparative study, 10 different instruments which 
were manual plastic curettes, manual carbon curettes, polishing cups, prophylaxis brushes, 
an ultrasonic scaler with a either a plastic tip or a carbon tip, an air scaler with a plastic tip, 
an ER: YAG laser, the vector system, and air-polishing with glycine were assessed for their 
effectiveness in the removing a 3-day in vitro S. mutans biofilm from 4 different titanium 
surfaces. Air polishing with glycine delivered the cleanest surfaces with the least surface 
alterations compared to all the other cleaning methods assessed (Schmage et al., 2012). 
Schwarz et al. (Schwarz et al., 2009a) have demonstrated it’s efficiency in removal of 
biofilms from sandblasted acid etched titanium surfaces, by measuring the amount of 
residual stained biofilm, using a software programme to analyze digital images obtained 
using a light microscope and found that the biofilm remaining after blasting was within the 
range of 0.0% ± 0.0% to 5.7% ± 5.7%. According to these findings and compared to other 
studies by the same authors in which biofilm removal was assessed using the same splint 
system, air-powder systems were more efficient than irradiation with an Er:YAG (5.8% ± 
5.1%), or an Er,Cr:YSGG laser (9.8% ± 6.2% to 53.8% ± 2.2%), the application of 
modified ultrasonic devices (28.3% ± 2.0% to 36.8% ± 4.5%), or plastic curettes in 
combination with chlorhexidine (58.5% ± 4.9% to 61.1% ± 11.4%) (Schwarz et al., 2006b, 
Schwarz et al., 2005a, Subramani and Wismeijer, 2012). 
In a similar study, but using a clinically more comparable model, Sahrmann and co-workers 
(Sahrmann et al., 2013) investigated the efficiency of air polishing with glycine to remove 
biofilms from implants that were embedded in acrylic models that simulated different peri-
implant defect morphologies. They used a permanent marker to resemble the presence of 
biofilm and the amount of residual biofilm after blasting was assessed using digital images 
and a specifically designed computer software. Comparisons were made between cleaning 
efficiency on coronally facing threads, apically facing threads and perpendicular to the 
implant surface and revealed that especially in narrow defects and in areas with 
compromised accessibility such as apically facing threads, it was not possible to completely 
remove the plaque biofilm, while cleaning efficiency was improved the wider the defect. 




reasonable technique for biofilm removal in areas that would be difficult to reach by 
conventional mechanical means (i.e. manual or ultrasound curettes). The cleaning observed 
on the apical threads was attributed to the ricochet effect, which produces a radial corona of 
secondary jets in addition to the central beam of the air-flow device, parallel to the surface 
to be treated and contributing to its efficiency.  
A randomized control trial with a split mouth design that included 27 patients indicated that 
subgingival plaque removal using glycine powder in pockets of 3 – 5 mm resulted in a 
significantly greater reduction in sub- gingival bacterial counts and was more comfortable 
for patients than hand instrumentation (Petersilka et al., 2003b). 
Another trial with 50 patients confirmed that air polishing with glycine was indeed more 
comfortable and quicker in subgingival biofilm removal than hand or ultrasonic scalers in 
periodontal pockets with probing depths (PDs) ≥ 5 mm, but a more pronounced reduction 
in total bacterial counts and specific bacterial strains was observed with conventional SRP 
using curettes compared to those with air-polishing and hand instrumentation was also 
superior in reducing inflammation as assessed by BOP 7 days after treatments. They 
concluded that air polishing might be useful for periodontal patients with residual pockets 
in the maintenance phase, provided that mineralized deposits are not present; otherwise 
conventional debridement techniques would be necessary beforehand for the removal of 
calculus (Moene et al., 2010).  
The same findings were observed in a pilot clinical study on dental implants in which the 
efficiency of glycine powder air polishing as an adjunct in the treatment of peri-implant 
mucositis was evaluated. 12 patients were treated using an ultrasonic scaler with carbon 
fiber tips and in 12 patients adjunctive glycine blasting was used in pockets ≥ 4 mm. 
Bleeding index and pocket depth reduction were measured at 1 month and 3 months post-
treatment. Results indicated that significant reductions were obtained by both methods, but 
mechanical debridement alone demonstrated greater bleeding reduction after 1 week. This 
may have been caused by the damage to the mucosa from high-pressure glycine slurry. 
Hence, adjunctive glycine polishing seemed to have a limited beneficial effect as compared 
with mechanical debridement alone, but in situations with deep pockets, narrow defects, or 




pathogenic biofilms, air abrasion with glycine might show some additional effects (Ji et al., 
2013). 
Contrary to these findings, a randomized controlled trial assessing the effectiveness of non-
surgical management of moderate peri-implantitis found less bleeding on probing after 6 
months with glycine air polishing compared to mechanical debridement + chlorhexidine 
(43.5 ± 27.7% versus 11.0 ± 15.7% reduction in BOP respectively). In this study, 15 
patients were allocated to receive glycine air polishing and 15 patients were allocated to 
receive manual debridement with carbon curettes supplemented with chlorhexidine 
disinfection. Other clinical parameters that were assessed, which included pocket and 
clinical attachment levels showed limited improvements and were comparable for both 
groups (Sahm et al., 2011). 
42 patients who presented with peri-implantitis were treated non-surgically with either air 
polishing using glycine (21 patients, 45 implants) or ER:YAG laser  (21 patients, 51 
implants). There were no differences in the results for both treatments after 6 months 
follow up. Both treatments showed limited improvement in pocket depths and bone loss, 
but there was a significant decrease in BOP and suppuration, but this could have been 
related to the significant improvement in oral hygiene observed (Renvert et al., 2011). 
3)#BIOACTIVE #GLASS #(BAG)#
BAG is another powder that could be potentially promising for the decontamination of 
implants with peri-implantitis. The original bioactive glass 45S5 composition is made up of 
45% silica (SiO2), 24.5% calcium oxide (CaO), 24.5% sodium oxide (Na2O), and 6% 
phosphorous pentoxide (P2O5) in weight percentages. This powder has a mean particle size 
of 56 µm (Milly et al., 2014). When exposed to body fluids, a series of surface reactions 
occur leading to the development of a silica gel and a calcium phosphate layer on their 
surface. Successively, the calcium phosphate layer will recrystallize into hydroxycarbonate 
apatite, which is a bioactive apatite layer that gives BAG the capability of bonding with soft 
and hard tissues. They also possess osteoinductive properties through the release of ions 
that stimulate osteoprogenitors to differentiate into mature osteoblasts (Hench, 2006). 
Their uses have mainly included bone repair and bone regeneration in maxillofacial and 




1998) that evaluated BAG and compared it to open debridement in the treatment of 59 
periodontal osseous defects in 16 patients, demonstrated that BAG significantly improved 
healing and resulted in significant improvement in osseous defect fill upon re-entry of the 
defect sites at 12 months. There was also greater probing depth reduction and greater gain 
in clinical attachment. 
Bioactive glasses have expressed antimicrobial properties against oral microorganisms in 
vitro (Stoor et al., 1998). In addition, BAG abrasion has been proposed for the removal of 
carious dentine as research has shown it to be more selective than alumina, the most 
commonly used powder in minimally invasive dentistry (Paolinelis et al., 2008). Another 
possibility for intra-oral use that has been explored is the treatment of dentinal 
hypersensitivity where a clinical study has indicated that air-polishing using BAG was 
more effective in desensitizing previously sensitive teeth whilst providing better polishing 
characteristics and greater patient comfort compared to sodium bicarbonate. This was 
evaluated directly after the procedure and 10 days later (Banerjee et al., 2010). 
Research on the incorporation of BAG on titanium has indicated increased bone to implant 
contact after blasting with a mixture of bioceramics in a rabbit model (Mueller et al., 2003). 
In vitro, titanium surfaces that were coated with BAG were effective in stimulating human 
osteoblast growth and differentiation, showing three times more cell proliferation than 
uncoated titanium alloy at 16 days. SEM observations of these BAG coated surfaces 
showed cells that were attached and completely spread (Oliva et al., 1998). Similarly 
another study using a human osteoblast-like cell line (MG63) revealed that Bioglass formed 
a suitable substrate for cell proliferation and function and was comparable to titanium alloy 
(Price et al., 1997). This indicated that BAG had an important potential as an implant 
coating.  1.4.4.2  CONCERNS+ON+USING+AIR3POLISHING+DEVICES + +
In addition to surface alterations and soft tissue trauma, which have been discussed before, 
one of the major concerns of using a high air pressurized device intra-orally and especially 
subgingivally is tissue emphysema. However, only a few cases have been reported in the 
literature, one was in 1988 after routine periodontal maintenance around a molar with 




another was during conservative caries removal using air abrasion (Liebenberg and 
Crawford, 1997) and a third case around implants during regular peri-implant prophylaxis 
(Bergendal et al., 1990). None of the 150 patients treated in the clinical studies described 
previously (125 with glycine and 25 with sodium bicarbonate) developed emphysema.  1.4.4.3  BIOCOMPATIBILITY +OF +TITANIUM+SURFACES +DECONTAMINATED+USING+AIR3POLISIHING+DEVICES + +
Only a few in vitro studies have evaluated cell response and biocompatibility of titanium 
surfaces that have been treated with air-powder polishing devices, however only one has 
used glycine and none have used BAG (Table 5). 
Shibli et al. (Shibli et al., 2003) investigated the effect of air-polishing treatment on the 
biocompatibility of sterile commercially pure titanium abutments (Sterngold, ImplaMed, 
Attleboro, MA, USA). In this study, the abutments were exposed for 30 seconds to sodium 
bicarbonate blasting and then fibroblasts were cultured on them for 24 hours. Cell numbers 
and morphology was assessed via SEM, which indicated lower cell numbers on air-blasted 
surfaces compared to control surfaces. However, no morphological alterations were 
observed on the surfaces.  
The remaining four studies were conducted on implant surfaces that were previously 
contaminated with biofilms and all suggest the biocompatibility of titanium surface 
following air polishing to be high. 
Parham et al. (Parham et al., 1989) did not find any differences in the number of attached 
fibroblasts between plasma-sprayed titanium surfaces subjected to air-powder sodium 
bicarbonate treatment and control surfaces.  
Similar results were observed in another study in which subjects wore stents for 7 days to 
grow biofilms on dental implants. The implants were cleaned using plastic scalers or an air-
powder system using sodium bicarbonate. Fibroblasts were cultivated for 24 hours in vitro 
and cell vitality was assessed using vital staining whereas cell spreading was evaluated 
using SEM. Results showed that implants that were cleaned with the air-powder system 
showed a similar percentage of vital cells compared to the control group of non-




50% reduction in cell numbers and reduced cell spreading. This difference was attributed to 
the differences in cleaning efficiency in favour of the air-powder system (Augthun et al., 
1998).  
Schwarz et al. (Schwarz et al., 2009a) evaluated the influence of different air-abrasive 
powders on cell viability at biologically contaminated dental implant surfaces. In this study, 
intraoral splints were worn to grow an in vivo biofilm on SLA titanium discs (Institut 
Straumann AG, Basel, Switzerland) for 48 h, and were then decontaminated by air 
polishing using different commercial powders, 3 of which were powders containing glycine 
and a fourth containing sodium bicarbonate. Discs were autoclaved, and then SaOs-2 cells 
were cultured for 7 days. Cell viability was quantified using mitochondrial activity and was 
significantly greater on surfaces treated with sodium bicarbonate compared to those treated 
with glycine, however both showed significantly lower cell viability than control sterile 
non-contaminated surfaces. The authors suggested that sodium bicarbonate particles being 
harder and more abrasive induced a minor degree of surface ablation that could have been 
necessary to improve cell viability at biologically contaminated titanium implants.  
To compare between ER: YAG laser and air-powder polishing, Kreisler et al. (Kreisler et 
al., 2005) incubated SLA titanium discs (Friadent GmbH, Germany) with P. gingivalis for 
one hour to form a biofilm, and then discs were subjected to either ER:YAG laser or air-
polishing for 60 seconds, but they did not mention which powder was used. Fibroblast cell 
proliferation was assessed using a colourimetric assay to assess metabolic cell activity at 
12, 24, 48 and 72 hours. Comparisons were also made with cell proliferation on 
contaminated and untreated discs in addition to sterile discs that acted as controls. There 
was no difference in the proliferation rates on both air-powder and Er:YAG laser treated 
surfaces and both were comparable to the controls. On the other hand, a significantly lower 





Study Surfaces Biofilm grown 
Treatment 
method Evaluation method Main findings  
(Shibli et al., 2003) CP Ti No biofilm Sodium bicarbonate SEM – fibroblasts 
Lower cell numbers on air-blasted surfaces 
compared to controls 
(Parham et al., 1989) TPS in vivo  Sodium bicarbonate SEM - fibroblasts 
No difference in cell numbers between air-
blasted surfaces and controls 




Vital staining/ SEM 
fibroblasts 
Similar percentage of vital cells to control 
group.  
Plastic scalers showed 50% decrease in cell 
numbers 
(Kreisler et al., 2005) SLA P. gingivalis 
Air-powder (does 
not mention type) 
ER:YAG laser 
alamarBlue/ 
Fibroblasts No difference in cell proliferation rates 








Controls > sodium bicarbonate > glycine  













The general agreement from early studies seems to be that healthy implants are 
surrounded by a microflora similar to that found around periodontally-healthy teeth, 
consisting primarily of cocci and non-motile rods, a low number of Gram-negative 
anaerobic species and low detection levels of “periodontal pathogens” and spirochaetes 
(Adell et al., 1986, Lekholm et al., 1986a, Bower et al., 1989, Ong et al., 1992, George 
et al., 1994, Mombelli et al., 1987, Quirynen and Listgarten, 1990). On the other hand, 
failing implants have been characterized by a significantly higher proportion of Gram-
negative anaerobic rods, spirochaetes and showed a decrease in coccoid cells 
(Alcoforado et al., 1991, Leonhardt et al., 1999, Mombelli et al., 1987, Listgarten and 
Lai, 1999, Rams et al., 1984). 
Species that appeared to consistently predominate around healthy implants included 
streptococci, Peptostreptococcus, Fusobacteria, Actinomyces and Veillonella species 
(Lekholm et al., 1986b, Mombelli et al., 1987, Maxson et al., 1992). A wide range of 
species has been implicated in implant failure. Fusobacterium species, P. intermedia, 
Wolinella recta (now Campylobacter rectus) and Capnoctyophaga were some of the 
earliest species that were described in relation to failing implants (Mombelli et al., 
1987, Rosenberg et al., 1991, Listgarten and Lai, 1999).  
A few studies reported that A. actinomycetemcomitans, staphylococci and yeasts were 
also detected from around failing implants (Alcoforado et al., 1991, Rosenberg et al., 
1991, Rams et al., 1990), possibly implicating these infrequently observed 
microorganisms in the aetiology of peri-implantitis. However, in most other studies 
these organisms, especially A. actinomycetemcomitans and yeasts could not be detected 
(Tabanella et al., 2009, Papaioannou et al., 1996, Listgarten and Lai, 1999).  
Organisms such as P. gingivalis and C. rectus were rarely detected in earlier studies 
(Mombelli and Mericske-Stern, 1990). This was explained by the fact that most 
examined patients with implants at that time were completely edentulous and it has been 
suggested that patients have significantly fewer ‘periodontopathogens’ when rendered 
edentulous. (Danser et al., 1994), however recent studies have all found these organisms 




2011) proving that it was not true that the microbial load ‘disappears’ following tooth 
extraction. 
It has been accepted that the bacteria associated with implants are related to those 
already resident in the oral cavity, that is the remaining teeth can act as reservoirs for 
the colonization of the subgingival environment around implants in partially edentulous 
patients (Apse et al., 1989, Quirynen and Listgarten, 1990, Quirynen et al., 1996b, 
Papaioannou et al., 1996, Takanashi et al., 2004, Sumida et al., 2002). The exact 
mechanisms by which these peri-implant pockets are colonized are still unclear. 
Recently, the theory of ‘microbial translocation’ has been debated. Evidence has 
emerged to show that there is a significant partitioning between both periodontal and 
peri-implant microbial profiles (Koyanagi et al., 2013, Kumar et al., 2012). Peri-
implantitis appears to be a site-specific infection. This has been supported in many 
studies where healthy implants had a similar microbial profile regardless of whether or 
not the patients had other implants exhibiting peri-implantitis (da Silva et al., 2013, 
Mombelli et al., 1987, Sanz et al., 1990, Hultin et al., 2002). 
After surgical exposure of implants during placement of abutments, rapid colonization 
of the surfaces occurs (van Winkelhoff et al., 2000). It then takes between 13 – 26 
weeks for a stable subgingival microbiota to form around the implants (Quirynen et al., 
2006). Some studies using experimentally induced gingivitis/periodontitis models have 
demonstrated that the progression of disease around implants is accompanied by a 
similar shift in microbiota to that which occurs around teeth. This being highlighted by 
the increase in Gram-negative and strictly anaerobic bacteria (Leonhardt et al., 1992).  
Most of our knowledge regarding the microbial flora surrounding implants have come 
from studies that utilized culture techniques and/ or direct phase contrast microscopy. 
More recently, molecular techniques such as DNA/DNA hybridization, using whole-
genomic and oligonucleotide probes have shown that other bacteria are also found in 
significantly greater numbers in failing implants, namely: P. gingivalis, T. forsythia, T. 
denticola, F. nucleatum ss. nucleatum, F. nucleatum ss. vincentii, E. corrodens, 
Campylobacter sp. and P. micra (Shibli et al., 2008, Papaioannou et al., 1996, 
Tabanella et al., 2009). However most studies have found that the bacteria associated 
with peri-implantitis were also found in healthy gingival crevices without any signs of 
destructive processes (Leonhardt et al., 1993, Quirynen et al., 2006, Shibli et al., 2008, 




marker to predict future disease (Meijndert et al., 2010) and that there were no 
significant correlations between the presence of these bacteria and the histological 
degree of inflammation (Ferreira et al., 2009).  
In conclusion, these findings indicate that the microbial community in peri-implantitis is 
complex. The great variability in study designs, methods used and presentation of data 
might have contributed to some of the conflicting results. Although these studies have 
helped detect the presence of specific target bacteria, they do not describe the true 
diversity and complexity of the peri-implant community.  
Thus the first part of this research was dedicated to identifying the microbial community 
around implants with and without peri-implantitis using an open-ended approach, which 









The aim of this study was to identify and compare the microbiota around dental 
implants with and without a clinical and radiological diagnosis of peri-implantitis.  
Objectives 
1. To examine the microbial diversity in both clinical presentations. 
2. To identify the predominant microorganisms around healthy implants and those 








Ethical approval for the study was obtained from the research ethics committee at 
King’s College Hospital, National Research Ethics Service (LREC Reference Number 
09/ H0808/ 112) 2.3.1 SUBJECT!RECRUITMENT!
Twenty-one subjects presenting with implants in function for at least one year were 
enrolled in this study. The subjects were patients attending Guy’s Hospital either for 
implant maintenance after placement or for treatment of peri-implantitis. Sample 
collection started in March 2010 and was completed by end of July 2012. All subjects 
were partially edentulous and had had fixed restorations, ranging from single crowns to 
full arch screw-retained restorations. The subjects were assigned to two groups: a peri-
implantitis group consisting of 11 patients who had at least one implant showing signs 
of peri-implantitis and a control group which consisted of 10 patients where all implants 
were healthy. This number of subjects was chosen according to a few factors. First, the 
literature was checked to compare how many numbers were reported in other studies. 
Then, preliminary statistical analysis was carried out after 13 patients, results of which 
are discussed in Appendix 2. Finally, recommendations which point out that studies 
with less than 20 patients are of negligible clinical and scientific value were taken into 
consideration. This was to ensure that the study had adequate statistical power to detect 
a clinically relevant risk and to correctly interpret negative results (Needleman et al., 
2012).   
Peri-implantitis was characterized by osseous defects of 3 mm or more from platform 
level (Figure 3), PPDs of 5 mm or more and an inflamed peri-implant mucosa 
exhibiting bleeding on probing and/ or suppuration (Table 6). The study protocol was 
explained to each patient and signed informed consent was obtained. 
The definition of peri-implantitis used in the present study followed the outline 
presented by the sixth consensus report of the EWOP (Lindhe et al., 2008). The other 
reference that was used to classify peri-implantitis in this study was the health scale 
(Table 7) for dental implants, which was devised during the consensus conference of the 




health scale, the definition of peri-implantitis used would fall into groups II (satisfactory 









Figure 3 Mandibular implants showing saucer-shaped osseous defects 
characteristic of the bone loss around implants (radiograph of patient number 1) 
 
Peri-implantitis  Healthy  
Inflamed peri-implant mucosa Healthy peri-implant mucosa 
Bone Loss ≥ 3mm Bone Loss  < 1mm 
Pocket Depth ≥ 5mm Pocket Depth < 4mm 
BOP +/- suppuration +/- BOP 







Health Scale for Dental Implants 
Implant Qual i ty Scale Group Cl in ical Condit ions 
I. Success (optimum health) 
a) No pain or tenderness upon function 
b) No mobility 
c) <2 mm radiographic bone loss from initial surgery 
d) No history of exudate 
II. Satisfactory survival 
 
a) No pain on function 
b) 0 mobility 
c) 2–4 mm radiographic bone loss 
d) No history of exudate 
III. Compromised survival 
 
a) May have sensitivity on function 
b) No mobility 
c) Radiographic bone loss > 4 mm (less than 
1/2 of implant body) 
d) Probing depth >7 mm 
e) May have history of exudate 
IV. Failure (clinical or absolute failure) 
 
Any of following: 
a) Pain on function 
b) Mobility 
c) Radiographic bone loss >1/2 length of implant 
d) Uncontrolled exudate 
e) No longer in mouth 
Table 7 Health Scale for Dental Implants, International Congress of Oral 
Implantologists. Pisa, Italy, Consensus Conference 2007 (Misch et al., 2008) 
 2.3.2 EXCLUSION!CRITERIA!
Patients were excluded if they had taken antibiotics or anti-inflammatory drugs within 
the previous month, had received oral prophylactic procedures (eg. scaling) within the 
past 3 months or had a chronic medical disease or condition that might affect the oral 
flora e.g. diabetes mellitus, oral cancer, HIV infection and those using 
immunosuppressant medications, bisphosphonates or steroids. Also subjects who were 
restored with removable prosthesis, i.e. overdentures and those who smoked more than 






2.3.3 CLINICAL!ASSESSMENT!2.3.3.1  IMPLANT!SELECTION!
In each subject, the implant with the greatest pocket depth was selected for sampling. If 
two or more sites presented with the same pocket depth, the most accessible, usually the 
most anterior, implant was chosen.  2.3.3.2  CLINICAL!AND!RADIOGRAPHIC !EXAMINATION!
Before sample collection, clinical data such as general oral hygiene, presence or 
absence of bleeding on probing around implants and probing pocket depths at 4 sites 
(midfacial, midlingual, mesial and distal) were recorded. If implants showed clinical 
signs of peri-implantitis, the level of bone loss was recorded on the mesial and distal 
surface of the implant using the most recent radiograph in the patient’s records. Bone 
level loss (average of mesial and distal measurements) was measured in millimetres 
between the implant shoulder and the first bone-to-implant contact. If measurements 
were taken from a DPT, a magnification of 1.25x was taken into consideration while 
digital radiographs were calibrated. It must be noted that it was sufficient to determine 
that the bone loss was more than 3mm rather than to accurately measure it. Other data 
were also collected such as medical health, reason for tooth loss, date implants were 
placed and loaded, date peri-implantitis was recorded, smoking status, parafunctional 
habits and the type and dimensions of the implants used. The form used to collect the 
clinical and radiographic data is shown in Appendix 3. 2.3.3.3  SAMPLE!COLLECTION!
Sampling sites were isolated with cotton rolls and the supragingival plaque was 
removed with cotton pellets. Subgingival plaque samples were obtained from the 
deepest parts of the buccal and lingual gingival sulci using a double-ended sterile 
curette (Dentsply, UK). One end was used for the buccal sample and the other for the 
lingual, and then both were pooled in a 7 ml polystyrene bijou bottle (Sterlin, UK) 
containing 1.0 ml of pre-reduced Fastidious Anaerobic Broth (FAB) by vigorously 





2.3.4 MICROBIOLOGICAL!ASSESSMENT!2.3.4.1  PROCESSING!OF !THE!PLAQUE!SAMPLES!
Six sterile glass beads, 2 mm in diameter were added to the transport media containing 
the plaque samples and the samples were dispersed by vortexing for 10 seconds on a 
vortex mixer (Stuart auto vortex mixer, UK). They were then serially diluted from 10-1 
to 10-5 and 0.1 ml aliquots of the ten-fold serial dilutions were plated in duplicates on 
non-selective agar plates: Fastidious Anaerobic Agar supplemented with 5% v/v 
defibrinated horse blood (FAA). The plates were incubated for 5 days at 37ºC in an 
aerobic incubator (LEEC Compact Incubator K2, LEEC, UK) and for 10 days at 37ºC 
in an anaerobic workstation (MACS-MG-1000-anaerobic workstation, Don Whitley 
Scientific, UK) in an atmosphere of 80% N2, 10% CO2, and 10% H2.  
Media used for serial dilutions and plates designated for anaerobic incubation were all 
pre-reduced in the anaerobic workstation for 3 hours.   !2.3.4.2  CALCULATION!OF !COLONY!FORMING!UNITS !(CFUS)!AND!SUBCULTURING!OF !COLONIES!
After incubation, plates with between 30 and 300 colonies were counted and total 
aerobic and anaerobic viable counts expressed as colony forming units (CFU) / sample. 
96 colonies (48 from the aerobically-incubated plates and 48 from the anaerobic plates) 
were then subcultured at random from the plates and incubated for a further 2 days. In 
addition, the colonies were stored in Brain Heart Infusion (BHI) broth supplemented 
with 10% glycerol (weight per volume) at -80ºC.  2.3.4.3  IDENTIFICATION!OF !BACTERIA !USING!16S!RIBOSOMAL!(RRNA)!GENE!SEQUENCING!
a) DNA Extraction 
Colonies were suspended in 50 µl of sterile deionized water in 1.5 ml Eppendorf tubes, 
then vortexed and bacterial DNA was extracted by boiling for 10 minutes at 95°C 
(Microtherm microtube incubator; Camlab, UK) with shaking at 50 rpm to disrupt the 
cells. After that they were cooled on ice for 1 minute, and then centrifuged for another 
minute at 13,000 rpm (Microlite – Thermoscientific, UK). The supernatant DNA was 





b) PCR amplification  
The PCR reactions were performed in sterile 0.2 ml microcentrifuge tubes in a total 
volume of 12.5 µl. The PCR reaction mixture contained 0.5 µl of extracted DNA, 0.25 
µl of each primer (from a stock of 10 pmol/µl) and 11.5 µl of Reddymix (a ready to use 
master mix which contains MgCl2, dNTP (0.2 mM of each), (NH4)2SO4, Tris-HCL, 
Tween® 20, ThermoPrime Taq DNA Polymerase, a precipitant and a red dye for 
electrophoresis).   
PCR amplification of a partial fragment of the 16S rRNA gene was performed using a 
Techne TC – 412 Thermal Cycler (Barloworld Scientific, Stone, Staffordshire, UK). 
The reaction sequence consisted of 34 amplification cycles, each involving dissociation 
of DNA at 94ºC for 30 seconds, annealing of primers at 49ºC for 30 seconds and primer 
elongation at 72ºC for 90 seconds. Initial dissociation of DNA was for 10 minutes at 
94ºC and the final extension was for 5 minutes at 72ºC. 
The primers used for PCR amplification were the universal primers 9F and 907R (Table 
8).  
PCR products were then analyzed by electrophoresis on agarose gels (Sigma) with a 
GelRed™ nucleic acid gel stain (Cambridge Biosciences) in 0.5 x TBE Buffer for 10 – 
12 minutes at 100V and visualized with UV light (Alpha Innotech Fluorchem Light 
Cabinet).  
 
Table 8 Primer Sequences used for PCR  
 
c) Purification and Cleaning of PCR products  
Purification of the PCR products in order to eliminate unincorporated primers and 
dNTPs (deoxynucleotides) was carried out using microCLEAN (Microzone Ltd, UK) 
for the first 7 samples and ExoSAP-IT® (USB, Cleveland, OH, USA) for the rest of the 
Primer name Primer Sequence 
9F 5’- GAGTTTGATCCTGGCTCAG-3’ 




samples. For the former, equal volumes of microCLEAN and the PCR product were 
added together. They were mixed by pipetting and the mixture was left at room 
temperature for 5 minutes then centrifuged at 13000 rpm for 10 minutes. The 
supernatant was carefully removed and the tubes were centrifuged again for a further 10 
seconds at 13000 rpm. Any remaining supernatant was then aspirated and discarded and 
the tubes were placed with lids open for 10 minutes in a vacuum to dry. An appropriate 
amount of sterile distilled water was subsequently added to rehydrate the pellet, the 
amount of which was determined according to the intensity of the band visualized by 
UV light in the previous step. The rest of the samples were cleaned and purified using 
ExoSAP-IT®. This was a simpler and faster method that gave more consistent and 
reliable results. It consisted of adding 2µl of ExoSAP-IT® to 5µl of the PCR product for 
a combined 7µl reaction volume. The mixture was incubated at 37°C for 15 minutes to 
degrade the remaining primers and nucleotides, followed by incubation at 80°C for a 
further 15 minutes to inactivate the ExoSAP-IT®.  
d) Sequencing of PCR products  
The PCR product was then sequenced immediately or stored at -20°C till the next day. 
Sequencing was accomplished using the 9F primer (except for the first sample which 
was also sequenced in both directions using 27F and 1492R), a Big Dye® Terminator 
Cycle Sequencing kit (Applied Biosystems, UK), and a 3730xl ABI Genetic Analyzer 
(Applied Biosystems, UK).  
For each Big Dye Sequencing reaction a mixture of 4 µl of 1:15 dilution of the 9F 
primer (stock is 10 pmol/ µl concentration), 1.75 µl of sterile distilled water, 1.75 µl 
sequencing buffer and 0.5 µl Big Dye (Applied Biosystems) was added to 2.5 µl of the 
cleaned PCR product in a 96-well microtitre plate. After a brief spin at 400 g, the plate 
was placed in a Techne TC – 412 Thermal Cycler (Barloworld Scientific, Stone, 
Staffordshire, UK) and the PCR products were subjected to a cycle of denaturation (96 
°C for 10 seconds), annealing (50 °C for 5 seconds) and extension (60 °C for 2 
minutes). This cycle was repeated 30 times.  
The products were then purified using the Big Dye Terminator clean up method. Ten µl 
of sterile distilled water was added to each well followed by 50 µl of a precipitation 
mixture (made up of 47 µl of 96 % ethanol, 2 µl of a 3 M sodium acetate solution and 1 




temperature for 15 minutes and then centrifuged at 2750 g for 20 minutes at 4 °C 
(Eppendorf Centrifuge 5810 R). The supernatant was discarded by tipping the plate onto 
clean tissue and then by centrifuging the plate upside down on fresh tissue for 2 seconds 
at 400 g. Next, 100 µl of 70 % ethanol was added to the wells and the plate was 
centrifuged at 2750 g at 4 °C for 5 minutes. The supernatant was discarded as described 
before and the plate was placed in a vacuum unsealed for 10 minutes. Finally, 10 µl of 
1/10 TE buffer was added to each well to rehydrate the DNA and the DNA sequences 
were determined using the 3730xl DNA analyzer (Applied Biosystems, UK). 2.3.5 DATA!ANALYSIS!
Most sequences were matched against sequences of reference organisms using the 
Human Oral Microbiome Database (HOMD) extended V1.1 and version 13.2 (Chen et 
al., 2010). In some instances, it was necessary to also compare the sequences to those 
stored in the NCBI sequence database using the BLAST (Basic Local Alignment Search 
Tool) algorithm (Johnson et al., 2008) or to use the Ribosomal Database Project (RDP) 
(http://rdp.cme.msu.edu/seqmatch/seqmatch_intro.jsp).  
Only sequences that were longer than 350 base pairs and had an identity match of 
98.5% or greater were considered in the results. The software BioEdit 7 .2 .5 (Hall, 
1999) was used to edit and analyze sequences. Sequences were aligned with the 
ClustalW multiple alignment application (Thompson et al., 1994) accessed through 
BioEdit and were corrected by manual inspection. Phylogenetic trees were constructed 
using the MEGA 5.2 software (Tamura et al., 2013a) and the Interactive Tree of Life 
website (http://itol.embl.de/index.shtml) (Letunic and Bork, 2011) 
The evolutionary history was inferred using the Neighbor-Joining method. The 
evolutionary distances were computed using the Jukes-Cantor method and a 500 
replicate bootstrap analysis. A bootstrap consensus tree was calculated and average 
bootstrap values were included on the trees (Saitou and Nei, 1987, Felsenstein, 1985) 2.3.6 STATISTICAL!ANALYSES!
Demographic variables and clinical parameters were compared for significant 
differences between groups using the Mann-Whitney U-test, independent samples t-test 




As the variance was very large for the data obtained from the quantitative culture counts 
(after aerobic and anaerobic incubation) and did not follow normal distribution, a log 
transformation was used. This normalized the data and an independent samples t-test 
was used to compare the means of this transformed variable. The aerobic and anaerobic 
data were analyzed separately to avoid double counting the facultative organisms that 
will grow in both atmospheres.  
The relative abundance of species in each group (peri-implantitis and healthy) was 
calculated based on the presence or absence of each species i.e. species were counted as 
present/absent irrespective of the number of isolates and then divided by the number of 
samples in each group. The distribution of species in peri-implantitis and healthy 
implants was compared using Fisher’s exact test.  
For descriptive statistics (percentages of isolates), the data was normalized to account 
for differences in group sizes.  Samples were corrected to 84 species each and then 
proportions of species, genera and phyla were calculated.  
Statistical analyses were performed using the data-processing software SPSS (Version 
21 for Mac; SPSS, Chicago, IL). The level of significance was set at p < 0.05. 2.3.7 PHENOTYPIC!DIFFERENTIATION!OF!STREPTOCOCCUS!AND!
ACTINOMYCES ! !
Although 16S rRNA sequence homology analysis is a useful tool for bacterial 
phylogenetic study, it cannot provide sufficient resolution to differentiate between some 
closely related species (Janda and Abbott, 2007). 
Isolates provisionally identified as Streptococcus constellatus or intermedius were 
further characterized by means of the sialidase test. Fifty µl of a bacterial suspension in 
TES buffer (n-Tris hydroxymethyl 2-aminoethanesulphonic acid buffer, pH7.5) (Sigma) 
was added to 20 µl of a fluorescent-labeled substrate (2’-4-methylumbelliferyl α−D-N-
acetylneuraminic acid at a working concentration of 100 µg/ ml) (Sigma) in a 96-well 
flat-bottomed microtitre tray. The trays were covered and incubated aerobically at 37ºC 
for 3 hours. Substrate hydrolysis was observed by measuring fluorescence at excitation 
and emission wavelengths of 355 and 460 nm respectively using a fluorimeter with a 
plate reader attachment (Flouoroskan plate reader, Labsystems iEMS Reader MF). S. 




constellatus (Whiley et al., 1990). P. gingivalis was used as the positive control for the 
sialidase test (Moncla et al., 1990).  
To differentiate between A. oris and A. naeslundii, partial sequencing based on the met-
G (methionyl-tRNA synthase, ANA_1898) house-keeping gene was used (Henssge et 
al., 2009). After DNA extraction using the method described above, gene amplification 
was carried out using a set of multiple met-G primers (Table 9). A similar PCR 
programme to the one described for 16S rRNA was used, the only difference being the 
primer annealing temperature, which was 55 ºC instead of 49 ºC.  
Table 9 Met - G primers; For each PCR reaction, 0.2µl of each primer was used 
with 1µl of the DNA extraction (a total of 15µl for each PCR reaction). 
!
Finally, the PCR products were cleaned using ExoSAP-IT® and DNA fragments were 
sequenced using both forward and reverse primers. Sequence analysis was completed in 
the same manner as previously described for 16S rRNA, but strains were identified by 




Primer Sequence Sequencing primer 








MetG-R 5’-CGGAGTCGGCGTAACG- 3’ 
5’ -ACTCGTCCAGCTTGGTGAA- 
3’ 







A total of 21 subjects (10 with healthy implants and 11 with peri-implantitis) were 
enrolled in this study. There were 14 women and 7 men with an age range from 20 – 82 
years (mean age 55 years). Demographical data for the patients are presented in Table 
10 and the clinical parameters for the implant sites in Table 11. 
Subject Age (years) Gender Smoker 
1 (p) 63 F No 
2 (h) 20 M No 
3 (h) 38 M No 
4 (p) 64 F No 
5 (h) 82 F No 
6 (p) 52 M No 
7 (h)  48 M No 
8 (p) 54 M No 
9 (h) 78 F No 
10  (h) 56 F Yes 
11 (p) 45 M No 
12 (p) 55 M No 
13 (p) 34 F No 
14 (p) 71 F No 
15 (h) 56 F No 
16 (h) 73 F No 
17 (p) 60 F Yes 
18 (h) 57 F No 
19 (h) 47 F No 
20 (p) 35 F Yes 
21 (p) 61 F Yes 
Table 10 Descriptive data for patients included in the study.  




Table 11 Clinical parameters for implant sites. Pi, peri-implantitis; PPD, probing pocket depth; (p), peri-implantitis; (h), healthy implants; 
 Pdl, periodontal; H, Healthy. G, gingivitis. P, periodontitis 

























1 (p) P Astra Osseospeed LR3 screw 13 7 2005 2005 9 6 
2 (h) H Astra Osseospeed UR1 screw 13 4 2008 - 2 0 
3 (h) H Brånemark Machined UR3 screw 15 14 1998 - 2 0 
4 (p) G Brånemark Machined UL3 screw 15 18 1994 1997 5 3.2 
5 (h) G Brånemark Machined LR3 screw 18 21 1991 - 3 0 
6 (p) H Astra TiOblast UR5 screw 11  12 1998 2002 8 8 
7 (h)  G Astra Osseospeed UR2 N/A 15 2 2009 - 4 0 
8 (p) G Astra Osseospeed LR5 screw 11 5 2006 2011 7 6 
9 (h) H Astra Osseospeed UR4 screw 13 6 2006 - 4 0 
10  (h) H Brånemark Machined UL1 screw 15 19 1993 - 4.6 0 
11 (p) G Astra TiOblast UL3 cement 13 8 2004 2010 4.75 3.9 
12 (p) G Astra Osseospeed UL2 screw 11 2 2010 2010 7.5 5.5 
13 (p) G Astra Osseospeed LL1 cement 11 4 2008 2011 5 5 




15 (h) G Brånemark Machined UR2 screw 13 18 1994 - 1 1 
16 (h) H Brånemark Machined UR1 screw 13 15 1997 - 2 0 
17 (p) G Astra Osseospeed UL5 screw 11 6 2012 2012 7 5 
18 (h) P Brånemark Machined UR4 screw 15 18 1994 - 3 1.5 
19 (h) G Astra Osseospeed UR1 cement 15 5 2007 - 3 0 
20 (p) G Astra Osseospeed LL2 screw 15 5 2007 N/A 7 6.5 




Table 12 provides an overall summary of patient and clinical data. It can be seen that 
the mean age was comparable between groups. As expected, mean bone loss and pocket 
depths were significantly greater (p<0.001) in peri-implantitis sites (5.8 mm and 7mm 
respectively) than in healthy ones (0.3 mm and 2.9 mm respectively). Examples of 
radiographs from sites sampled in the study can be seen in Figure 4 where one can 
appreciate the extent of bone loss around failing implants. The implants had been in 
function ranging from 2 – 21 years (average of 9.7 years). 
 
  Healthy Implants (n=10)  
Peri-implantitis 
(n=11) p-value 
Age  55.4 ± 18.9  54 ± 11.8 0.84 (t-test) 
Gender 
(male:female)  3 : 7  5 : 6 0.66 (FE) 
Implant type      
Astra   4  10 
NA 
Brånemark  6  1 
Years in 
function  12.3 ± 7  7.4 ± 4.4 0.065 (t-test) 
PPD (mm)  2.9 ± 1.1  7 ± 1.4 < 0.001** (t) 
Radiographic 
bone loss (mm)  0.3 ± 0.5  5.8 ± 1.5 < 0.001** (MW) 
Smoker  
(% frequency)  10%  27% 0.33 (FE) 
 
Table 12 Summary of demographic and clinical variables of subjects (PPD, probing pocket 
depth). Data shown represent mean ± standard deviation. Tests of significance performed 
were t-test, MW (Mann-Whitney U-test), FE (Fisher’s exact test) according to whether or 





Figure 4 Examples of radiographs taken from subjects enrolled in the study. Top 
picture: Implants with peri-implantitis showing saucer shaped bone loss 
commonly found with peri-implantitis. Top row left to right patient 13, 8, 11, 1 
lower row 12, 14 17, 6. Bottom picture: Healthy implants showing no loss of 





! !2.4.2.1  QUANTITATIVE-CULTURE-ANALYSIS -
Table 13 compares the mean CFU/ml in healthy and peri-implantitis sites. The raw data 
for CFU/ml for every sample can be found in Appendix 4 - Table 28 







Table 13 Mean (S.D.) of CFU/ml (colony forming units/ ml) around healthy implants 
(n=10) and in peri-implantitis (n=11) after being cultured aerobically for 5 days and 
anaerobically for 10 days. *T-test of log transformation of the data 
The average CFU from peri-implantitis samples was generally 10 times more than that 
found around healthy implants and the mean number of bacteria cultured under 
anaerobic conditions showed approximately 3 times more bacteria than when cultured 
aerobically, but no significant differences could be detected (Table 13, Figure 5). 
 
Figure 5 Difference in mean total viable counts (CFU/ml) between 








































 2.4.2.2  CULTIVABLE-TAXA-FROM-HEALTHY-AND-FAILING-DENTAL- IMPLANTS-
Due to an error during laboratory procedures, sequences from sample 2 (healthy) were 
lost and were not considered in subsequent sequencing or statistical analyses. Thus, 
from 20 samples (9 healthy and 11 failing), a total of 1670 sequences were identified 
(80 – 93 sequences per sample) representing 5 phyla: Firmicutes (57%), Actinobacteria 
(17%), Proteobacteria (11%), Bacteroidetes (10%), and Fusobacteria (5%). The 
number of bacterial species identified from the healthy group were 80 species (from 753 
sequences) and those from the peri-implantitis group were 89 species (from 917 
sequences). The relative proportion of each species in each group can be seen in figures 
6 and 8. Their corresponding phylogenetic trees (figures 7 and 9) show the evolutionary 











Figure 7 Neighbour joining tree of bacterial species & phyla detected in healthy implants 
(n=9) constructed using the Jukes Cantor method.  
 Actinomyces gerencseriae | HOT 618
 Actinomyces israelii | HOT 645
 Actinomyces johnsonii | HOT 849
 Actinomyces oris/ naeslundii
 Actinomyces georgiae | HOT 617
 Actinomyces odontolyticus






 Lachnoanaerobaculum umeaense | HOT 107
 Pseudoramibacter alactolyticus | HOT 538
 Parvimonas micra | HOT 111
 Eubacterium XI G-3 brachy | HOT 557
 Mogibacterium diversum | HOT 593
Firmicutes
 Campylobacter showae | HOT 763
 Haemophilus sp. | HOT 036
 Haemophilus parainfluenzae
 Pseudomonas psychrotolerans
 Kingella oralis | HOT 706
 Neisseria bacilliformis | HOT 013
 Eikenella corrodens | HOT 577
 Neisseria elongata | HOT 598
 Neisseria flavescens / subflava
 Neisseria flava / mucosa/ pharyngis/ sicca
 Neisseria sp. | HOT 016
Proteobacteria
 Fusobacterium nucleatum/ polymorphum/ vincentii/ naviforme
 Fusobacterium nucleatum ss. animalis Fusobacteria
 Porphyromonas gingivalis | HOT 619
 Capnocytophaga gingivalis | HOT 337
 Capnocytophaga granulosa | HOT 325
 Capnocytophaga sp. | HOT 326
 Capnocytophaga sputigena | HOT 775
 Bacteroidaceae G-1 sp. | HOT 272
 Prevotella denticola | HOT 291
 Prevotella multiformis | HOT 685 |
 Prevotella melaninogenica | HOT 469
 Prevotella nigrescens | HOT 693
 Prevotella oralis | HOT 705
 Prevotella oulorum | HOT 288
 Prevotella maculosa | HOT 289
 Prevotella salivae | HOT 307
Bacteroidetes
 Selenomonas sputigena | HOT 151
 Selenomonas noxia | HOT 130




 Streptococcus sp. | HOT 071
 Streptococcus cristatus
 Streptococcus mitis bv 2
 Streptococcus parasanguinis I
 Streptococcus mitis/ oralis/ pneumoniae
 Streptococcus infantis
 Streptococcus australis
 Streptococcus intermedius | HOT 644
 Streptococcus constellatus
 Streptococcus sanguinis | HOT 758
 Streptococcus sp. | HOT 056
 Streptococcus salivarius/ vestibularis
 Streptococcus anginosus | HOT 543
 Gemella sanguinis | HOT 757
 Gemella morbillorum | HOT 046
 Gemella haemolysans | HOT 626
 Staphylococcus epidermidis
 Granulicatella adiacens | HOT 534
 Abiotrophia defectiva | HOT 389
Firmicutes
 Anaeroglobus geminatus | HOT 121
 Megasphaera micronuciformis | HOT 122
 Veillonella atypica | HOT 524
 Veillonella parvula/ dispar
Firmicutes
















































































Figure 9 Neighbour joining tree of bacterial species & phyla detected in peri-implantitis 
(n=11) constructed using the Jukes Cantor method.  
 Streptococcus australis | HOT 073
 Streptococcus salivarius | HOT 755/ vestibularis HOT 021
 Streptococcus constellatus | HOT 576
 Streptococcus intermedius | HOT 644
 Streptococcus sanguinis | HOT 758
 Streptocococcus mitis/ oralis/ pneumoniae
 Streptococcus cristatus | HOT 578
 Streptococcus sp. | HOT 071
 Streptococcus gordonii | HOT 622
 Streptococcus parasanguinis I | HOT 721
 Streptococcus sp. | HOT 057
 Streptococcus mutans | HOT 686
 Streptococcus anginosus | HOT 543
 Streptococcus sobrinus | HOT 768
 Gemella haemolysans | HOT 626
 Gemella morbillorum | HOT 046
 Abiotrophia defectiva | HOT 389
 Bacillus firmus
 Lactobacillus delbrueckii
 Lactobacillus gasseri | HOT 615/ johnsonii HOT 819
 Lactobacillus salivarius | HOT 756
 Lactobacillus parabuchneri
 Lactobacillus paracasei | HOT 716
 Lactobacillus XVII catenaformis | HOT 569
 Bulleidia extructa | HOT 603
 Solobacterium moorei | HOT 678
 Veillonella atypica | HOT 524
 Veillonella dispar/ parvula
 Dialister pneumosintes | HOT 736/ Dialister sp. HOT 502
 Dialister invisus | HOT 118
 Anaeroglobus geminatus | HOT 121
 Megasphaera micronuciformis | HOT-122
Firmicutes
 Fusobacterium necrophorum | HOT 690
 Fusobacterium nucleatum/ vincentii/ naviforme
 Fusobacterium nucleatum ss. animalis
Fusobacteria
 Atopobium rimae | HOT 750
 Olsenella uli | HOT 038
 Slackia exigua | HOT 602
 Rothia aeria | HOT 188
 Rothia dentocariosa | HOT 587
 Rothia mucilaginosa | HOT 681
 Brevibacterium casei
 Micrococcus luteus
 Corynebacterium durum | HOT 595
 Propionibacterium acnes | HOT 530
 Propionibacterium propionicum | HOT 739
 Actinomyces meyeri | HOT 671
 Actinomyces odontolyticus | HOT 701
 Actinomyces naeslundii/ oralis
 Actinomyces gerencseriae | HOT 618
 Actinomyces israelii | HOT 645
 Campylobacter gracilis | HOT 623
Actinobacteria
 Eubacterium XI G-6 nodatum
 Mogibacterium timidum | HOT 042
 Peptostreptococcus stomatis | HOT 112/ anaerobius
 Eubacterium XIG-7 yurii | HOT 377
 Filifactor alocis | HOT 539
 Pseudoramibacter alactolyticus | HOT 538
 Peptoniphilus sp. | HOT 836
 Parvimonas micra | HOT 111
 Parvimonas sp | Oral Taxon 110
Firmicutes
 Blastomonas natatoria
 Neisseria flava/ mucosa/ sicca/ pharyngius
 Neisseria subflava | HOT 476/ flavescens HOT 610
 Eikenella corrodens | HOT 577
 Neisseria bacilliformis | HOT 013 |
 Cardiobacterium valvulum | HOT 540
 Aggregatibacter aphrophilus | HOT 545/ paraphrophilus
 Haemophilus parainfluenzae
 Haemophilus haemolyticus | HOT 851 |
 Haemophilus sp. | HOT 036
Proteobacteria
 Porphyromonas gingivalis | HOT 619
 Capnocytophaga sp. | HOT 412
 Capnocytophaga sp. | HOT 902
 Bacteroidaceae G-1 sp. | HOT 272
 Prevotella intermedia | HOT 643
 Prevotella nigrescens | HOT 693
 Prevotella fusca | HOT 782
 Prevotella melaninogenica | HOT 469
 Prevotella baroniae | HOT 553
 Prevotella buccae HOT 560
 Prevotella sp. | HOT 820
 Prevotella oralis | HOT 705
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A total of 45 genera were identified, 41 in peri-implantitis and 31 in healthy. The major 
genera that made up the subgingival microbiota around implants was comprised of the 
following Actinomyces (oris, naeslundii, meyeri and israelii), Streptococcus (oralis/ 
mitis/ pneumoniae, constellatus, anginosus, intermedius, sanguinis, gordonii, 
parasanguinis II, sp. HOT-071, salivarius and cristatus), Veillonella (parvula/ dispar 
and atypica), Fusobacterium (nucleatum), Neisseria (flavescens, subflava, elongata and 
bacilliformis), Parvimonas (micra and sp. HOT -111), Rothia (dentocariosa, 
mucilaginosa, sp. HOT-188), Filifactor (alocis), Prevotella (nigrescens and 
intermedia), Gemella (haemolysans and morbillorum), Capnocytophaga (sp. HOT- 
412), Haemophilus (parainfluenzae), Eikenella (corrodens), Porphyromonas 
(gingivalis) and Pseudoramibacter (alactolyticus). A comparison between their 















Figure 10 Graph showing the percentage of samples in which most frequently observed 





Overall S. constellatus was the most abundant sequence in terms of how many times it 
was isolated (141/1670 sequences i.e. 8.5% of all sequences) and was present in 11 out 
of the 20 sampled sites (55%). Species that were found in most sampling sites were A. 
oris/ naeslundii (85% of sampled sites and 8.3% of isolates), F. nucleatum (75% of 
sampled sites and 3% of isolates) and S. mitis/ oralis/ pneumoniae (60% of sampled 
sites and 6% of isolates).  
In sites with peri-implantitis, F. alocis (p<0.001), S. constellatus, P. micra and A. 
meyeri (p<0.05) were significantly more prevalent than in healthy sites. F. alocis was 
detected in nearly all (75%) the failing samples, yet in none of the healthy sites. On the 
other hand, V. parvula (p<0.01) and N. elongata (p<0.05) were more likely to be 
isolated in the healthy sites (Table 14) 
!
 





Veillonella parvula 0.89 ± 0.33 0.27 ± 0.47 0.01 
Streptococcus constellatus 0.22 ± 0.44 0.82 ± 0.41 0.022 
Parvimonas micra 0.22 ± 0.44 0.82 ± 0.41 0.022 
Filifactor alocis ND 0.73 ± 0.47 0.001 
Neisseria elongata 0.44 ± 0.52 ND 0.026 
Actinomyces meyeri ND 0.45 ± 0.5 0.038 
Table 14 Means ± standard deviations of species that were significantly 
different between both groups *Fisher’s exact test (ND, not detected) 
 
Organisms that were only detected around healthy implants and those only in peri-
implantitis are summarized in the following table (Table 15). Most of these did not 
reach statistical significance.  
Healthy Peri-implantitis 
Actinomyces georgiae | HOT-617 Actinomyces meyeri* | HOT - 671 
Actinomyces johnsonii  | HOT-849 Aggregatibacter aphrophilus / paraphrophilus 
Actinomyces massiliensis  | HOT-852 Atopobium rimae | HOT-750  
Actinomyces radicidentis | HOT-746 Bacillus firmus 




Capnocytophaga sputigena | HOT 775 Bulleidia extructa | HOT 603 
Campylobacter showae | HOT-763 Campylobacter gracilis | HOT 623 
Capnocytophaga granulosa | HOT-325 Capnocytophaga sp. | HOT 380 
Gemella sanguinis | HOT 757 Cardiobacterium valvulum | HOT 540 
Granulicatella adiacens  | HOT-534 Dialister invisus | HOT 118 
Kingella oralis | HOT-706  Dialister pneumosintes | HOT 736 
Lachnospiraceae [G-1] sp. | HOT 107 Eubacterium [XI][G-6] nodatum | HOT_694 
Micrococcus sp. Eubacterium [XI][G-7] yurii | HOT 377 
Mogibacterium diversum | HOT-593 Filifactor alocis* | HOT 539 
Neisseria sp. | HOT-016 Fusobacterium necrophorum | HOT 690 
Neisseria elongata | HOT 598* Haemophilus haemolyticus | HOT 535 
Bacteroidetes [G-1] (Prevotella) sp. | HOT 272 Lactobacillus [XVII] catenaformis | HOT_569 
Prevotella denticola | HOT-291 Lactobacillus delbrueckii 
Prevotella maculosa | HOT-289 Lactobacillus gasseri | HOT-615 
Prevotella multiformis | HOT-685 Lactobacillus parabuchneri 
Prevotella oulorum | HOT 288 Lactobacillus paracasei | HOT_716 
Prevotella salivae | HOT 307 Lactobacillus salivarius | HOT-756 
Pseudomonas psychrotolerans  
Rothia aeria | HOT_188 Micrococcus luteus 
Selenomonas sp. | HOT 137 Mogibacterium timidum | HOT 042 
Selenomonas noxia | HOT_130 Olsenella uli | HOT-038 
Selenomonas sputigena | HOT 151 Peptoniphilus sp. | HOT 836 
Streptococcus infantis | HOT 638 Peptostreptococcus stomatis | HOT 112 
Streptococcus mitis bv 2 | HOT 398 Prevotella baroniae | HOT-553 
Staphylococcus epidermidis | HOT 601 Prevotella buccae | HOT 560 
 Prevotella intermedia | HOT 643 
 Prevotella sp. | HOT-317 
 Prevotella sp. | HOT-782 
 Prevotella sp. | HOT-820 
 Propionibacterium acnes | HOT 530 
 Propionibacterium propionicum | HOT 739 
 Slackia exigua | HOT 602 
 Solobacterium moorei | HOT_678 
 Streptococcus sobrinus | HOT 768 
 Streptococcus vestibularis | HOT 021 
Table 15 Summary of species found ‘only in healthy’ and ‘only in peri-implantitis.  
















Streptococcus mitis bv 2
Streptococcus cristatus































































































































































































































































Pseudoramibacter alactolyticusParvimonas sp | Oral Taxon 110Parvimonas micra*
































































































































































































































































































A summary of the overall results (proportion and phylogenetic relationship) of the 
subgingival peri-implant microbial community (phyla, genera and species) detected in 






















Figure 11 Phylogenetic relationship (N-J) of all subgingival peri-implant bacterial 
species identified and their overall proportional abundance (%) in health (green) and in 
peri-implantitis (red). Created using the Interactive Tree of Life (ITOL).  




2.4.2.3  RESULTS -FROM-THE-SIALIDASE-TEST-
In the present study, when sequences were identified as S. constellatus using the 
forward primers, blasting results from the same isolates that were sequenced using the 
reverse primers, identified them to be S. intermedius. The sialidase test showed that S. 
constellatus and S. intermedius were correctly identified using the 16S forward primers, 
but could not be differentiated using the reverse primers. 
!2.4.2.4  RESULTS -FROM-MET=G-SEQUENCING-
Met-G sequencing revealed that 32 out of the 36 strains were A. oris (Table 16). The 
rest were A. naeslundii and were all from Sample 4, which was from an implant with 
peri-implantitis. This was different to the results obtained from 16S rRNA (where most 
were identified as A. naeslundii) supporting the evidence that 16S rRNA PCR is not the 
best method to reliably differentiate between these 2 species (Henssge et al., 2009). Due 
to time constraints however, this method of differentiation was limited to samples 4, 5, 
6 and 7. In this study, A. naeslundii and A. oris were grouped into the same category A. 
naeslundii/ oris. 
 
Isolate Met – G Identification 16S Identification 
7o5_MF Actinomyces oris  Actinomyces naeslundii | Oral Taxon 176  
7o11_MR Actinomyces oris Actinomyces naeslundii | Oral Taxon 176  
7a15_MF Actinomyces oris Actinomyces naeslundii | Oral Taxon 176  
7o16_MF Actinomyces oris  Actinomyces naeslundii | Oral Taxon 176  
7o22_MR Actinomyces oris Actinomyces naeslundii | Oral Taxon 176  
7o25_MF Actinomyces oris Actinomyces naeslundii | Oral Taxon 176  
7a27_MR Actinomyces oris Actinomyces naeslundii | Oral Taxon 176  
7o32_MF Actinomyces oris  Actinomyces naeslundii | Oral Taxon 176  
7o33_MF Actinomyces oris  Actinomyces naeslundii | Oral Taxon 176  
7o37_MF Actinomyces oris Actinomyces naeslundii | Oral Taxon 176  
7o39_MF Actinomyces oris  Actinomyces naeslundii | Oral Taxon 176  
7o40_MF Actinomyces oris Actinomyces naeslundii | Oral Taxon 176  
4a7_MF Actinomyces oris  Actinomyces naeslundii | Oral Taxon 176  
4a33_MR Actinomyces naeslundii  Actinomyces naeslundii | Oral Taxon 176  
4o4_MR Actinomyces naeslundii  Actinomyces naeslundii | Oral Taxon 176 
4o20_MR Actinomyces naeslundii  Actinomyces sp. | Oral Taxon 170  
4o22_MF Actinomyces oris  Actinomyces sp. | Oral Taxon 170  










































Actinomyces oris (reverse metG primer)
0.05
4o25_MF Actinomyces oris  Actinomyces sp. | Oral Taxon 180  
4o27_MF Actinomyces oris Actinomyces naeslundii | Oral Taxon 176  
5o3_MF Actinomyces oris Actinomyces sp. | Oral Taxon 170  
5o13_MF Actinomyces oris Actinomyces sp. | Oral Taxon 170  
5o15_MF Actinomyces oris  Actinomyces radicidentis | Oral Taxon 746  
5o16_MF Actinomyces oris  Actinomyces sp. | Oral Taxon 170  
5o20_MF Actinomyces oris Actinomyces sp. | Oral Taxon 170  
5o22_MF Actinomyces oris  Actinomyces sp. | Oral Taxon 170  
5o23_MR Actinomyces oris  Actinomyces sp. | Oral Taxon 170  
5o28_MF Actinomyces oris Actinomyces sp. | Oral Taxon 170  
5o31_MR Actinomyces oris  Actinomyces sp. | Oral Taxon 170  
5o32_MF Actinomyces oris Actinomyces sp. | Oral Taxon 170  
5a37_MF Actinomyces oris Actinomyces sp. | Oral Taxon 170  
5o47_MF Actinomyces oris Actinomyces sp. | Oral Taxon 170  
6o8_MF Actinomyces oris Actinomyces sp. | Oral Taxon 169  
6o14_MF Actinomyces oris  Actinomyces sp. | Oral Taxon 169  
6o16_MF Actinomyces oris Actinomyces sp. | Oral Taxon 169  
6o46_MF Actinomyces oris  Actinomyces sp. | Oral Taxon 171  













Peri-implantitis is becoming an increasingly common occurrence. At present, the 
management of the condition is often difficult and therapeutic success is unpredictable 
(Claffey et al., 2008, Heitz-Mayfield and Mombelli, 2014, Kotsovilis et al., 2008, 
Renvert et al., 2008). The current consensus is that peri-implantitis is a bacterially-
induced inflammation of the supporting peri-implant tissues (Lindhe et al., 2008). 
Therefore, it would be valuable to obtain a comprehensive picture of the microbial 
composition at peri-implantitis sites since this could provide useful information for the 
development of effective therapeutic approaches.  
When the protocol for this study was proposed in November 2009, there were no 
studies that had explored the microbiota using an open-ended approach. Previous 
studies focused mainly on specific microorganisms especially those designated as 
‘periodontal pathogens’, and were not designed to detect other species.  These studies 
used culture methods, microscopy, (Botero et al., 2005, Leonhardt et al., 1999, 
Listgarten and Lai, 1999, Mombelli et al., 1987, Rams et al., 1990, Tabanella et al., 
2009, Alcoforado, 1991 #7), DNA-DNA checkerboard hybridization (Salcetti et al., 
1997, Heuer et al., 2007, Shibli et al., 2008) and 16S rRNA gene sequencing utilizing 
species specific molecular probes (Heuer et al., 2007, Tabanella et al., 2009, Ferreira et 
al., 2009). 
Although our study used a preliminary culture method, which has its limitations of not 
detecting the unculturable bacteria, it was our aim to obtain a clearer picture of the 
microbial diversity around implants by utilizing a 16S rRNA gene sequence analysis to 
identify the species that were cultured. This has become a useful approach to assess the 
phylogenetic and taxonomic diversity of bacterial isolates (Tamura et al., 2013b) and 
results were confirmed through Gram staining and biochemical testing when necessary.  2.5.1 MICROBIAL-DIVERSITY-AROUND-DENTAL-IMPLANTS-
During the past two years, four studies have been published that have employed non-
specific open-ended approaches to determine the microbial diversity around implants 
(da Silva et al., 2013, Koyanagi et al., 2013, Kumar et al., 2012, Tamura et al., 2013b) 
and these are summarized in Table 17. This discussion will focus primarily on the 





Study Method Main Findings 
 
(Tamura et al., 2013b) 
 
Anaerobic culture and identification 
using 16S rDNA sequencing 
 
15 peri-implantitis & 15 healthy 
 
Genera: 
Peri-implantitis (Pi): Streptococcus (34%), Eubacterium (13%), Prevotella (10%), 
Actinobacteria (6%), Fusobacteria (4%) 
 




Peri-implantitis: 69 species (10x higher CFU count) 
F. alocis, P. micra, P. intermedia, E. nodatum, E. brachy, S. exigua, Parascardovia 
denticolens, F. nucleatum were the predominant obligate anaerobes 
 
Healthy: 53 species 
Veillonella, P. acnes, P. alactolyticus, P. micra were the predominant obligate anaerobes: 
 
 
(da Silva et al., 2013) 
 
16S rRNA clone-sequencing 
 
20 subjects, 30 implants (10 control 
group with 10 healthy implants and 10 
test group with 10 healthy + 10 failing 
implants) 
Genera 43 Total Genera 
Pi Campylobacter, Desulfobulbus, Dialister, Eubacterium, Filifactor, Mitsukella, 
Parvimonas, Porphyromonas, Pseudoramibacter, Fusobacterium 
 
H: Actinomyces, Atopobium, Gemella, Kingella, Rothia, Veillonella 
 
Species 1387 clones 
Pi: F. alocis, P. micra, P. intermedia, C. gracilis, D. invisus, F. nucleatum, Streptococcus 
sp. HOT-064, Eubacterium infirmum, Mitsukella sp. HOT-131 
 





(Koyanagi et al., 2013) 
 
16S rRNA gene clone library 
 
6 patients  
(6 failing implants, 6 periodontitis 
sites) 
 
Total: 799 clones, 333 different taxa 
Pi: 192 taxa, Pdtitis:  148 taxa 
Pi showed greater diversity than pdtitis.  
Microbial population was different from pdtitis 
F. nucleatum (most abundant sequence) 
Dialister and Eubacterium higher prevalence in Pi than pdtitis 
P. micra, P. stomatitis, P. alactolyticus, S. moorei were only present in Pi, not in pdtitis 
Prevalence of periodontopathogenic bacteria was not high 
 
Note: Only reports presence/ absence. No mention of proportions or statistical significance. 
 




10 subjects; healthy implants 
10 subjects; peri-implantitis 
10 subjects; pdl healthy 
10 subjects; periodontitis 
Healthy Implants:  
Microbial profile of healthy implants was more diverse than failing. 
Had the highest levels of Gram-negative anaerobes and lowest Gram-positive aerobes 
Leptotrichia, Propionibacter and Veillonella were significantly greater than in Pi.  
 
Peri-implantitis: 
Pi is a simple, heterogeneous infection, had the fewest species of all. 
Species belonging to 4 genera made up 75% of the Pi microbial community. 
Butyrivibrio, S. mutans, Actinomyces, non-mutans streptococci, Campylobacter greater 
proportion than healthy 
 
Significant differences between peri-implant and periodontal microbiota 
 
 




In the present study, peri-implantitis was accompanied by an increased bacterial load. This 
is in agreement with the study by Tamura et al. (Tamura et al., 2013b). The remainder of 
the studies did not comment on the bacterial load.  
The distribution of phyla were comparable between peri-implantitis and health, with 
Firmicutes, which are mainly Gram-positive making up the greatest proportion. Similarly, 
Firmicutes made up the greatest proportion of phyla in the other studies (da Silva et al., 
2013, Koyanagi et al., 2013, Kumar et al., 2012, Tamura et al., 2013b). However Silva et 
al. found that Bacteroidetes were significantly raised in peri-implantitis while 
Actinobacteria were significantly less. The other studies did not compare between the 
phyla. It is worth mentioning that some other phyla, particularly those considered difficult 
to culture or unculturable, namely TM7, Synergistetes and Spirochaetes were not detected 
in our study, but were detected in the studies by Kumar, da Silva and Koyanagi. These were 
detected in both peri-implantitis and healthy groups, however their proportions were very 
small (< 1%) and no significant differences were detected between groups (Kumar et al., 
2012, da Silva et al., 2013, Koyanagi et al., 2013).  
The present study has demonstrated that in these partially dentate subjects, a complex and 
heterogeneous subgingival microbiota is generally found around dental implants that have 
been in function for more than one year. These findings are in agreement with the majority 
of the other studies (Tamura et al., 2013b, da Silva et al., 2013, Koyanagi et al., 2013). On 
the other hand our findings diverge from those by Kumar et al. (Kumar et al., 2012) who 
have reported that peri-implantitis was a simple infection with relatively low diversity and 
that only 4 genera made up 75% of the peri-implantitis microbial community in each 
individual. The composition they reported for the peri-implant microbiome was also 
surprising, in that the genera Streptococcus and Actinomyces were more prevalent in the 






When the flora of the two groups was compared at the species level, there seemed to be a 
shift towards a proportionally more ‘pathogenic flora’ in the peri-implantitis sites. It was 
noted that some potentially important organisms were consistently found in higher 
proportions in the peri-implantitis group and vice-versa.  
F. alocis, S. constellatus, P. micra and A. meyeri were predominantly more in the peri-
implantitis group. These findings are supported by the results of Tamura et al., da Silva et 
al. and Koyanagi et al. (Tamura et al., 2013b, da Silva et al., 2013, Koyanagi et al., 2013, 
Kumar et al., 2012). However there was no mention of A. meyeri except in the study by 
Tamura et al. (Tamura et al., 2013b), in which contrary to our findings, was predominant in 
the healthy sites.  
V. parvula/ dispar and N. elongata on the other hand were predominantly more in the 
healthy group. This is in accordance with other studies that have designated the same 
species to be health-compatible periodontal bacteria (Tamura et al., 2013b, da Silva et al., 
2013, Kistler et al., 2013). 
Other species that were significant in peri-implantitis in the other studies (Table 17) e.g. 
species like Dialister invisus, Campylobacter gracilis, Eubacterium nodatum, P.  
intermedia, Peptostreptococcus stomatitis, Solobacterium moorei and Slackia exigua were 
also isolated solely from peri-implantitis samples in our study, however they were not 
abundant enough to reach a statistically significant level. Similarly, the other studies have 
shed the light on the importance of Kingella oralis and Granulicatella adiacens in healthy 
sites. Again these species were only found in healthy sites in our study, but their 


















Most bacteria live in a biofilm state. This enhances their survival, metabolism, and 
propagation especially under adverse conditions. The formation of a biofilm depends on 
two main factors, the microorganisms present in the environment and the surface on which 
this biofilm is formed (Costerton et al., 1999, Mah and O'toole, 2001). 3.1.1 EARLY'COLONIZERS'OF'ORAL'BIOFILMS'
Oral streptococci are early colonizers of intra-oral biofilms, making up 80% of the early 
biofilm constituents (Rosan and Lamont, 2000). They play an important role in biofilm 
progression and the resultant biofilms maybe related to health or disease depending on the 
bacterial composition. They are part of the genus Streptococcus and are generally referred 
to as viridans streptococci, although viridans streptococci also contain other members that 
are not found in the oral cavity. As the name implies, they inhabit predominantly the oral 
cavity and upper respiratory tract of humans and animals (Aas et al., 2005). 
They are divided into five different groups (1) Mutans group (prominent members are S. 
mutans and S. sobrinus) (2) Salivarius group (S. salivarius) (3) Anginosus group (S. 
anginosus and S. intermedius) (4) Sanguinis group (S. sanguinis and S. gordonii) and (5) 
Mitis group (S. mitis and S. oralis) (Whiley and Beighton, 1998).  3.1.1.1  STREPTOCOCCUS #ORALIS '
S. oralis are facultatively anaerobic gram-positive, non-spore forming, non-motile cocci 
approximately 1 µm in diameter that grow in short or long chains. They utilize intracellular 
glycogen to form lactic acid, form alpha haemolytic colonies on blood agar (0.7-1.2 mm in 
diameter) and G+C content is 41% mol % (van Houte and Jansen, 1970).  
They are normal commensals of the oral flora and are important pioneer bacteria in the 
initial attachment of multispecies biofilms on oral surfaces. They are not usually 
pathogenic, but can be opportunistic pathogens and are associated with subacute bacterial 
endocarditis and septicaemia in immunocompromised patients (Kreth et al., 2009). 
S. oralis is closely related phylogenetically to the other viridans streptococci, S. mitis, S. 




share over 99% 16S rRNA sequence identity and are difficult to differentiate using 
conventional biochemical tests (Do et al., 2009, Park et al., 2010, Whatmore et al., 2000). 3.1.2 IMPLANT'SURFACES'
Titanium implant surfaces provide an ideal biological niche for the development of a 
biofilm.  The surfaces play a crucial role in biological interactions, as they are the only part 
in contact with the bio-environment and hence influence the implant/ tissue interface.  
The first implants (known as machined or turned implants) had a moderately smooth 
machined surface. Surface coatings have since been developed to promote and enhance 
bone apposition and decrease the healing time for osseointegration. The modifications used, 
whether being an altered surface chemistry and/or an increase in surface texture may 
however influence biofilm formation if the implant were to become exposed, as in the case 
of peri-implantitis (Palmquist et al., 2010b). 
Currently, there is controversy as to which implant surfaces and modifications affect 
biofilm formation (Zhao et al., 2005, Lin et al., 2013). There is also controversy regarding 
if different implant surfaces affect the progression of peri-implantits (Heitz-Mayfield, 









To assess whether there was a difference in biofilm formation on different titanium implant 
and abutment surfaces. 
Objectives 
1. To use identified relevant microorganism(s) in an in vitro biofilm model system. 
2. To investigate characteristics of dental implant surfaces that could influence the 
formation of a biofilm. 








In order to enable us to study the development of a biofilm on different implant surfaces, 
and so that we could subsequently study its ease of removal from various implant surfaces, 
it was necessary to develop a simplified and standardized in vitro model. Hence a single 
species biofilm model was developed, made up of a representative species identified in 
chapter 2. Initial attempts to develop a multispecies biofilm yielded inconsistent and 
unpredictable results. The results of these initial attempts are presented in Appendix 5.  3.3.1 CHOICE'OF'ORGANISMS'
After analysis of the 21 patient samples (see chapter 2), S. oralis was chosen to develop a 
single species biofilm since it represented an abundant species isolated from both peri-
implantitis and healthy implant sites. The strain was identified using 16S rRNA sequencing 
analysis and Gram staining. 3.3.2 GROWTH'CURVES'FOR'STREPTOCOCCUS'ORALIS'
To give a general idea of the growth patterns of S. oralis, growth curves were monitored 
using the Flouoroskan plate reader. A suspension was prepared in mFUM, then 200µl were 
dispensed in replicates of 4. The following procedure was programmed into the reader: 
temperature was set at 37 ºC and plates were shaken and absorbance measured every 15 
minutes at a wavelength of 600 nm for 48 hours.  3.3.3 STRAINS'AND'INOCULUM'PREPARATION'
A strain identified as S. oralis | Oral Taxon 707 | Strain ATCC 35037/ S. mitis | Oral Taxon 
677 | Strain ATCC 49456 (Human Oral Microbiome Database (HOMD)) was obtained 
from the frozen preserves of sample number 10. It was grown anaerobically on FAA 
supplemented with 5% (v/v) defibrinated horse blood for 2 days. A loopful of each 
bacterial strain was then inoculated into 5 ml of sterilized modified fluid universal medium 
(mFUM) containing 0.2% glucose and further incubated anaerobically at 37ºC.  
After 4 hours (mid-exponential phase), 1ml of the pre-cultures were drawn into a cuvette 
and Optical Density (O.D.) was measured at a wavelength of 600 nm using a 




Spectrophotometer). Bacterial suspensions were adjusted for an O.D. of 0.5 ± 0.05 (seed 
cultures).  3.3.4 TITANIUM'SURFACES'
Titanium discs were produced at Astra Tech (Dentsply Implants, Astra Tech, Mölndal, 
Sweden). The discs, which were used as a substrate for biofilm formation, were round in 
shape (6.5 mm in diameter, 2 mm thick and 33.2 mm2 in surface area) and were made out of 
commercially pure (CP) grade IV titanium, except surface number 7873, which was made 
of Grade V CP Ti. They were modified in four different ways to create four different 
surfaces (Table 18 and Appendix 6). The surfaces were coded and researchers were blinded 
to what the surfaces were until after completion and analysis of all experiments. 6905 and 
7874 were characterized as being moderately rough (Albrektsson and Wennerberg, 2004b). 
6905 was produced by blasting with titanium dioxide particles, while 7874 was produced 
by first blasting with titanium dioxide particles then subsequently treating the surface with 
hydrofluoric acid according to the OsseoSpeed manufacturing procedure. Surfaces 7676 
and 7873 were characterized as being smooth (Albrektsson and Wennerberg, 2004b) and 
were produced by machining to achieve a final surface roughness of Sa ≈ 0.2 µm. 
Palmquist et al., (Palmquist et al., 2010b) have proposed that sterilization and storage in a 
sterile package may influence the surface of a dental implant, suggesting that this occurs 
via the transfer of molecules from the packaging material to the implant surface. This 
means that in order to produce reproducible implant surfaces, all aspects of the 
manufacturing process and resultant logistics need to be carefully controlled. In our study 
this was strictly adhered to. The discs were provided in exactly the same manner by which 
Astra implants are packaged and stored. They were degreased, cleaned, double packaged 
and fixed to a mount, and thus could be handled aseptically without any need to touch or 
contaminate them. Furthermore, they received the same rigorous sterilization process (beta-
sterilized by >25<75kGy) that the Astra dental implants are subjected to. Although not 
rough and smooth in the true sense of the words, for the purpose of this study, surfaces 








Surface Modification to the titanium discs 
6905  
TiOblast 
Titanium discs blasted using titanium dioxide particles 
7874  
Test, Tioblast + HF 
Titanium discs blasted with titanium dioxide particles then acid-





Test Ti Gr.5 
Machine produced 
Table 18 Surfaces and surface modifications investigated in this study '3.3.5 GROWTH'OF'THE'BIOFILM'
The titanium discs were placed in a 24-well polystyrene cell culture plate and pre-incubated 
for 6 hours with 1ml of mFUM (modified Fluid Universal Medium) to precondition the 
discs. The mFUM was originally described by Gmür and Guggenheim (Gmür and 
Guggenheim, 1983) in 1983. It contains (per litre of distilled water) 10 g tryptone, 5 g yeast 
extract, 2 g glucose, 0.4 ml stock hemin (5 mg/l) solution, 0.5 ml stock menadione (2 mg/ l) 
solution, 0.5 g cysteine hydrochloride, 0.1 g dithiothreitol, 2.9 g NaCl, 0.5 g Na2CO3, 1 g 
KNO3, 0.45 g K2HP04, 0.45 g KH2PO4, 0.9 g (NH4)SO4, MgSO4.7H20 and finally heat-
inactivated, filter-sterilized, horse serum.  
100 µl of seed cultures were added to the discs with the mFUM. The growth medium was 
replenished every 24 hours by aspirating the spent medium carefully from the wells and the 
addition of fresh medium taking care not to disturb the early biofilm. This was carried out 
with the plates still in the anaerobic incubator and was repeated for 4 days (i.e. 3 media 
changes) after which the plates were taken out of the anaerobic chamber and prepared for 




















































































3.3.6 EXAMINATION'OF'THE'BIOFILM'3.3.6.1  HARVESTING'OF 'THE'BIOFILM'
The discs were dip-washed twice and swirled gently in sterile Phosphate Buffered Saline 
(PBS) to remove the loosely adherent bacteria. Each disc was then transferred to a sterile 
7ml bijou containing 1ml of Fastidious Anaerobic Broth (FAB) and a few sterile glass 
beads. It was vortexed vigorously for 30 seconds to disrupt the biofilm and harvest adherent 
bacteria, after which the suspension was serially diluted (100-105). 100 µl of each diluted 
sample was plated on FAA and the plates were incubated anaerobically at 37ºC. Tests were 
performed in duplicates and after 5 days, the numbers of CFUs per mL were counted.  
 3.3.6.2  CONFOCAL'LASER'SCANNING'MICROSCOPY'(CLSM)'
STAINING'OF 'THE'BIOFILM'
To enable us to assess bacterial vitality, the biofilms were stained with a LIVE/DEAD® 
BacLight™ Bacterial Viability Kit for microscopy and quantitative assays (Molecular 
Probes, Invitrogen, UK).  These kits utilize a STYO® 9 green-fluorescent nucleic acid stain 
and the red-fluorescent nucleic acid stain, propidium iodide. These stains differ in their 
spectral characteristics and in their ability to penetrate healthy bacterial cells. With an 
appropriate mixture of the STYO® 9 and propidium iodide stains, bacteria with intact cell 
membranes are stained fluorescent green, whereas those with damaged bacterial cell 
membranes stain fluorescent red, whilst the background remains virtually non-fluorescent.  
After dyes were left to warm to room temperature, 2 µl of component A (STYO® 9) and 2 
µl of component B (propidium iodide) were added to 4 ml of PBS and kept in a bijou 
covered with tin foil to protect against light. For each biofilm-covered disc, 500 µl of the 
dye mixture was placed in a dry well of a 24-well plate. The disc was immersed inside this 
and the plate was covered with tin foil and left aside for 15 minutes. After staining, the disc 
was dipped once more in PBS and placed inverted in a glass-bottomed 35 mm diameter 







Confocal imaging of the biofilms was accomplished by means of a Leica inverted CLSM 
(TCS SP2; Leica Microsystems, Wetzler, Germany) equipped with an x63 oil immersion 
lens (HCX PL APO CS; NA = 1.4, Leica Microsystems) with a numerical aperture of 1.4. 
An Ar-Kr Laser was used with an excitation wavelength of 488 nm and 569 nm for STYO® 
9 and propidium iodide respectively. A negative control was used to set the microscope 
parameters to avoid reflection of the titanium itself as much as possible. After the gain was 
adjusted to reduce reflection, the lens was moved away from the surface, until reflection 
became minimal. This z-level was recorded and used as a starting level for each set of 
biofilm images.  
The biofilm structure was examined at 5 random points (5 stacks) as a series of horizontal 
optodigital sections, each 2 µm thick (z-step) for an overall height of 20 µm (i.e. 10 two-
dimensional (2-D) images per stack). Images were obtained at a zoom factor of 2.0, a pixel 
resolution of 0.42 µm pixel-1 and a field resolution of 512 x 512. The mean of the 50 
measurements was taken for statistical analysis.  
Digital images were transformed to the tiff format and processed using the bioImage_L 
software (Chavez de Paz, 2009). Using this software, cell counting, biovolume, mean 
height, and substratum coverage can be analyzed.  
All experiments (confocal and culture counts) were carried out 10 times for each surface 
using independent bacterial cultures. 
 3.3.6.3  SCANNING'ELECTRON'MICROSCOPY'(SEM)'AND'ENERGY'DISPERSIVE 'X1RAY'SPECTROSCOPY'(EDS)'
Topographic characterization of the surfaces was carried out using scanning electron 
microscopy (SEM) before and after biofilm formation. In addition, chemical analysis of the 






The original titanium surfaces were analyzed (SEM & EDS) with no coating. They were 
mounted on 12 mm pin stubs (Hitachi High Technologies, Berkshire, UK) with double 
sided adhesive carbon tab (TAAB Laboratories Equipment, Berkshire, UK). No fixing, 
osmication or dehydration was necessary.  Discs were directly mounted and carbon coated 
(Emitech K250 sputter coater). 
PREPARATION'OF 'SURFACES 'WITH'BIOFILM'FOR'SEM'
The biofilm samples were first fixed for 1 hour at 4°C with 2.5% glutaraldehyde in 0.1m 
Phosphate buffer (pH 7.2), then washed twice for 5 minutes in 0.1M Phosphate buffer. 
After which they were osmicated at 4°C for 40 minutes (1% osmium tetroxide) and then 
dehydrated through a series of graded ethanol (30%, 50%, 70% and 95% ethanol for 5 
minutes each and 3 times in 100% ethanol for 10 minutes each).  
They were then transferred to 100% ethanol in critical point drying holders and were 
critical point dried using carbon dioxide in a Polaron E3000 critical point dryer (Quorum 
Technologies Ltd, West Sussex, UK).  
Finally, the samples were sputter coated with gold in an Emitech K550X sputter coater 
(Quorum Technologies Limited, West Sussex, UK) using a 45mA current for 1 minute and 
40 seconds and were then mounted as described above for the pristine surfaces.  
Surfaces were examined and representative images were recorded using a FEI Quanta™ 
200F field emission scanning electron microscope fitted with an EDAX Genesis x-ray 
microanalysis system.  
ANALYSIS 'USING'EDS'
EDS was performed in order to test differences in chemical composition between the 
surfaces in their pristine state and after biofilm decontamination. This is accomplished 
through the interaction of primary electron beams from the SEM with surface atoms 
producing characteristic measurements, which represent the elements present on the 
surface. The analysis software was Genesis Spectrum, SEM Quant ZAF Version 3.60 





Data for these tests are presented in Appendix 6. 3.3.7.1  CONTACT'ANGLE'MEASUREMENTS' '
All four surfaces had a contact angle of 90° (measured by the tensile drop method) and 
were considered to be slightly hydrophobic 3.3.7.2  PRE1STERILIZATION'TESTING' '
Samples were taken (3 discs per reference number) from the lot prior to the beta-
sterilization process. Each sample was transferred into a bottle containing 50ml NaCl with 
0.1% peptone. The bottle was shaken for 10 minutes and then the solution was filtered. The 
filter was transferred to a TSA-plate and the plates were incubated at 32° C ± 2° C. The 
amount of colonies on the filter were counted. 3.3.7.3  ENDOTOXIN'TESTING' '
Endotoxin samples (3 discs per reference number) were taken from the lot after the beta 
sterilization process. Test samples were transferred into an endotoxin free tube and covered 
with 2ml sterile water and shaken for five minutes. Water was put in four different cups, 
then a solution of Control Standard Endotoxin (Endosafe) and LAL Reagent (Endosafe) 
water was added to two of them. The solutions were then inspected with Tecan/ Sunrise 
(microplate reader) equipment with the Endoscan V software. 3.3.7.4  XPS' '
The discs were analyzed on the surface with a XPS microscope (Quatum 2000 ESCA 
Scanning Microscope, Physical Electronics, USA). The monochromatic AlKα was used as 
the as the X-ray source. The beam was focused to 100 µm with the effect about 20W. 
Evaluation was accomplished using a matlab-based program, MULTIPAK (Physical 
Electronics, Lake Drive East, Chanhassen, MN). Three samples of the same batch were 
analyzed. The only XPS was performed on the Test discs 7874 TiOblast + HF due to the 







Statistical analyses was performed using the data-processing software SPSS (Version 21 for 
Mac; SPSS, Chicago, IL). The data was not found to be normally distributed, so the non-
parametric analysis of variance, Kruskal-Wallis test was used to analyze the differences 
between the different surfaces regarding: 
1. Number of Colony forming units/ ml 
2. Biofilm surface areas (total, live and dead) 
3. Biofilm volume (total, live and dead) 
4. Biofilm thickness 
5. Biofilm quantity and quality (live/dead) between the different layers of the biofilm 






Results showed that in 200 µl of mFUM media, S. oralis had a very short lag phase, 
followed by an extremely rapid growth rate in the exponential phase. Stationary phase was 
reached after 5 hours and continued for the rest of the 48 hours experiment (Figure 13). 
 
 
Figure 13 Growth curves for S. oralis. (media: mFUM, time = 48 h, absorbance λ = 600nm, 
n= 4) showing a rapid growth rate till 5h then stationary phase for the rest of the experiment 3.4.2 SURFACE'CHARACTERIZATION'OF'TITANIUM'DISCS'3.4.2.1  SEM'OF'PRISTINE'SURFACES'
SEM images of discs 6905 and 7874 showed a relatively homogeneous roughened 
microstructure. Low-power images (800x) reveal similar micron-level topography. At a 
higher magnification (3000x and 6000x), 7874 appeared to have additional finer nano-sized 
irregularities interspersed between the larger micro-irregularities (Figure 14). Surfaces 7676 
and 7873 showed a pronounced circular configuration of alternating plane and flattened 
areas consistent with a machining process. Surface imperfections or tags of rough areas 
were commonly observed. 7873 appeared to have some modification of this surface 
compared to 7676. These latter 2 surfaces could be classified as ‘smooth’ as compared to 
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Figure 14 SEM of pristine rough surfaces 6905 (left) and 7874 (right)  
a) magnification x800 b) magnification x3000 c) magnification x 6000.  
TiOblast (left) The first clinically introduced moderately rough implant (Sa≈1.0 µm)  
Osseospeed (OS) surface (right) is a nanomodified version of the TiOblast (Sa ≈ 1.5 µm). 






Figure 15 SEM of pristine smooth surfaces 7873 (left) and 7676 (right) at a) x800 
magnification and b) x6000 magnification. Test discs show undulating regions, with 








EDS analysis revealed titanium as the predominant element in all four surfaces (Figures 16 
and 17). Oxygen was only detected on the rough surfaces confirming the grit blasting 
procedure used with titanium dioxide particles to achieve a moderately rough surface 












Figure 16 Elemental spectrum obtained by the EDS analysis of rough surfaces a) 6905 b) 
7874 showing peaks caused by X-rays given off as electrons return to the K electron shell. 












































Figure 17 Elemental spectrum obtained by the EDS analysis of smooth surfaces a) 7873 


























3.4.3 BIOFILM'FORMATION'ON'THE'DIFFERENT'SURFACES'AFTER'96'HOURS'3.4.3.1  SEM'OF'SURFACES 'WITH'BIOFILM'
SEM images in (figures 18 and 19) show the adhesion of S. oralis to the different titanium 
surfaces. A biofilm made up of intertwined cocci arranged in short and long chains 
characteristic of streptococcal species could clearly be seen. However no differences in 
colonization patterns could be distinguished amongst the four surfaces.  
 
Figure 18 Representative SEM micrographs of smooth surfaces 7873 (left) and 7676 
(right) with S. oralis 96h biofilm a) x800 magnification and b) x6000 magnification 
showing confluent layers of cocci on the surfaces 
  a) 





Figure 19 Representative SEM micrographs of rough surfaces 6905 (left) and 7874 
(right) with 96h S. oralis biofilm showing confluent layers of cocci a) 800 x b) 3000x 
c) 6000 x 
  a) 





3.4.3.2  BACTERIAL 'COUNTS'
CFU counts obtained from harvesting and culturing the adherent biofilms are summarized 
in Figure 20 and in table 19. There was no significant difference between the numbers of 
colonies counted for any of the surfaces tested.  
 
Figure 20 The number of colony forming units after 96 h in vitro biofilm growth 
(n=10). Medians and 25/75 percentiles are shown. Kruskal Wallis ANOVA analysis 
failed to reveal any significant differences (P>0.05) between the surfaces 
Surface 













p = 0.998* 
Table 19 Total Bacterial Counts (medians and 25/75 percentiles) of 96 h biofilm 























 3.4.3.3  CLSM'ANALYSES'
Examples of the CLSM microscopic images are shown in Figure 21. S. oralis species 
adhered readily to all surfaces. Using the STYO® 9 and propidium iodide enabled visual 
differentiation of the live and dead bacteria. The software bioimage_L processed the 
confocal images using in situ colour segmentation based on the colour additive theory, 
which classifies each pixel of the image into predefined colour classes. The colour to be 
segmented is identified by green, red, and blue codes which are subtracted from each pixel 







Figure 21 CLSM evaluation of 96h biofilm. Chains of S. oralis are apparent. Live green 
(STYO®9 stain) bacteria, dead red (propidium iodide stain) bacteria and overlaid image 





Although rougher surfaces, 6905 and 7874 theoretically provided a greater surface 
area for bacterial adhesion and protection for the bacteria against shear removal 
forces, no significant differences could be detected in surface areas covered by 














Figure 22 Surface area covered with S. oralis after 96 h in vitro biofilm growth (n=10). 
Medians and 25/75 percentiles are shown. Kruskal Wallis ANOVA analysis failed to reveal 
any significant differences (P>0.05) between the surfaces. 
 
Table 20 Biofilm analysis showing medians (and interquartile range between parentheses) of 


















































































Furthermore, the biofilm volume produced was also comparable between the four surfaces 










Figure 23 Biofilm volume formed on surfaces after 96h (n=10). Medians and 25/75 
percentiles are shown. Kruskal Wallis analysis failed to reveal any significant 











































The percentage of the surface area covered by biofilm was between 78-79% for surfaces 
6905, 7874 and 7676, whilst surface 7873 tended to have less surface coverage (59%). The 
difference did not reach statistical significance (Figure 24, Table 22).  
Figure 24   Percentage of biofilm coverage on the different surfaces after 96 h incubation 
with S. oralis (n=10). Medians and 25/75 percentiles of biofilm coverage are shown. Kruskal 
















67.2 - 93.0! 0.351!










The mean height/thickness of the developed biofilm was 8.3 ± 0.5 µm (Figure 25)  
 
Figure 25 Mean height of S. oralis biofilm after 96h on titanium surfaces (n=10). Mean 
height was lowest on the nanorough surface with fluoride (7874). 
!
!
Despite previous analyses showing a tendency for the nanorough surface with fluoride 7874 
to consistently have lower bacterial adhesion, biofilm volume and surface coverage 
compared to both the moderately rough 6905 surface and the smooth 7676 surface, this was 

































The proportion of live/dead cells was approximately 90% live to 10% dead cells on all four 














Figure 26 a) Surface area and b) volume covered by live and dead S. oralis bacteria 




































Finally, The biofilm nearest the disc surface (at 2 and 4 µm) was compared to that furthest 
away from it (at 18 and 20 µm) to determine whether physiochemical surface differences 
had an effect on biofilm characteristics. Assessment of the biofilm did not reveal any 
significant differences (Table 23). An illustration of the mean biofilm mass at the different 
z-levels can be seen in Figure 27. 
! Disc!Type!
P!value*!













































































































































Table 23 Medians (inter-quartile range) of biofilm surface area (µm2) at different Z-levels (2 





































































































































Dental biofilms have been associated with the initiation and progression of caries and 
periodontal disease (Liljemark et al., 1997). The control of these biofilms is fundamental 
for maintenance of a healthy mouth and the prevention of gingivitis and periodontitis. 
Similarly there is considerable evidence that supports the cause and effect relationship 
between biofilm accumulation and implant related disease.  
Biofilms have been shown to be resistant to standard antibiotic therapy and the 
development of new implant surfaces that aim to optimize bone healing, but reduce 
microbial colonization may provide a potentially more promising approach (Palmquist et 
al., 2010b) 
Some research has shown that titanium has inherent antibacterial properties indicating that 
250-500 ppm of pure titanium and 125 ppm of titanium alloy would inhibit the growth of 
some oral microorganisms in vitro. However these findings have limited clinical 
application since it is unlikely that such high concentrations exist in the intra-oral 
environment (Berry et al., 1992) 
In our current study, we used a single species model to investigate in vitro microbial 
adhesion to four different titanium surfaces and intended to correlate the findings to 
specific surface characteristics (roughness and chemical modification). The aim was to 
provide an insight to which surface characteristics could minimize biofilm formation and 
reduce the risk of peri-implant disease.  
There were no significant differences in biofilm formation on any of the surfaces after 96 
hours regardless of surface roughness or chemical composition. This is in contrast to the 
opinion that a roughness threshold value of 0.2 µm will affect colonization (Quirynen et al., 
1996a).  
It has been proposed that rougher surfaces provide more microniches that may provide a 
more favourable, protective environment that facilitates bacterial interactions. Similarly, 
fluoride has been proposed to reduce adhesion of oral bacteria (Loskill et al., 2013, 
Yoshinari et al., 2001). Although, the fluoride treated discs (7874) tended to exhibit less 




It appears that once initial colonization and early biofilm formation is established the 
surface has little effect thereafter. This is in line with other studies conducted on titanium 
by Frojd et al. (Frojd et al., 2011a, Frojd et al., 2011b) which showed that differences in 
surface roughness may have an effect after 2 hours, but after 14 hours this effect was not 
sustained suggesting that the influence of the surface characteristics on adhesion was 
compensated for by biofilm development. The same observations were also seen on 
different implant and dental surfaces (Siegrist 1991, Leonhardt et al., 1995). Dezelic et al. 
showed that surface roughness may influence initial biofilm adherence after 15 min, but 
differences disappeared following growth and maturation after 15 hours (Dezelic et al., 
2009). Furthermore, Nakazoto et al. observed that surface roughness of materials may 
affect initial bacterial adherence at 4 hours, but at 48h, there was no difference in bacterial 
adhesion among any of the materials tested (Nakazato et al., 1989). Another study showed 
that the influence of surface roughness was still apparent after 3 days, but disappeared after 
5 days (Al-Ahmad et al., 2010). Following on from this, it may be surmised that moderately 
roughened implant materials could possibly increase initial bacterial adhesion but had little 
effect as the biofilm developed. Nonetheless, a recent study has observed that even at 20 
minutes biofilms were similar on materials that had different surface roughness (Schmidlin 

















Evidence is still limited as to which therapeutic strategies are the most efficacious for the 
treatment of peri-implantitis. The vast heterogeneity of studies, which have used empirical 
combinations of different decontamination methods, and the variability of implant surfaces 
being treated, make it is difficult to establish a single protocol for peri-implantitis 
treatment, but this does not suggest that the currently implemented treatment modalities 
may not provide beneficial outcomes in clinical practice (Kotsovilis et al., 2008).  
Favourable treatment outcomes have been be correlated with non-smoking and late disease 
development (Charalampakis et al., 2011) and the following clinical guidelines for therapy 
are recommended (Heitz-Mayfield and Mombelli, 2014): 
- Oral hygiene instruction and smoking cessation advice. 
- Assessment of the prosthesis for access for plaque control and if required, removal 
and adjustment of the prosthesis.  
- Non-surgical therapy should be attempted initially, with or without antimicrobials, 
before resorting to surgical techniques (Lindhe et al., 2008, Renvert et al., 2008).  
- Surgical access to allow thorough cleaning of the decontaminated implant surface. 
This may involve resective or regenerative treatment and also the modification of 
the implant surface topography.  
- Continuous maintenance, including oral hygiene instructions and supramucosal 
biofilm removal.  
Detailed algorithms set by the ADI for the non-surgical and surgical therapeutic approaches 







Because peri-implantitis is initiated by microorganisms, the primary objective of treatment, 
is the elimination of infection through removal of the biofilm and decontamination of the 
implant surface rendering the surface biocompatible for re-osseointegration (Renvert and 
Giovannoli, 2012).  
A promising method of achieving this seems to be the use of air abrasion (Meyle, 2012). 
Two interesting powders that can be used in APDs for the decontamination of dental 
implants are glycine and BAG. The former is a soft alternative to the conventional sodium 
bicarbonate powder. It has been developed recently in order to be used subgingivally 
without inducing substantial soft and hard tissue damage (Flemmig et al., 2007, Petersilka 
et al., 2008). The latter, BAG possesses osteoinductive, osteoconductive and antimicrobial 
properties (Hench, 2006, Stoor et al., 1998) and has not been tested before for the treatment 
of peri-implantitis. It would seem reasonable to presume that BAG, used in an air-polishing 
device would be able to effectively disrupt the plaque biofilm on dental implants and at the 
same time impart a level of bioactivity to the surfaces. An anticipated beneficial effect of 
BAG particles being retained on the implant surface would be to enhance 
reosseointegration and prevent the formation of an intervening fibrous tissue.  
In vitro studies give an important insight to the expected biocompatibility results in vivo. 
Generally, two types of cells are used for in vitro studies, these are primary cells and cell 
lines. Primary cells are advantageous for studies of bone cell metabolism and 
differentiation because they retain a normal phenotype since no dedifferentiation has taken 
place (Aubin et al., 1995, Di Silvio and Gurav, 2001). A few in vitro studies (Augthun et 
al., 1998, Kreisler et al., 2005, Parham et al., 1989, Schwarz et al., 2009a, Shibli et al., 
2003) have suggested that the biocompatibility of titanium surface following air-polishing 
to be high. However, only one (Schwarz et al., 2009a) has used glycine and none have used 
BAG. Furthermore, all the aforementioned studies used cells other than those of human 
origin or used cells that do not represent dental implant targets (i.e. they used human 
osteosarcoma cells, mouse preosteoblast cell lines or fibroblasts). In an ideal in vitro 
approach, biomaterials should also match the cell populations typical of the implant site. In 




shown that osteoblasts taken from different sites of the body may exhibit different 
proliferation rates and phenotypic expression.  
Therefore, the aim of this in vitro study was to assess using primary alveolar human 
osteoblasts (HOB), how decontamination procedures with air polishing devices using 2 
different powders, one ‘soft’ (glycine) and one ‘bioactive’ (BAG) would re-establish 
biocompatibility of previously contaminated, commercially-available implant surfaces and 
how this compared to decontamination using mechanical debridement and non-








Investigate and compare the effect of different decontamination methods on dental implant 
surfaces in recreating a biocompatible surface to which cell reattachment can occur.  
Objectives 
Biocompatibility and effect of decontaminants on the titanium surfaces will be assessed 
using human alveolar osteoblast cells. This will be measured using: 
1- MTT to test cytotoxicity 
2- Alamar blue to test cell proliferation  
3- Alkaline Phosphatase activity as a marker of differentiation 










Biofilms were grown on the implant discs as described in the previous chapter. 
Immediately after the biofilm experiment was complete, the discs were allocated to the 
specific treatment procedures. Two discs of each implant surface per treatment method 
were analyzed in addition to two control discs of each surface which were non-
contaminated and untreated. 
 4.3.2 TREATMENT'PROCEDURES'
The following treatments were compared: 4.3.2.1  MECHANICAL'DEBRIDEMENT'
Disposable scalpels (Swann-Morton, Sheffield, UK) with a number 11 blade were used as a 
sterile, reproducible and simple alternative to a curette for scaling the disc. A new blade 
was used for each disc to avoid bacterial contamination from one disc to the other. 
Each disc was scaled for 20 seconds (from top to bottom ≈10 times then ≈10 times from 
left to right). The blade was placed at a 90 degrees angle to the disc.   
According to Duarte et al. (Duarte et al., 2009b), 6 strokes with a curette simulate 
approximately 1 clinical visit for implant decontamination. Thus 20 strokes should simulate 
around 4 clinical visits.  4.3.2.2  AIR1POWDER'ABRASIVE/POLISHING'SYSTEM'
Two different types of powders were used: 
a) Glycine (Airflow® subgingival PERIO powder, EMS Electro Medical Systems, UK) 
b) Bioactive Glass (BAG) 45S5 – calcium sodium phosphosilicate (Sylc®, Denfotex 





An AIR-FLOW® handy 2+ hand piece (EMS Electro Medical Systems, UK) was mounted 
on an adjustable stand and air-powder blasting was performed in a standardized manner 
according to the following parameters: 
Pressure: 4.5 bar according to manufacturer recommendation. 
Nozzle distance: 5 mm from the centre of the disc 
Nozzle angle: 90˚ to the surface 
Duration: 5 seconds static and 15 seconds rotation (total 20 seconds).  
Nozzle distance and angulation were deduced from previous studies (Kreisler et al., 2005, 
Augthun et al., 1998) that used the same parameters.  
The movement and duration parameters were determined after conducting the following 
pilot study: 
Discs were painted with nail polish and blasted with the hand piece nozzle at  
a) 5 mm for 5 seconds static, then 15 seconds rotation  
b) 10 mm static only for 15 seconds 
c) 5 mm static only for 15 seconds 
d) 5 mm rotation only for 15 seconds 
It was concluded that the best results were achieved using the combination of static and 















Figure 28 a) Experiment setting b) discs painted with nail polish c) left disc was 
blasted using rotation + static settings, middle disc static with tip 10 mm away, right 
disc static with tip at 5 mm away d) rotation movement only 
A vortex mixer (Whirlmixer™ Fisons SGP-202-010J, Fischer Scientific UK) was used to 
act as a rotary mechanical stage. The potentiometer on the underside of the unit and the dial 
control on the front were adjusted to the lowest setting to provide the slowest rotational 
speed motion. 
A putty – mount assembly was used to mount the discs in the vortex mixer. Initially the 
disc was placed in a suitable indentation created in the putty. However there were 2 
problems that arose during piloting of the method. First, was it was difficult to put the disc 
in place without touching the top and disturbing the biofilm. The second problem was the 
air pressure occasionally causing the disc to fly out. To overcome this, the mount supplied 
with the implant disc packaging was embedded in the putty material (Aquasil Soft Putty, 
Dentsply, UK) and the discs were screwed on to it. This provided a firm and secure 





Finally, the AIR-FLOW® handy 2+ reservoir was filled to the same level (maximum line) 
before every set of discs (a set of disc denotes 4 discs, 1 of each type) was blasted. This 
ensured that the reservoir was never less than half-way full at any instance.  4.3.4 STERILIZATION'OF'THE'DISCS'
Sterilization of test samples was performed prior to cell culture. Two methods were 
considered, autoclaving and gamma radiation. According to previous studies, the chemical 
composition of the titanium implant surfaces that were sterilized by Gamma radiation 
showed a similar distribution of elemental concentration as control surfaces while the 
surfaces sterilized by autoclaving showed a higher percentage of Carbon. Autoclaving also 
induced an increase in water contact angle (Park et al., 2012, Drake et al., 1999) and 
resulted in a decreased surface roughness due to the deposition of steam-borne 
contaminants (Park et al., 2012). When re-exposed to S. sanguinis, surfaces that were 
autoclaved showed an increased bacterial colonization (Drake et al., 1999). Taken together, 
this data suggested that gamma radiation was the better method suited to sterilize the discs 
for the objectives of this study, hence discs were gamma radiated after the treatment 
procedures and before the cell culture assays. 4.3.5 CELL'CULTURES' '
Primary human osteoblast (HOB) cells derived from the alveolar bone of subjects 
undergoing third molar extraction were used at passages 10-15. Ethics and patient consent 
was obtained and approved (05/ Q1803/ 85). 
All cell culture procedures were performed under aseptic conditions in a Class 2 safety 
cabinet (Astec-Microflow Class II ABS, Bioquell UK) and incubation was carried out in a 
humidified atmosphere with CO2 at 37˚C in 5% CO2 (Heracell™ 150i, Thermo Scientific, 




4.3.5.1  RESUSCITATION'OF 'CRYOPRESERVED'CELLS'
HOB cells were resuscitated for expansion for cellular studies. Cells were thawed by 
warming them to room temperature and adding 1 ml of HOB culture media drop wise in 
order to avoid osmotic shock to the cells. The HOB culture media was made up of 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma, UK), supplemented with 10% 
foetal calf serum (FCS, Sigma UK), 1% minimal non-essential amino acids (Sigma UK), 
200 mM L-glutamine (Sigma UK), 1M HEPES (Sigma UK), penicillin-streptomycin 100x 
(Sigma UK) and L- ascorbic acid (150 µg/ ml) (Sigma UK). The cells were then transferred 
to a sterile universal tube and made up into 10 ml with the media.  
This mixture was centrifuged at 2000 rpm for 5 minutes (Eppendorf Centrifuge 5702, 
Eppendorf, UK). Following centrifugation, excess media was discarded and the remaining 
cell pellet was resuspended in fresh HOB media and homogenized then transferred to one 
or two 25 cm3 culture flasks according to the size of the pellet.  The flasks were incubated 
in a humidified atmosphere with CO2 at 37˚C in 5% CO2 (Heracell™ 150i, Thermo 
Scientific, UK).  4.3.5.2  SUBCULTURING' '
Cells were checked microscopically daily to ensure they were healthy and growing as 
expected and the media was changed every 3 days. Cells were subcultured when they were 
80% - 90% confluent. 
Confluent cells were harvested by trypsinization. This involved removing the spent 
medium from the flasks, rinsing the cells with phosphate buffered saline (PBS, Sigma UK), 
adding 1ml of diluted (1x) trypsin (Sigma UK) and incubating for 5 minutes. 
Detached cells were observed under an inverted light microscope (Primo Vert, Carl Zeiss, 
UK) and dislodged by gentle tapping or scraping with a cell scraper if necessary. 10 ml of 
HOB media was added to inactivate the trypsin and stop the enzymatic reaction. The cell 
suspension was removed to sterile universal tubes, centrifuged at 2000 rpm for 5 minutes, 
the supernatant was then discarded and the pellet re-suspended in fresh media and cells 
were either subcultured in a 1:2 split ratio or counted and used for the experiments as 





Cell counting was conducted before cells were seeded on the implant discs using Trypan 
Blue, 0.4% vitality dye (Life Technologies, UK). A Bio-Rad TC10 automated cell counter 
(Bio-Rad, UK) was used to count the total and live cells. This was done in duplicates and 
the mean number of live cells recorded.  4.3.5.4  SEEDING'CELLS 'ON' IMPLANT'DISCS '(FOR'ALAMARBLUE'AND'ALKALINE'PHOSPHATASE'ASSAYS)'
After gamma radiation, the discs were placed in 96 well plates with treated surfaces for cell 
culture (Nunc™ MicroWell™ 96-Well Microplates, Thermo Scientific UK). 200µl of HOB 
cell suspension containing 1 x 104 cells was pipetted onto each disc and the plate was 
incubated. Tissue culture plastic was used as the negative (non-toxic) control. 
!4.3.6 CYTOTOXICITY'TESTING'BY'MTT'
MTT was performed to measure cell metabolic activity. Material toxicity was assessed 
indirectly by exposing cells to media containing leachable components from the 
decontaminated discs (eluant). 
This colourimetric assay is based on the reduction of tetrazolium salt (MTT) by 
mitochondrial dehydrogenases. During incubation, the redox system reduces this yellow 
salt to an intracellular insoluble bluish - purple formazan. The amount of purple formed 
should be proportional to the number of viable cells as this enzyme is only present in intact, 
living cells.  
Discs were placed in bijous containing 5 ml HOB media under sterile conditions. The 
bijous were rotated for 24 and 72 hours on a DENLEY Spiramix. The eluants were 
collected and transferred to clean bijou vials and stored at – 20˚ C till they were ready to be 
used for the MTT assay. In the meantime, 96 well plates were seeded with cells at a density 
of 1 x 104 cells/well and incubated for 24 hours with 100 µl of media to allow the cells to 
acclimatize. After that, the media was replaced with 100 µl of the eluants and incubated for 




An MTT solution was prepared by dissolving 5 mg of 3-(4,5) dimethythiazol-2-yl-2,5 
diphenyl tetrazolium bromide in 1 ml of sterile phosphate buffered saline. This was added 
to 10 ml of HOB medium without ascorbic acid.  
At the selected exposure times, the elution media was discarded and replaced with 100 µl 
of MTT solution per well. Negative  (non toxic) and positive (toxic) controls were prepared 
comprising media only and 10% alcohol diluted in media respectively. The plates were 
incubated for a further 4 hours and then the solution was replaced with 100µl of DMSO 
(Sigma) per well and shaken for 5 minutes to ensure dissolution of formazan crystals. 
Absorbance was measured using a spectrometer (Dynex) at 570 nm test and 620 nm 
reference wavelengths.  
!4.3.7 OSTEOBLAST'PROLIFERATION'ASSAY'–'ALAMARBLUE®'
The alamarBlue® is a fluorometric/ colourimetric assay which uses the reducing power of 
viable cells to measure the proliferation of cells. When cells are metabolically active, they 
maintain a reducing environment within the cytosol of the cell. Resazurin (REDOX 
indicator), the active ingredient of alamarBlue® reagent, is a non-toxic, cell permeable 
compound that is blue in color and virtually non-fluorescent. Upon entering cells, resazurin 
is reduced via an oxidation-reduction reaction to resorufin, a compound that is reddish-pink 
in color and highly fluorescent. Viable cells continuously convert resazurin to resorufin, 
increasing the overall fluorescence and colour of the media. The reduction of alamarBlue® 
is relative to cell growth allowing quantitative analysis of cell metabolic activity. The 
lighter the pink colour of the alamarBlue®, the higher the mitochondrial activity, and hence, 
the cell proliferation.  
Advantages of this assay is that it is relatively simple, highly sensitive, quantitative and 
does not necessitate killing cells i.e. not an end point assay, thus allows continuation of 
culture or further assays to be performed if necessary  
Cell proliferation was evaluated at days 3, 7, 14, 21 and 28. At each time point, the culture 
media was replaced with 250 µl of alamarBlue® solution (10% v/v alamarBlue® in phenol 
red-free medium) and the plate returned to the incubator for 4 hours. After 4 hours, 100 µl 




(100 µl per well) and the absorbance was measured at a wavelength 570 nm (reference 
wavelength 620 nm) wavelengths using a spectrophotometric plate reader (DYNEX Opsys 
technologies reader). Excess alamarBlue® was removed and the samples were washed 3 
times with PBS then 200 µl HOB media was added to each well for further incubation to 
the next time point. Media was changed twice a week.  
!4.3.8 OSTEOBLAST'DIFFERENTIATION'ASSAY'1 'ALKALINE'PHOSPHATASE''
Proliferation is followed by matrix maturation, during which the matrix is prepared for the 
deposition of the mineral phase of bone by alkaline phosphatase (ALP), an enzyme 
associated with mineralization within bone and cartilage and is used as a marker of 
osteoblast differentiation (Figure 29). 
 
Figure 29 Proliferation of osteoblasts is shown to decrease as the cells terminally 










ALP production in HOB cells was determined by measuring the ALP activity in cell lysates 
obtained from freeze/ thaw procedure. At the required time-point, the supernatant HOB 
media was removed from the samples (including controls) and 200 µl of sterile UHQ 
distilled water was added to each sample. The samples were freeze-thawed 3 times by 
placing the well plate at – 80˚ C for 20 minutes followed by thawing at 37˚ C for 15 
minutes. In between each cycle, the suspensions were thoroughly mixed to ensure cell 
dispersion and to obtain a homogenous cell lysate. The lysates were collected and stored at 
– 80˚ C until needed.  
50 µl of cell lysates were aliquoted in 96 well plates, to which 50 µl of ALP substrate 
reagent (p-nitrophenol phosphate, magnesium chloride hexahydrate, and triton X-100 in 0.1 
M glycine, all Sigma) was added. A standard curve was obtained by serially diluting p-
nitrophenol (Sigma) in 0.1 glycine (Sigma) at pH 10.3 from 100 to 1.563. 100 µl of each 
dilution was pipetted into the appropriate wells. Plates were shaken for 2 minutes on a 
Titertek plate shaker and then incubated at 37˚ C for 20 minutes.  
In this reaction, the substrate p-nitrophenylphosphate is hydrolyzed into phosphate and p-
nitrophenol in the presence of the enzyme alkaline phosphatase. The product is yellow in 
colour and the intensity is proportional to the concentration of alkaline phosphatase.  
After 20 minutes, the plates were placed in a plate reader (Dynatech) and absorbance was 







!4.3.9.1  PREPARATION'OF 'SURFACES 'FOR'SEM'AND'EDS'
For descriptive analysis of titanium surface changes after the samples were decontaminated, 
24 discs (2 discs of each surface subjected to each type of treatment i.e. 2 x 4 surfaces x 3 
treatments) were evaluated using SEM and images were acquired at 3000x and 6000x 
magnification. EDS operating at 12 kV was also carried out on the discs that were 
decontaminated using air-powder blasting to compare the chemical composition of the 
surface with that of the pristine surfaces Figure 16 
The same protocol used for the pristine surfaces was used for the decontaminated surfaces 
(chapter 3, page 127). In addition, the samples were sputter coated according to the 
decontamination method used as follows: 
a) Mechanically cleaned samples were gold coated, as described previously because we 
were not intending to carry out any EDS analysis on them.  
b) Samples decontaminated with bioactive glass blasting were carbon coated using an 
Emitech K250 sputter coater. 
c) Samples cleaned with glycine powder blasting were gold coated after EDS analysis was 








The alamarBlue and alkaline phosphatase experiments were repeated three times while the 
MTT and scanning electron microscopy experiments were performed only once. Two 
measurements were taken from each disc in the alamarBlue and alkaline phosphatase 
assays, and three measurements per disc for the MTT assay.  
Titanium discs were allocated to assays as described in Table 24. 
Surface Total SEM MTT AB ALP 
6905 110 6 8 24 72 
7874 110 6 8 24 72 
7873 110 6 8 24 72 
7676 110 6 8 24 72 
Table 24 Allocation of titanium discs to different assays (SEM- scanning electron microscopy, 
MTT - 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; AB - alamarBlue; ALP - 
Alkaline phosphatase)  
 
Data were expressed as means ± standard deviation and one way ANOVA followed by post 
hoc testing using Scheffe’s correction for multiple comparisons (p < 0.05) to detect if there 
were statistically significant differences between the different types of treatments and 
osteoblast proliferation and/or differentiation.  










Figure 30 Schematic diagram showing the workflow of the tissue culture assays. Discs were 
decontaminated at day ‘0’ then sent for gamma radiation/ SEM. As soon as they were back, 
cells were plated at the desired concentration on the discs and assayed after 1, 2 days of 
culture (MTT); 3, 7, 14, 21, 28 days of culture (AB); 7, 14, 21 days of culture (ALP). (AB, 






4.4 RESULTS'4.4.1 CELLULAR'RESPONSE'TO'DECONTAMINATED'TITANIUM'SURFACES'4.4.1.1  CYTOTOXICITY 'AS 'ASSESSED'BY 'MTT'
Samples were eluted for 24 and 72 hours to detect if any leached products could affect cell 
behavior. The cytotoxicity of samples and metabolic activity of the cells were assessed by 
exposure to MTT for 24 and 72 hours. The results of these indirect test elution studies are 
shown in Figure 31 and 32. 
Eluants taken after 24 hours from decontaminated and control implant surfaces showed 
slightly less absorbance values compared to the negative ‘media only’ control (figure 31). 
There was an increase in absorbance values after 72 hours exposure for all the materials in 
general, and were comparable to the negative control indicating that there were no 
cytotoxic detrimental effects to the cells (figure 32). Also, the elutions obtained after 72 
hours from the rougher surfaces (7874 and 6905), showed greater absorbance irrespective 
of incubation (exposure time) or treatment method (figure 32). One way ANOVA test 
demonstrated that there were no significant differences (p > 0.05) found between any of the 
decontamination methods used, while a significant difference (p < 0.001) was observed 


































 Figure 31 MTT assay showing mitochondrial activity of HOB cells after 24 h and 72 h 
exposure to the 24 h eluants of different implant surfaces after being subjected to different 

















































































Figure 32 Results of MTT assay showing HOB cell response after 24 h and 72 h exposure to 
the 72h eluants of each surfaces. There was an increase in absorbance values after 72 h 
































































































4.4.1.2  DIRECT'CONTACT'PROLIFERATION'ASSAY'(ALAMARBLUE)' '
Results were obtained at day 3, day 7, day 14, day 21 and day 28. Proliferation activity of 
the cells on the titanium surfaces in the four groups is presented in Figure 33. Proliferation 
pattern was more or less similar for all surfaces and treatment methods. There was a 
progressive increase in cell number with proliferation peaking at days 14 and 28. A drop in 
proliferation rate was observed at day 21 compared to day 14. Tissue culture plastic was 
used as a negative control and showed the same pattern of proliferation for the osteoblasts. 
Each experiment was conducted in duplicates obtaining 2 readings from each disc. This 










































Figure 33 Proliferation of HOB cells as determined by the alamarBlue assay showing each 
surface and variation with time after being subjected to various decontamination methods. 
Control discs were non-contaminated and non-treated. The values are means   standard 
deviation (n=6). Significantly lower proliferation rate on surface 7873 at days 7, 14 and 21 
after air blasting, with BAG and glycine, compared to the mechanical debridement (p<0.05).  









































A positive proliferative response of HOB cells was observed with all samples and 
treatments, proving re-establishment of biocompatibility comparable to control specimens. 
However, there was significantly lower proliferation rate on surface 7676 at day 14 after 
glycine blasting compared to those that were mechanically debrided (p=0.04). For surfaces 
7873, significant differences were observed at days 7, 14 and 21 in which air-blasted 
surfaces, with BAG and glycine, showed less proliferation compared to the scaled surfaces 
(p<0.05). Differences are summarized in Table 25. 
 
Day Surface Decontamination method  
Less proliferation than 
decontamination by p-value 
14 7676 Glycine Scaler 0.04 
7 7873 BAG Control 0.02 
14 7873 Glycine Scaler Control 
0.02 
0.03 
21 7873 BAG Scaler 0.004 
21 7873 Glycine Scaler 0.03 
!
Table 25 Time points, surfaces and decontamination methods at which significant 
differences in HOB cell proliferation were observed 
 
When osteoblast proliferation on pristine implant surfaces was compared, proliferation was 
greatest on the smooth surface 7873 at all time points, followed by 7676 (smooth), then 
7874 (nanorough) and was always lowest on 6905 (moderately rough) (Figure 34). The 
same trend was observed at all time points, however differences were only significant at 







Figure 34 HOB proliferation at different time points on different pristine implant surfaces. 
Highest proliferation rates were observed on surface 7873 (smooth) and lowest on 6905 




















7 7873 6905 0.000 14 7873 6905 0.000 
  7676 0.33   7676 0.26 
  7874 0.43   7874 0.002 
 7676 6905 0.028  7676 6905 0.005 
  7873 0.331   7873 0.26 
  7874 0.998   7874 0.15 
 7874 6905 0.02  7874 6905 0.39 
  7676 0.99   7676 0.15 
  7873 0.43   7873 0.002 
 6905 7676 0.028  6905 7676 0.005 
  7873 0.000   7873 0.000 
  7874 0.02   7874 0.39 
!
Table 26 Time points and surfaces at which significant differences in HOB cell proliferation 






























!4.4.1.3  OSTEOBLAST'DIFFERENTIATION'BY 'ALKALINE'PHOSPHATASE'ASSAY' '
!
ALP activity was lowest after decontamination using BAG. This trend was observed on all 
surfaces at all time points and was shown to be significant at day 14 on surface 6905 after 
BAG compared to the same surface decontaminated using a scaler (p=0.006). Similarly, 
7874 surfaces decontaminated using BAG at day 14 showed significantly lower ALP levels 
compared to using glycine (p<0.049). The only instance where ALP level was not the 
lowest after BAG decontamination was at day 28 on surface 6905. ALP levels were also 
significantly lower on control 6905 surfaces compared to those decontaminated with scalers 
at day 14 (p=0.012). However this was not repeated at any other time point or surface 

























































Figure 35 Alkaline phosphatase activity of alveolar osteoblasts cultured on different implant 
surfaces after being subjected to different decontamination methods.  
Data is plotted as means ± standard deviation (n=6).  











































The morphologic characteristics after treatment procedures were investigated by means of 
SEM. After mechanical debridement, scratch marks were evident from the blade, which 
removed some of the original surface coating resulting in exposure of the titanium base 
underneath (Figure 36). Surfaces decontaminated using BAG blasting resulted in a surface 
that appeared homogenously rough regardless of original surface topography (Figure 37), 
while surfaces decontaminated with glycine powder blasting were covered with remnants 
of the rhomboidal – cylindrical powder particles, but did not seem to visibly alter the 
underlying titanium surfaces (Figure 38). The SEM images show both air powder abrasion 
systems to be more efficient in eliminating the attached biofilm compared to mechanical 









Figure 36 SEM micrographs of surfaces treated by mechanical debridement (left x3000 
magnification, right x6000 magnification). Scratch marks from mechanical debridement and 





Figure 37 SEM micrographs of surfaces treated by air-powder blasting using BAG 
(left x3000 magnification, right x6000 magnification). Surfaces appear homogenously 


































Figure 38 SEM micrographs of surfaces treated by air-powder blasting using glycine (left 
x3000 magnification, right x6000 magnification) (Top to bottom: 6905, 7874, 7873, 7676) 




The surface composition of the four discs after air-powder blasting was determined using 
EDS. The spectrum for discs decontaminated with BAG revealed the presence of calcium, 
phosphate and silicon, which are constituents of BAG indicating the inclusion of the 
particles within the titanium surface. Oxygen levels were comparable, but titanium levels 
















Figure 39 Elemental spectrum obtained by the EDS.  Analysis of different titanium surfaces 
after decontamination using BAG blasting – Spectrum shows peaks for titanium and oxygen 
typical of these surfaces as well as peaks for calcium, phosphate and silicon which are 




















































After glycine (NH2CH2COOH) blasting, EDS analysis showed that oxygen levels were 
comparable, but titanium levels were lower compared to the pristine surfaces. Silicon and 
carbon were also found. Contrary to expectations, nitrogen and hydrogen were not detected. 
One explanation can be that Hydrogen gives off such a low energy x-ray and has no energy 
levels that it cannot be picked up by most EDS detectors used. The Nitrogen's K alpha 
energy is at 0.392 meaning that it could be a small peak overlapped and hidden in the area 
between the carbon (K alpha 0.277) and oxygen peak, possibly under the Titanium L alpha 







































Figure 40 Elemental spectrum obtained by the EDS analysis of different titanium surfaces 
after decontamination using glycine air blasting (from top to bottom 6905, 7874, 7873, 7676). 
Oxygen levels were comparable to the corresponding pristine surface, but titanium levels 
were lower. In addition, Silicon and Carbon were detected. The elemental constituents of 


































The removal of the bacterial biofilm and the cell components that might adversely 
influence host cell growth on implant surfaces seems to be essential for the treatment of 
peri-implantitis. Amongst various methods, air-powder systems have been shown to be a 
feasible alternative to conventional mechanical debridement for the elimination of biofilms 
from dental implants.  
A powder of potential interest is glycine, which is a soft powder with documented safety to 
be used subgingivally. Research has shown that this powder induces the least gingival 
erosion compared to conventional sodium bicarbonate or hand instrumentation (Petersilka 
et al., 2008). In addition, it has been demonstrated that glycine was effective in removing 
biofilms from dental implants without any adverse surface effects. (Schmage et al., 2012, 
Schwarz et al., 2009a). 
Another potentially interesting powder is BAG, which has been reported to be a successful 
osteoconductive and osteoinductive material (Froum et al., 1998). Furthermore, its use as a 
powder for the treatment of peri-implantitis has not been previously reported.  
The primary purpose of the present in vitro study was to assess the influence of different air 
abrasive powders in re-establishing biocompatibility of S. mitis - contaminated implant 
surfaces. The results of the present in vitro study indicate that reestablishment of 
biocompatibility of implant surfaces was possible using any of the three methods tested, 
which were mechanical debridement, air-blasting using BAG and air-blasting using 
glycine.  
No residual cytotoxicity could be detected and treated surfaces showed comparable results 
to sterile non-contaminated surfaces. Cell growth and proliferation was also observed on all 
surfaces regardless of the decontamination method. However, on smooth surfaces, cell 
proliferation was lower after air-blasting procedures compared to their control or 
mechanically debrided counterparts. One explanation could be the response of osteoblast 
cells to certain degrees of roughness, where it has been shown that osteoblast cell 




blasting procedures used could have resulted in slight roughening (however this was not 
measured) of these surfaces resulting in a reduced cell proliferation rate.  
These present results corroborate, to a certain extent, the findings from an in vitro study by 
Schwarz et al. (Schwarz et al., 2009a) in which cell viability was established on SLA 
titanium surfaces treated with glycine powders. In their study however, mitochondrial 
activity of the cells was significantly lower compared to their untreated control titanium 
discs. This was not the case in the present study. This difference may be attributed to 
differences in cell type, assay or time point. In the study by Schwarz et al. (Schwarz et al., 
2009a), human osteosarcoma SaOS-2 cells were used and transformed cell lines have 
different characteristics than primary cells. In the current study, primary alveolar HOB cells 
were chosen for the cell culture experiments due to their similarity to the types of cells that 
the implant surfaces would encounter during osseointegration. Furthermore, Schwarz et al. 
(Schwarz et al., 2009a) only assessed differences at day 7 and used a different ATP-based 
luminescent cell viability assay to measure mitochondrial activity. Another reason that they 
may have found lower cell viability could have been because surfaces were autoclaved after 
being treated with air blasting and prior to the cell culture experiments. Autoclaving has 
been shown to increase the carbon content of titanium surfaces, which in turn would affect 
cell viability (Park et al., 2010). They also found that powders that were harder and were 
able to produce a slight degree of surface ablation resulted in better cell viability. Again this 
was not the case in the present study, where using the harder BAG particles did not 
correlate with better proliferation. To the best of our knowledge, the study by Schwarz et al. 
(Schwarz et al., 2009a) was the only other study that has assessed biocompatibility after 
blasting using glycine.  
We had postulated that the residual or embedded BAG particles would be released into the 
fluid with time due to their absorbable properties and that the ions initially released such as 
calcium and phosphate would play a direct role in improving the surface bioactivity and 
enhancing cell differentiation. Indeed, remnants of the blasting material were detected by 
EDS, which revealed the presence of calcium, phosphate and silica. However, results 
obtained from the ALP assay, showed that this did not result in increased cell 
differentiation. In fact, ALP activity was always lowest after decontamination using BAG 




blasting, which showed lower cell differentiation at day 14 compared to the same surfaces 
treated with glycine-blasting or a mechanical cleaning with a scaler respectively (see Figure 
35). 
Air polishing in this study was shown to be more effective in removing the attached biofilm 
compared to mechanical debridement. The efficiency of both these powders in this respect 
was demonstrated using SEM, although for the glycine powder there was a possibility that 
the powder remnants obscured underlying bacterial aggregates (Figure 38). This is 
consistent with other studies that reported that air polishing delivered the cleanest surfaces 
(Schmage et al., 2012) and removed 100% of the biofilm from SLA titanium surfaces 
(Schwarz et al., 2009a). This cleaning efficiency could be more pronounced in vivo where 
access for mechanical debridement could be more problematic. 
The amount of bacterial or powder remnants that remained on the titanium surfaces did not 
seem to affect the biocompatibility of the surfaces. Despite the presence of observed 
bacterial colonies after treatment with mechanical debridement for example, growth of vital 
HOB cells was still observed on all surfaces treated using this method. It is unknown to 
what extent bacterial and non- bacterial residues have to be removed from an implant 
surface in order to obtain a predictable, stable clinical result after treatment (Mombelli, 
2002) 
Although, it was not one of the aims of the study to measure surface alterations caused by 
the different decontamination instruments, SEM observations showed surface alterations 
after BAG blasting and after scaling. It is debatable whether surface alterations would 
affect re-osseointegration. McCollum et al. (McCollum et al., 1992) states that de novo 
plaque accumulation was similar regardless of surface texture of abutments after being 
treated with different instruments. However, some authors recommend using instruments 
that cause least surface alterations (Schmage et al., 2012, Schwarz et al., 2009a), whereas 
others recommend burnishing and polishing exposed implant threads (implantoplasty) to 
aid in the treatment of peri-implantitis (Lang et al., 2000).  
Due to BAG’s highly abrasive nature, an obvious dulling of the surfaces was observed. In 
addition sparks were produced during the collision of the glass particles with the titanium 




implant defects and may be associated with an increased risk of soft tissue trauma. Other 
studies have stated that BAG can remove enamel at half the volume of a slow speed 
tungsten carbide bur (Banerjee et al., 2008). A recommendation could be to reduce the 
pressure/flow settings when using BAG but this was not tested in the present study and 
more research is needed to support the safety of BAG powder in air polishing in general 

















Implant dentistry has progressed significantly in terms of surgical techniques and surfaces 
that accelerate osseointegration, however when peri-implantitis is diagnosed, there are no 
predictable treatments to resolve the problem (Donos, 2012). In 2008, The 6th EWOP 
(Lindhe et al., 2008) came to the conclusions that peri-implantitis lesions were caused by 
bacteria and that it was difficult to treat, warranting research in the microbiota making up 
the peri-implantitis community and the methods used for implant surface decontamination. 
In addition, there was conflicting evidence showing that different surfaces of implants may 
be more susceptible to peri-implantitis (Heitz-Mayfield, 2008). 5.1 THE'MICROBIOTA'ASSOCIATED'WITH'PERI1IMPLANTITIS'
A complex and heterogeneous subgingival microbiota was generally found around dental 
implants that have been in function for more than one year.  
Peri-implantitis was accompanied by an increased bacterial load, with the phylum 
Firmicutes, which are mainly Gram-positive organisms, making up the greatest proportion 
of this load. On the species level, F. alocis, S. constellatus, P. micra and A. meyeri were 
consistently found in greater proportion in these sites suggesting that these Gram-positive 
anaerobes and facultative anaerobes may play an important role in the pathogenesis of the 
disease. This is a very different picture to that described by previous studies which targeted 
the presence of specific bacteria. In those studies significantly higher proportion of Gram-
negative anaerobic bacteria were reported in peri-implantitis (Alcoforado et al., 1991, 
Leonhardt et al., 1999, Mombelli et al., 1987, Listgarten and Lai, 1999, Rams et al., 1984, 
Charalampakis et al., 2012). Our results, however, are supported by recently published 
studies that have used an open-ended approach to describe the peri-implant bacterial 
community (da Silva et al., 2013, Koyanagi et al., 2013, Tamura et al., 2013b). 
This highlights the importance of using such an approach when studying bacterial 
communities especially if treatments involving antimicrobials are proposed. The current 
results suggest that a broad spectrum antibiotic, which covers both aerobes and anaerobes 
should be prescribed in the treatment of peri-implantitis. This supports the study by Rams 
et al. (Rams et al., 2014) who found that peri-implantitis patients frequently yielded 




clindamycin, amoxicillin, doxycycline, or metronidazole, but only rarely to both 
amoxicillin and metronidazole.   
Species that were isolated in significantly greater proportions in the peri-implantitis 
samples are considered in the following section. 
5.1.1 FILIFACTOR#ALOCIS#
F. alocis is commonly being reported in recent studies as an important species that is 
strongly associated with oral diseases including periodontitis (Abusleme et al., 2013, 
Griffen et al., 2012) and peri-implantitis (da Silva et al., 2013, Tamura et al., 2013b). In the 
present study, it’s prevalence in peri-implantitis ranked higher than traditionally established 
pathogens such as P. gingivalis. It was consistently isolated in nearly every sample with 
peri-implantitis and in none of the healthy samples. F. alocis  are Gram-positive, 
asaccharolytic, obligate anaerobic rods. They were initially identified in 1985 as 
Fusobacterium alocis and reclassified in 1999 into Filifactor according to their observed 
phylogentic relationship based on the 16S rRNA gene (Jalava and Eerola, 1999). A recent 
study evaluating the virulence properties of F. alocis and it’s ability to interact with P. 
gingivalis have reported that F. alocis was more resistant to oxidative stress and that its 
growth was stimulated under oxidative stress when compared to P. gingivalis. Sialidase 
activity, which is important for survival, persistence and pathogenesis of periodontal 
pathogens, was also present in all the F. alocis strains tested, but was 40% less than P. 
gingivalis. Last but not least, cocultures of P. gingivalis and F. alocis revealed enhanced 
biofilm-forming capacity and enhanced invasion and adhesion of epithelial cells (Aruni et 
al., 2011). The fastidious nature of F. alocis has been implicated as the reason for its lack of 
being detected by culture studies and hence being overlooked as an important periodontal 
pathogen, however this was not the case in our in our study, where it was cultured without 
difficulty. Schlafer et al. (Schlafer et al., 2010) have also detected the species in 77% of 
subjects with chronic periodontitis and 78% of those with generalized aggressive 
periodontitis, reflecting on the importance of F. alocis in periodontal disease. Its prevalence 
was on a par with the organisms considered to be key players in periodontal disease, but 
was the lowest compared to the same pathogens in healthy individuals (Schlafer et al., 
2010). This is similar to our current findings in peri-implantitis patients and is confirmed by 




Tamura et al., 2013b). Moreover, the close colocalization of F. alocis with periodontal 
pathogens that was observed in an in vivo biofilm model may indicate that these species are 
important in coaggreation events that take place during the establishment and maturation of 
biofilms (Schlafer et al., 2010).  
5.1.2 PARVIMONOS#MICRA#
The significantly increased proportion of P. micra in peri-implantitis in the present study as 
well as all the other studies mentioned in table 17 seems to implicate them strongly in peri-
implantitis (Tamura et al., 2013b, da Silva et al., 2013, Koyanagi et al., 2013, Kumar et al., 
2012). In addition they were detected by Rams et al. (Rams et al., 2014) in 111 out of 120 
patients with peri-implantitis and by Alcoforado et al. in a failing implant with 
inflammation (Alcoforado et al., 1991) when the species was formerly known as 
Peptostreptococcus micros. They are obligate, asaccharolytic, anaerobic, Gram-positive, 
and non-spore-forming bacterial species that are part of the ‘orange complex’ of species 
(Socransky et al., 1998) and have been described in oral health as well as in relation to a 
variety of oral diseases such as periodontitis (Rams et al., 1992), endodontic infections 
(Siqueira et al., 2007) and dentoalveolar infections. 
5.1.3 STREPTOCOCCUS#CONSTELLATUS#
S. constellatus is also a member of the ‘orange complex’ of species (Socransky et al., 
1998). They are Gram-positive, non-spore forming, non-motile cocci, which are part of the 
milleri group. They have been reported to be more common in subgingival plaque than the 
other two members of the milleri group (S. intermedius and S. anginosus), which were 
more common in supragingival plaque (Whiley et al., 1990). S. constellatus were the most 
numerically elevated streptococci in refractory periodontitis in patients with poor response 
to scaling and root planing (SRP) (Colombo et al., 1998) and have been commonly 
associated with abscesses (Claridge et al., 2001) and dental infections (Whiley et al., 1990). 
Regarding dental implants, Tamura et al. support the findings of this study regarding the 
importance of S. constellatus in peri-implantitis, which they found in high proportions in 
their failing sites, but were not detected in any of the 15 healthy implant sites. They also 
noted that although streptococci were the predominant genus in both peri-implantitis and 




were found only in peri-implantitis in their study and our findings concur with their results 
as we only found S. sobrinus in the peri-implantitis samples. 
5.1.4 ACTINOMYCES#MEYERI#
In contrast to our findings, Tamura et al. (Tamura et al., 2013b) found that A. meyeri 
predominated in healthy sites. There was no mention of A. meyeri in the other studies. In an 
in vitro biofilm study, A. meyeri was the most prominent colonizer on various titanium 
surfaces compared to A. naeslundii, A. odontolyticus and A. israelii (Sarkonen, 2007). The 
same authors found that A. odontolyticus was the most prominent species isolated from 33 
failing implants (Sarkonen et al., 2005). A. odontolyticus and A. meyeri are closely related 
phylogenetically and biochemical testing may have been necessary for accurate phenotypic 
differentiation of the two. There is a possibility that the species identified in this study may 
be A. odontolyticus and that would coincide with the observations of Sarkonen et al. 
(Sarkonen et al., 2005). On the other hand, the presence of a considerably high proportion 
of A. meyeri would reinforce the fact that they are important initial colonizers in the process 
of biofilm formation on dental surfaces. However what was surprising was the total absence 
of A. meyeri in healthy sites in this study.  
Traditionally, A. meyeri has been described as a facultative anaerobe isolated from gingival 
crevices of periodontally healthy individuals. However, it has also been isolated in samples 
from active destructive periodontitis (Moore and Moore, 1994), brain abscesses, liver 
abscesses (Felekouras et al. 2004) and chronic pancreatitis (Harsch et al. 2001). 
It is important to remember that the mere isolation of bacteria from sites with disease is not 
enough to understand the complex pathogenesis of peri-implantitis and it was not the aim 
of this study to try to pinpoint specific species, but rather to describe and compare the 






In the current study, peri-implantitis was observed more around implants with a moderately 
roughened surface compared to those with a machined surface, however there was no 
intention to investigate the prevalence of peri-implantitis according to the different surface 
textures or manufacturer, as this would have required a much larger and preferably 
randomized study. In the literature, there is inconsistent evidence to suggest that implant 
surface may be a risk indicator for peri-implantitis (Heitz-Mayfield, 2008). A retrospective 
study which compared 2,182 smooth-surface implants with 2,425 rough-surface implants 
found no difference in the survival rates of these implants (Balshe et al., 2009), while a 
Cochrane systematic review that compared the occurrence of peri-implantitis between 
turned and roughened surfaces showed that more implants with rough surfaces were 
affected by peri-implantitis over a 3 year period and that turned machined implants had 
20% less risk of being affected. These findings were based on 3 randomized clinical trials, 
with relatively few participants, often with a risk of bias and the authors concluded that 
there was no evidence to show that any particular type of implant has superior long-term 
success (Esposito et al., 2007). 5.3 BIOFILM'FORMATION'ON'IMPLANT'SURFACES'
The first generation of implants were mainly concerned with improving mechanical 
properties, while the current generation of implants have focused more on surface 
modifications both topographically and chemically. It seems that the development of the 
future generation of implants will be aimed at surface modifications using pharmacological 
components and molecules to direct and enhance cellular interactions (Palmquist et al., 
2010b).  
Of particular importance is the possibility of surfaces in minimizing biofilm formation. In 
the present study, no differences observed in biofilm formation after 96 hours between any 
of the moderately rough surfaces (with or without fluoride) or the smooth surfaces used. It 
appears that once initial colonization has been established, the surface has little effect 




which rougher implant surfaces were commonly associated with increased biofilm 
formation (Bollen et al., 1996, Quirynen et al., 1993, Quirynen and Listgarten, 1990), 
however corroborate to a large extent the results of recent studies on biofilm formation 
(Schmidlin et al., 2013, Lin et al., 2013, Frojd et al., 2011b, Frojd et al., 2011a, Al-Ahmad 
et al., 2010) and clinical studies on progression of peri-implantitis on moderately rough 
implant surfaces(Wennstrom et al., 2004, Astrand et al., 2004b), in which no differences 
could be found regardless of the surface (moderately rough or smooth) used.  5.3.1 IN#VITRO 'BIOFILM'MODEL'
It could be argued that this study used a single-species biofilm that is associated with 
healthy implant sites. However, as previously mentioned, streptococci are important early 
colonizers (Marsh 1995, Li 2004) and make up a major component of a biofilm (Al-Ahmad 
2010). It is their adhesion, which facilitates the colonization of subsequent organisms that 
would otherwise be incapable of binding to host surfaces and could ultimately lead the 
formation of a pathogenic biofilm. A single species was used because it was found to yield 
more standardized results in term of bacterial counts than when a multispecies biofilm was 
attempted (Appendix 5). Other studies have shown very different bacterial adhesion when a 
2 species (S. sanguinis + A. naeslundii) and a 3 species (S. sanguinis + A. naeslundii + L. 
salivarius) biofilm were grown in vitro (Frojd et al., 2011a). Conversely biofilm formation 
and virulence expression by S. mutans were altered when grown in a dual-species model 
(Wen et al., 2010), whereas V. dispar seemed to have profited from the lactic acid produced 
by the streptococci and continued to grow increasingly up to the 16.5 hours of the 
experiment, whereas others only showed minimal increase or remained stagnant (Schmidlin 
et al., 2013). These studies emphasize the fact that in addition to the characteristics of the 
surface, the model bacteria used will influence the biofilm formation on titanium surfaces 
in vitro (Frojd et al., 2011a). In this study it was essential to keep confounding factors to a 
minimum and thus it was agreed that a single species would be most suitable.  
The in vitro model system was based on the previously validated Zurich biofilm model 
described by Guggenheim et al. (Guggenheim et al., 2001). Various models of in vitro oral 
biofilm models have been described and applied to problems of clinical relevance. These 
models can be classified according to the type of delivery of the growth medium into two 




either flow cells (Larsen and Fiehn, 1995, Christersson et al., 1987) or of chemostats 
(Bradshaw et al., 1996) modified to allow insertion and removable of colonizable surfaces 
and utilize fluid flow or scraper blades to generate continuous detachment forces of the 
biofilm. Examples include the artificial mouth (Sissons et al., 1991) and the constant depth 
film fermenter (CDFF) flow cells, which has been widely used in oral biofilm development 
and research (Pratten, 2007, Peters and Wimpenny, 1988) 
While these devices have contributed to our understanding of biofilm adhesion and 
formation, their use has certain drawbacks. They are complex instruments that involve 
different types and sizes of vessels, tubes and valves. This complex structure leads to 
difficulties in ensuring sterile conditions are maintained throughout the duration of the 
experiment.   In addition, they require a thorough knowledge of the device assembly, hence 
they are technically demanding and difficult to adjust and control.   Furthermore, most of 
the time, limited number of samples can be used and sometimes these samples need 
specific dimensions. Moreover, the pulsed particles are cleared from the culture by the 
action of the flow rate and volume.  As a result, chemostats with large volumes and 
relatively slow flow rate could mean long residence times, making them inappropriate for 
studying agents with short exposures. For example, if it were decided to test the effect of 
different antimicrobial rinses applied for 30 seconds on the biofilms grown on the titanium 
implants, this would have not been possible. In addition, artificial models that use a 
working volume of more than a few millimetres would not allow the use of media made up 
of natural substrates such as human saliva (Guggenheim et al., 2004). 
Static models on the other hand such as the microtitre plate model used in this study or the 
minimum biofilm eradication concentration assay are simple to prepare, maintain and 
analyze and do not require specialized laboratory equipment. They allow convenient 
changes of experimental parameters (species, medium, additives), which can be applied and 
removed from the system virtually instantaneously if necessary. Drawbacks of these models 
include that the biofilms cultivated are subjected only intermittently to detachment forces in 
the form of dip-washing or gentle swirling. In the present study, these forces were enough 
to dislodge the loose bacteria surrounding the biofilm, but not the firmly attached cells from 
the disc surfaces. In addition, such systems are closed without in or outflow during the 




static biofilm model will change during the experiment (e.g. nutrients become depleted, 
signalling molecules accumulate, etc.) unless the fluid is regularly replaced and 
replenished, as was done in the current study.  
An important parameter of the in vitro model is the medium used. In the current study we 
used a medium containing serum. The aim was to reflect the state of the titanium surface 
when implanted in vivo since one of the earliest events that occurs during the placement of 
dental implants is the coating of the titanium surface with serum proteins. This happens as 
the implant contacts blood at the implant site and is coated with the abundant cell 
attachment proteins. Consequently, using a medium containing serum was deemed to 
reflect the clinical situation more accurately than using a serum free medium.   5.3.2 TITANIUM'SURFACES'(APPENDIX#6) '
One mechanism that is used to increase bone to implant contact and to promote rapid 
osseointegration is to increase implant surface roughness (Steveling et al., 2001). The 
moderately roughened titanium surfaces used in this study have been well documented in 
the clinical scientific literature and have an excellent history of successful osseointegration 
(Rasmusson et al., 2005). The TiOblast™ surface (disc reference number 6905) was 
introduced in 1990 and is a titanium surface that has been grit blasted with titanium dioxide 
particles to achieve a moderately rough surface (Sa ≈ 1.1 ± 0.2 µm). It has shown excellent 
outcomes when compared to machined titanium in terms of in vitro cell biocompatibility 
(Mustafa et al., 1998), in vivo histomorphometrical comparisons and human histological 
(Ivanoff et al., 2001) and clinical studies (Gotfredsen et al., 1992). In a clinical study, only 
minor marginal bone level alterations of 0.3 mm were recorded during a 5-year follow up 
(Palmer et al., 2000). The OsseoSpeed™ surface (disc reference number 7874) is a 
development of the TiOblast™ surface and was introduced in 2004. It is characterized by 
the incorporation of small amounts of fluoride ions in the oxide layer and a slight 
topographic modification resulting in the appearance of nanometer-sized peaks and a slight 
increase in the micrometer scale of surface roughness (Sa ≈ 1.5 ± 0.07 µm). In vitro and 
animal studies (Berglundh et al., 2007a, Ellingsen et al., 2004, Guo et al., 2007, Isa et al., 
2006) have indicated increased bone-to-implant bonding at shorter healing times compared 
to TiOblast™ and there was no significant dip in Implant Stability Quotient, often seen with 




these surfaces and the tendency of lesser biofilm formation patterns, it may be postulated 
that fluoride might have contributed to this.  
The machined titanium surface 7676 (Sa ≈ 0.2 ± 0.05 µm) is the base surface, which is 
either polished to be used as an abutment surface that is smooth (as seen in the SEM) or is 
blasted to produce the implant surfaces TiOblast/ Osseospeed.   
Finally, the smooth test surface 7873 (Sa ≈ 0.16 ± 0.15 µm), was a titanium surface made 
of Grade V CP Ti. This surface is used for different products, but not for the implants.  
To exclude the possibility that any differences seen in biofilm formation could be attributed 
to surface wettability, all surfaces used in this study exhibited a comparable contact angle 
of 90 degrees and were considered slightly hydrophobic. 5.3.3 BIOFILM'ANALYSIS'
In this study, biofilm analysis was achieved using 3 different methods; traditional bacterial 
culture count, SEM which provides high resolution imaging and good depth of field but 
requires dehydration and fixation of the biofilm and CLSM which enabled a non-invasive 
evaluation of the hydrated biofilms and allowed 3D imaging of fluorescent data, by taking a 
series of XY images and superimposing them on one another in the Z-axis. The Leica SP2 
used is an inverted laser scanning confocal microscope and because the scope is inverted, 
much thicker specimens can be imaged, compared to an upright scope, making it ideal for 
live imaging.  
Using CLSM, titanium reflection proved to be difficult to overcome and could have 
produced a procedural error, however every effort was done to minimize reflection by using 
a negative control to omit background reflection before the start of each imaging session 
and adjusting the start point of biofilm analysis (approximately 2 µm away from the disc 
surface).  Also all discs for the same experiment were imaged in the same session directly 
after staining to avoid any adverse storage effects on the biofilm.  
An alternative to using CLSM imaging titanium could be the use of the 2-photon 
microscope. The concept of the 2-photon is that a laser with double the wavelength 




excitation. For example, if the intention were to excite a fluorophore of a wavelength of 
400 nm, a laser with 800 nm would be necessary for excitation. The reflected light will be 
800 nm, however the fluorescence from the excited fluorophore would be much less than 
800 nm, consequently, there is much wider separation between the wavelength of the 
reflected and the fluorescence, making images much clearer when there are reflection 
problems as in titanium. 
Regarding image analysis, most colour image analysis methods use the original confocal 
image data file to perform a monochromatic segmentation of the image. The software used 
in our study enabled in situ colour segmentation without prior transformation of the 
micrographs into monograph channels. This colour segmentation relies on the colour 
additive theory, which classifies each pixel of the image into predefined colour classes. The 
colour to be segmented is identified by green, red, and blue codes which are then subtracted 
from each pixel in the image enabling differentiation between live and dead subpopulations 
of the biofilm. 5.4 THE'EFFECT'OF'VARIOUS'DECONTAMINATION'METHODS'ON'RE1ESTABLISHING'BIOCOMPATIBILITY'OF'CONTAMINATED'IMPLANT'SURFACES'' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
The most common method to debride implant surfaces and remove the plaque biofilm is to 
use manual or ultrasonic scalers. However, accessibility problems and inherent difficulties 
for implant debridement imposed by implant threads and surface roughness may hinder 
effective cleaning. APDs may overcome some of these difficulties if direct access to the 
surface cannot be achieved (Meyle, 2012).  
In the present study, three decontamination methods were evaluated in their ability to re-
establish biocompatibility of the implant surface. These were mechanical debridement and 
air polishing using a glycine powder or BAG. The first powder was chosen in order to 
minimize surface alterations that may occur during air polishing, since glycine is 
characterized by a small particle size with low abrasiveness, while BAG was chosen to 
deliver bioactive molecules on the implant surface.  
To assess biocompatibility in vitro, two types of cells are generally used, primary cells and 




differentiation because they retain a normal phenotype since no dedifferentiation has taken 
place (Aubin et al., 1995, Di Silvio and Gurav, 2001). In the current study, it was decided 
to use primary cells characteristic of the implant site (i.e. alveolar HOB cells). 
Results of the current study indicated that regardless of the decontamination method used, 
HOB cells cultured on the implant surfaces showed that all discs, allowed cell attachment, 
cell proliferation, and osteoblastic differentiation after decontamination and their 
biocompatibility was comparable to pristine surfaces. However, air-polishing using BAG or 







1) This study was culture-based, and thus did not detect phyla (eg. TM7, Synergistetes and 
Spirochaetes) and species that may either be unculturable or difficult to detect with culture 
based methods. It is important in order to obtain a comprehensive representation of the 
diversity around implants to combine a similar culture study with one that is not non-
culture dependent. Da Silva et al. stated that the not-yet-cultivated bacterial species 
accounted for 32% - 40% of their results, but there were no observed differences in the 
mean proportion of these bacteria in peri-implantitis and health (da Silva et al., 2013). 
Recently, next generation pyrosequencing technology has been introduced that has enabled 
researchers to examine thousands of sequences from several samples simultaneously, 
providing a more comprehensive coverage than was previously possible. The only study 
that has done this in peri-implantitis is by Kumar et al. (Kumar et al., 2012) and has only 
discussed phylum and genus level results. They have reported a very different microflora to 
the present study and to others employing an open-ended approach (Tamura et al., 2013b, 
Koyanagi et al., 2013, da Silva et al., 2013) (Table 17).  Further investigations are 
necessary to confirm their findings and to distinguish taxa at the species-level, as different 
species within the same phylum and/or genus may be health-associated or disease-
associated.  
2) Bacterial identification was carried out using 16S rRNA gene sequencing. A limitation 
of this method is its inability to discriminate between closely related species and when 
identity match is 99% or more. In the present study, when multiple hits above 98.5% were 
identified with HOMD, all possibilities for species were reported. In addition, this 
limitation was explored further in the following two situations. 
i) Differentiation of S. constellatus and intermedius using the sialidase test 
In 1990, Beighton and Whiley (Whiley et al., 1990) described a simple method, using the 
sialidase (neuraminidase) activity of bacterial strains and based on the use of the 
fluorescent substrate (4-methylumbelliferyl a-D-N-acetylneuraminic acid). Using this test, 
they showed that strains of S. intermedius could be easily distinguished from S. constellatus 




intermedius. In the present study, 16S sequencing using the forward primer was confirmed 
to be a reliable method to differentiate between these two closely related species. 
ii) Met-G PCR Sequencing analysis for Actinomyces 
Identification of Actinomyces species is problematic. Furthermore, strains of genospecies 1 
and 2 exhibit > 99% 16S rRNA gene sequence similarity (Henssge et al., 2009). Henssge et 
al. (Henssge et al., 2009) showed that using the partial sequences of atpA and metG gave 
the best separation of the two species, where A. naeslundii genospecies 1 and 2 formed two 
distinct clusters. Thus, A. naeslundii genospecies 2 became A. oris sp. nov and A. 
naeslundii genospecies 1 remained as A. naeslundii sensu strictu. The present study 
confirmed that 16S rRNA gene sequencing was not the most reliable method for the 
identification the A. naeslundii genospecies. 
3) Regarding sampling technique; the advantage of using curettes as opposed to paper 
points is that the latter may sample only a small fraction of the bacterial biofilm present in 
the peri-implant pocket, possibly underestimating the presence of certain species (Gerber et 
al., 2006). For instance, rough surfaces harboured 25 times more bacteria than smooth 
surface when curettes were used to obtain plaque samples, whereas when paper points were 
used, minor differences were observed (Quirynen et al., 1993).  The paper point sampling 
technique may also recover less cells of species adherent to tooth surfaces such as 
Actinomyces and increase the proportion of organisms adherent or loosely adherent to the 
soft tissues (Quirynen et al., 2006). On the other hand, using paper points is a more 
standardized procedure and combining both sampling methods would be optimum.  
Another issue to bear in mind regarding sampling from around implants is that it could be 
technically challenging, especially if using paper points, due to implant-crown contours and 
implant surface configurations. Ideally it would be best if the supra structure was removed 
first, however this is not always practically feasible.  5.5.2 STUDY'2'
Intraoral biofilm formation is a complex process which involves hundreds of different 
species and cannot be reproduced in vitro and care should therefore be exercised in 




more easily standardized, more reproducible and provide results that are easier to interpret 
than in vivo studies. The latter have the advantages of providing more realistic conditions 
(complex plaque), however with many variations and confounding factors (salivary content, 
salivary forces, soft tissue movement, dietary habits, oral hygiene habits, etc.). Further 
clinical investigations are required to determine if surface characteristics affect the 
properties of the attached microbial biofilms. 5.5.3 STUDY'3''
1) It was necessary to gamma radiate the discs to inactivate bacteria and provide a sterile 
surface in order to permit cell culture assays. This is not a clinical possibility for treating 
implants associated with peri-implantitis associated and indeed the cell response could have 
been different if gamma radiation was not performed. On the other hand, this inactivation 
of bacteria alone should not have been insufficient to re-establish a biocompatible surface 
since it is necessary to also remove cell components which would adversely affect cell 
growth on implant surfaces (Kreisler et al., 2005). It would have been interesting to use a 
contaminated surface that was only gamma radiated. 
2) No water was used during operation, which does not reproduce the settings in clinical 
practice. On one hand, water has been considered to improve substance removal by acting 
as an acceleration medium for particles. On the other hand, it has been proposed that water 
may reduce the impact effect of abrasive particles (Petersilka, 2011). The intention was to 
compare BAG vs. glycine vs. mechanical scraping and limit the effect of any other 
confounding factors. Nevertheless, this still makes it different than the intended use in a 
clinical setting.  
3) Finally, from a clinical point of view, an in vitro single species biofilm collected after 96 
hours is non-mineralized and is very different from subgingival plaque and calculus that 





 5.6 CONCLUSIONS'5.6.1 STUDY'1'
• Peri-implantitis is a polymicrobial, complex and heterogeneous infection that is 
accompanied by an increased bacterial load.  
• Various species, namely F. alocis, P. micra, S. constellatus and A. meyeri were 
predominantly isolated in peri-implantitis sites. These are not the so-called 
‘periodontal pathogens’ that were traditionally associated with periodontal disease, 
however they were more dominant than the latter and seem to play an equally, if not 
more important role while V. parvula/ dispar and N. elongata were more prevalent 
in health. 5.6.2 STUDY'2'
• Within the limitations of the current study, our findings indicate that titanium 
surfaces that were different topographically or chemically did not have any 
differential effects on a single-species biofilm accumulation after 96 hours. It 
appears that once initial colonization has been established, the effect of the surface 
diminishes with maturation of the biofilm. 
• Most current implant surfaces have some sort of chemical treatment after the initial 
micro roughening to enhance osseointegration. From a clinical point of view, this 
could indicate that surfaces currently available will not increase biofilm 
accumulation and the most important factor in preventing peri-implantitis seems to 
lie in the patient’s ability to maintain proper oral hygiene.  5.6.3 STUDY'3'
• Although the present results cannot be extrapolated directly to the clinical setting, 
the present study indicates regardless of the decontamination method used 
biocompatibility of the surfaces was established and was comparable to their 




• No added bioactive beneficial effects were observed after BAG-blasting. In 
addition, its abrasive nature may contraindicate its safe use in subgingival air 
polishing. On the other hand glycine was shown to achieve a biocompatible surface 
similar to the other decontamination methods, but its low abrasiveness and 
documented safety would support its use as an adjunct cleaning method after the 







• Organisms detected around implants with peri-implantitis, especially F. alocis could 
be considered as disease-associated organisms and warrant further research.  
• It has been suggested that butyrate plays an important role in local tissue destruction 
by Tamura et al. (Tamura et al., 2013b) who reported elevated levels of butyrate-
producing E. nodatum, Eubacterium saphenum and Eubacterium minutum in peri-
implantitis. Conversely, Kumar et al. (Kumar et al., 2012) detected Butryvibrio 
fibrisolvens, a butyrate producer in the human gastrointestinal tract in all peri-
implant crevices. Interestingly, F. alocis which were predominantly increased in 
peri-implantitis in the current study are butyrate producers. How this could be 
related to the pathogenesis of peri-implantitis maybe a possible aspect that could be 
worth investigating.  
• It is important in order obtain a comprehensive representation of the diversity 
around implants to combine a similar culture study with one that is not non-culture 
dependent.  5.7.2 STUDY'2'
• Using an in vivo plaque sample or using patient’s saliva to form a multispecies in 
vitro biofilm, could reflect more realistic clinical conditions than the current study.  
• A comparison of the biofilm characteristics during the initial stages of biofilm 
formation on the different surfaces could also be of interest.  5.7.3 STUDY'3'
• To date only two clinical studies (Renvert et al., 2011, Sahm et al., 2011) are 
available for glycine air-powder polishing for peri-implantitis. Both have showed 
limited clinical improvements. However both studies were non-surgical and non-
surgical treatment for peri-implantitis has been deemed ineffective in the Sixth 




therefore justified to evaluate the applicability and efficacy for glycine air-powder 
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Review in 6 weeks
Minocycline
Tetracycline
Non-surgical Algorithm for Treatment of PID:
Non-surgical Treatment
Remove risk factors Prosthetic Design: Retained cement





 Poor oral hygiene
Susceptibility Uncontrolled diabetes
Antimicrobial mouthwash 0.2% Chlorhexidine for 3-4 weeks
Is there any CBL? Yes
No
Debride implant sulcus with a 
titanium or metal handscaler
Consider removing  
restorative component
Debride implant sulcus









Prosthesis stability / occlusion














*Please refer to the ADI Guidelines on Peri-implant Monitoring and Maintenance for this algorithm.
Maintenance Algorithm* Surgical Algorithm
250mg Amoxycillin TDS for 10 days and
200mg Metronidazole TDS for 10 days.












Prosthesis stability / occlusion




















Surgical Algorithm for Treatment of PID:
Surgical Treatment
Is there sufficient residual bone?
Remove risk factors
Yes
Prosthetic Design: Retained cement





 Poor oral hygiene
Susceptibility: Uncontrolled diabetes
No Explantation
Antimicrobial mouthwash 0.2% Chlorhexidine for 3-4 weeks
Systemic antibiotics Start 24 hours Prior to Surgery:
250mg Amoxycillin TDS for 10 days and 
200mg Metronidazole TDS for 10 days
(250mg Erythromycin QDS for 10 days for penicillin allergy)
360 degrees surgical debridement and 




Regeneration of lost tissue 1st Choice:




Consider removing the  
restorative component





Preliminary statistical analyses were carried out after samples were obtained from 13 
patients. Species that showed significant or near significant differences (p ≈ 0.05 or less) 
are outlined in Table 27. After evaluating the results, it was decided that double the current 
sample size would be necessary to determine whether or not these observed differences 
would be maintained. It was concluded that the target number of patients would be a 
minimum of 20 and a maximum of 24. This would ensure that the study had sufficient 
clinical and scientific value and would be appropriate to the amount of time and resources 
available (Needleman et al., 2012). 
  
 





Filifactor alocis 0 5 0.024 
Neisseria elongata 2 0 0.052 




2 0 0.052 
Parvimonas micra 1 6 0.053 
Streptococcus constellatus 1 6 0.053 
Veillonella parvula 4 2 0.053!





Table 27 Number of samples in which each species was detected. The species in the table 






Consent Form    Sample Number  Patient Number 
 




- Smoker  Yes   No     Previous Pack Years………. 
- No Antibiotics taken during the past month      
- No Anti inflammatory taken during the past month   
- No perio treatment during the past month     
 
Implant 
Type  Branemark     Straumann  Astra tech   
Location  …………………………………………………………………………….. 
Length/ Diameter …………………………………………………………………….. 
Surface characteristics  ……………………………………………………………….. 
Comments …………………………………………………………………………….. 
 
Prothesis   Type:    Single/ multiple   Cement/ screw 
Year dental implant treatment completed 
Date peri-implantitis first recorded   
Previous treatment for peri-implantitis    Yes  No  
 
I/O CLINICAL EXAMINATION: 
 
General O.H.:   Healthy   Gingivitis  Periodontitis  
 
           B 
 
Probing 




         Li 
*bleeding on probing 
 
Bone Loss from abutment/ implant junction 
Mesial =     Distal   = 
 
Picture of radiograph  Yes  No  








Sample Aerobic!Incubation!(5!days) Anaerobic!Incubation!(10!days) 
1!(p) 6.8!x!105 2.5!x!106 
2!(h) 3.2!x!103 3!x!105 
3!(h) 8.8!x!105 1.93!x!106 
4!(p) 2.1!x!105 6.0!x106 
5!(h) 5.5!x!105 3.9!x!106 
6!(p) 2.71!x!105 2.55!x!106 
7!(h)! 5.8!x!105 2.1!x!106 
8!(p) 5.5!x!104 1.02!x!107 
9!(h) 1.18!x!106 1.6!x!106 
10!!(h) 2.5!x!105 3.6!x!105 
11!(p) 2!x!106 9.6!x!106! 
12!(p) 8.3!x!104 2.8!x!105 
13!(p) 6.7!x!10!5 4.7!x!106 
14!(p) 2.1!x!106 9.3!x!106 
15!(h) 7.9!x!10!5 2!x!106 
16!(h) 8.5!x!106 2.77!x!107 
17!(p) 2.8!x!104 1.96!x!107 
18!(h) 8.5!x!106 1.57!x!107 
19!(h) 1!x!106 3.4!x!106 
20!(p) 1.2!x!108 1.4!x!108 
21!(p) 1.6!x!106 1.94!x!108 
Table 28 CFU/ ml from samples cultured aerobically for 5 days  







The aim of these was to establish a method by which a consistent and repeatable biofilm 
formed of representative organisms could be grown together in vitro.   
1)#S. #CONSTELLATUS#AND#P.#GINGIVALIS #BIOFILMS '
From the preliminary data that was available from the 7 samples, it was decided that S. 
constellatus and P. gingivalis, would be appropriate representatives for Gram positive 
facultative anaerobic cocci and Gram negative strictly anaerobic rods respectively, 
especially that they have been associated with periodontal infections in other studies.  
The method was slightly different than that described in chapter 3, and is described briefly 
in the following section.   STRAINS 'AND'INOCULUM'PREPARATION'
S. constellatus and P. gingivalis were obtained from the frozen preserves from sample 
number 1. They were grown anaerobically on FAA supplemented with 5% (v/v) 
defibrinated horse blood for 2 days. A loopful of each bacterial strain was inoculated into 3 
ml of sterilized mFUM containing 0.2% glucose and further incubated anaerobically at 
37ºC.      
After 24 hours, 100 µl of the pre-cultures were drawn into a 96-well microtitre tray and the 
O.D. was measured at a wavelength of 540 nm. Bacterial suspensions were adjusted for an 
O.D. of 0.5 ± 0.05 (seed cultures).  PREPARATION'OF 'BIOFILMS'
Hydroxyapatite discs (HA discs), round in shape (9.5 mm and 1.5 mm in thickness) were 
used as a substrate for biofilm formation after being autoclaved (121ºC for 20 minutes). 
The discs were then placed in a 24-well polystyrene cell culture plate and pre-incubated 
with 1ml of mFUM to precondition the discs. 100 µl of seed cultures were added to the 
discs with the mFUM. The growth medium was replenished every 24 hours by aspirating 
the spent medium from the wells and the addition of fresh medium, with the plates still in 
the anaerobic incubator. This was repeated 7 times (i.e. for 1 week) after which the plates 





The HA discs were dip-washed twice and swirled gently in sterilized PBS to remove 
loosely adherent bacteria. Each disc was then transferred to a sterile 7ml bijou containing 
1ml of FAB and six glass beads and was vortexed vigorously for 30 seconds to harvest 
adherent bacteria, after which the suspension was serially diluted (100 - 105). 100 µl of each 
diluted sample was plated on FAA (in duplicates) and the plates were incubated 
anaerobically at 37ºC. After 10 days, the numbers of CFUs were counted and 
differentiation of the species was achieved by observation of colonial morphology and by 
Gram staining. 
Staining, imaging and analysis of the biofilm was carried out as described in chapter 3.  RESULTS 'AND'CONCLUSIONS'OF 'THE'PILOT'TRIALS'
After 10 days of incubation, only S. constellatus could be seen on the FAA plates, but P. 
gingivalis could not be detected. The effects of interactions of different species in dental 
plaque biofilms have been described to range from mutualistic to antagonistic. One 
possibility was that S. constellatus inhibited P. gingivalis and that would be quite similar to 
results found by Christopher et al. (Christopher et al., 2010), who reported that out of 79 
Streptococcal strains, 61 resulted in the lysis of P. gingivalis, 17 had no effect, whilst one 
which was S. intermedius completely abolished biofilm formation by P. gingivalis in vitro. 
Another possibility was that P. gingivalis being an acid-sensitive species, sensitive to pH 
levels below 6.5 (Kuramitsu et al., 2007) could have been affected by the acid metabolic 
products (secondary metabolites) produced by S. constellatus.  
Thus, the following modifications to the first biofilm method were attempted: 
• Adding 100 µl of the inoculum containing P. gingivalis to the discs first. 100 µl of 
S. constellatus was then added on the fourth day, thus permitting sufficient growth 
of the P. gingivalis beforehand. The biofilm was grown for a further 3 days (i.e. a 




• Reducing the glucose level in the mFUM to 0.1 and 0.05% instead of 0.2%. The 
objective was to slow down the growth rate of S. constellatus, but not the P. 
gingivalis. 
• After dip-washing the discs in PBS, each disc was placed in a sterile plastic petri 
dish. Half of the disc was scraped off using a number 15 scalpel blade on a bard-
parker handle. The biofilm collected was transferred to a bijou containing glass 
beads and FAB by vigorously agitating the tip of the scalpel in the solution. 
Samples were serially diluted and plated out, inspected and counted as previously 
described. The other half of the disc was stained and analyzed using a CLSM. 
Although, P. gingivalis was observed in some biofilms and these modifications enabled 
both species to grow together, results were inconsistent and unpredictable as can be 
seen in the following tables (Tables 29 – 31). Both organisms were observed only on a 
few discs and dilutions. 
Disc 2 S. constellatus  P. gingivalis  
Dilution 3 14 37 
Dilution 4 6 1 
Table 29 Biofilm CFU/ml counts grown on discs in mFUM first with 0.2% glucose 
replaced to mFUM with 0.05% glucose on the 4th day (i.e. on the day S. constellatus were 
added. Both organisms were detected on 1 out of 3 discs. 
   
Disc 1 S. constellatus  P. gingivalis  
Dilution 3 (x 104) 37 22 
Dilution 4 (x 105) 33 3 
Disc  2   
Dilution 4 (x 105) 9 200 
Dilution 5 (x 106) 2 21 
Table 30 Biofilm CFU/ml counts grown on discs in mFUM with 0.05% glucose. Both 





Disc 1 S. constellatus  P. gingivalis  
Dilution 3 (x 104) 23 5 
Disc 2   
Dilution 2 (x 104) 138 29 
Dilution 4 (x 105) 56 7 
Disc 3   
Dilution 3 (x 104) 42 11 
Dilution 4 (x 105) 1 6 
Dilution 5 (x 106) 1 1 
Disc 5   
Dilution 4 (x 105) 30 1 
Dilution 5 (x 106) 21 1 
Disc 6   
Dilution 4 (x 105) 31 91 
Dilution 5 (x 106) 4 4 
Table 31 Biofilm CFU/ml counts grown on discs in mFUM with 0.1% glucose. Both 
organisms were detected on 5 out of 6 discs 
The pH levels were measured daily before each media change. There was no significant 
drop in pH over the 7 days of biofilm formation (mean pH = 7.1 ± 0.28, range = 6.49 – 
7.37, n = 42) 
A different experiment was set up in which the amount of P. gingivalis added to begin with 
was doubled (200 µl) followed by S. constellatus (100 µl) on the fourth day, but the same 
inconsistent biofilms were formed Pre-incubation using saliva + serum showed no 






2)#S. #GORDONII, #F. #NUCLEATUM#AND#P.#GINGIVALIS #BIOFILM '
A multispecies biofilm composed of S. gordonii, F. nucleatum and P. gingivalis was 
attempted. The species were chosen because S. gordonii (initial colonizer) was present in 
all samples that contained P. gingivalis (late colonizer). Furthermore, some studies have 
shown that strains of P. gingivalis co-aggregate with several oral streptococci such as S. 
gordonii, and seem to augment the ability of each other to colonize into biofilms (Cook et 
al., 1998, Kuboniwa et al., 2006, Slots and Gibbons, 1978). Whilst, F. nucleatum has been 
suggested to possess the ability to coagrregate initial and late colonizers, acting as a 
“bridge” between species and was chosen for this reason. 
The mFUM media used contained 0.1% glucose and pH levels were measured daily. There 
was no significant drop in pH over the 7 days of biofilm formation (mean pH was 7.35 ± 
0.28, range was 7.01 – 7.88, n=36). Viability of organisms was tested before the biofilm 
experiment, by plating 100 µl of bacterial suspension. Half of the disc was plated on FAA 
to determine numbers of CFUs and the other half was analyzed using CLSM.  
Results on HA discs are shown in Tables 32 – 34. 
Disc S. gordonii F. nucleatum P. gingivalis 
1 63 x 105 8 x 105 N.D. 
2 62 x 105 6.5 x 105 N.D. 
3 22 x 105 5 x 105 N.D. 
Table 32 Inoculum 1 - Mean CFU/ ml counts on HA discs. P. gingivalis was undetected. 100 
µl of each S. gordonii, F. nucleatum, P. gingivalis was added on day 1. Biofilms were grown 






Disc S. gordonii F. nucleatum P. gingivalis 
4 59 x 104 63 x 104 0.03 x 104 
5 105 x 104 110 x 104 0.2 x 104 
6 5.5 x 104 13 x 104 N.D. 
Table 33 Inoculum 2 - Mean CFU/ ml counts on HA discs. P. gingivalis was detected on 2 out 
of 3 discs. 100 µl of S. gordonii, F. nucleatum and P. gingivalis were added on day 1. Biofilms 
were grown for 7 days.  
!
Disc S. gordonii F. nucleatum P. gingivalis 
7 52 x 105 11 x 105 N.D. 
8 11.5 x 105 5.5 x 105 2 x 105 
9 5 x 105 7 x 105 N.D. 
Table 34 Inoculum 3 - Mean CFU/ ml counts on HA discs. 100 µl of P. gingivalis was added 
on the 1st day, then 100 µl of S. gordonii and 100 µl of F. nucleatum were added on the 4th 
day. Biofilms were grown for 7 days. P. gingivalis was detected on 2 out of 3 discs.  
Minimal growth was still observed for P. gingivalis and colonies were too few to 
enumerate. The conclusion from these trials was to use a 2 species biofilm composed of S. 






3)#S. #GORDONII #AND #F. #NUCLEATUM#BIOFILMS'GROWN'ON'TITANIUM'DISCS #
The 2-species biofilm was grown on 4 different titanium implant surfaces (described in 
chapter 3). The biofilm was grown for 7 days and the experiment was repeated 10 times 
(i.e. n = 40). Mean CFU/ml counts from duplicate FAA plates are shown in Table 35 and 
CLSM representative images are shown in Figure 36. 
Disc type 
Experiment 
7676 7873 7874 6905 
S.g. F.n. S.g. F.n. S.g. F.n. S.g. F.n. 
1 350 60 147 1.8 2320 100 405 75 
2 74 0.5 1690 110 63 50 810 0 
3 69 0.15 139 11 460 75 53 17 
4 2580 75 70 8.5 126 33.5 20 20 
5 905 50 95 20 44 22 29 5.5 
6 340 50 15 2 2325 105 405 75 
7 63 0.35 1690 110 630 50 810 0 
8 6.9 0.15 139 11 460 75 53 17 
9 2580 75 70 8.5 126 34 20 20 
10 905 50 950 20 44 22 29 5.5 









Table 36 CLSM images of a 2 species biofilm composed of S. gordonii and F. nucleatum, 
stained using Live/Dead stain. The green channel represents the live cells, while the red 
represents the dead cells. The characteristic spindle shape for F. nucleatum and cocci for S. 
gordonii can be observed.  
A successful biofilm composed of both species was established. However, after careful 
evaluation of the aims of the study and the experience gained from the previous pilot trials, 
it was decided to revert to a single species biofilm. The researchers did not feel that the 
addition of another species would add any benefits, but may rather hinder interpretation of 
results. Furthermore, a 2-species biofilm was no closer to the clinical situation than a single 
species biofilm.  
To reiterate, other studies have shown very different bacterial adhesion when a 2 species (S. 
sangiunis + A. naeslundii) and a 3 species (S. sanguinis + A. naeslundii + L. salivarius) 
biofilm were grown in vitro (Frojd et al., 2011a). Conversely biofilm formation and 
virulence expression by S. mutans were altered when grown in a dual-species model (Wen 
et al., 2010), whereas V. dispar seemed to have profited from the lactic acid produced by 
the streptococci and continued to grow increasingly up to the 16.5 hours of the experiment, 
whereas others only showed minimal increase or remained stagnant (Schmidlin et al., 
2013). These studies emphasize the fact that in addition to the characteristics of the surface, 




(Frojd et al., 2011a). In conclusion, it was decided that it was best to keep confounding 






5.7.4 ARITHMETIC'MEAN'DEVIATION'OF'THE'SURFACES  (SA, µM) 
Roughness 
Parameter 
6905 7874 7873 7676 
Sa (µm) 0.8 ± 0.2 1.5 ± 0.07 0.16 ± 0.15 0.2 ± 0.05 
Table 37 Arithmetic Mean Deviation of the surfaces (Sa, µm) 
 5.7.5 PRE1STERILIZATION'CONTAMINATION'TESTING'AND'POST1STERILIZATION'ENDOTOXIN'TESTING'
  
Table 38 Endotoxin testing of discs - The accepted endotoxin value is 0.5EU /ml and all discs 




Surface reference number 
 
Pre-sterile Sterile (endotoxin) 
6905 TiOblast  0 (no bacterial colonies) < 0,5EU /ml 
7676 Test machined  0 (no bacterial colonies) < 0,5EU /ml 
7873 Test Ti Gr.5  0 (no bacterial colonies) < 0,5EU /ml 




 5.7.6 XPS' '
The elemental composition of surface 7874 is shown in Table 39 in atomic percent and 
indicates the presence of fluoride on these surfaces.  
 
Surface Ref. Nr Sample Position C1s N1s O1s F1s Si2p Ti2p Fe2p 
7874 1 130415:1 Centre 20,1 0,8 55,5 0,5 0,3 22,9 - 
7874 1 130415:1 Side 1 25,3 0,9 52,6 0,6 0,4 20,2 - 
7874 1 130415:1 Side 2 25,6 0,9 52,5 <0.3 <0.3 21,0 - 
          
7874 2 130415:2 Centre 23,0 0,7 54,9 <0.3 <0.3 21,5 - 
7874 2 130415:2 Side 1 22,5 0,6 55,1 <0.3 <0.3 21,7 <0.3 
7874 2 130415:2 Side 2 20,4 0,5 56,7 <0.3 0,3 22,1 - 
          
7874 3 130415:3 Centre 19,6 0,5 57,3 0,3 <0.3 22,2 - 
7874 3 130415:3 Side 1 22,4 0,9 54,5 0,5 <0.3 21,7 - 
7874 3 130415:3 Side 2 20,0 0,6 57,6 0,5 <0.3 21,4 - 
Table 39 Elemental composition of surface 7874 indicating traces of fluoride 
 
